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In mammals, pigment cells (melanocytes) are a biologically and medically important 
derivative of the neural crest, an embryonic cell population that delaminates from the 
dorsal neural tube to give rise to many derivatives including: pigment cells, neurons and 
glia from the PNS, and most head cartilage. Unlike in mammals, fish neural crest cells 
give rise to three distinct types of pigment cells: melanophores (black), xanthophores 
(yellow) and iridophores (shiny, silver). These together form the characteristic body 
pigmentation that underlies camouflage, courtship and communication. We are 
interested in the mechanisms whereby apparently multipotent neural crest cells generate 
specific derivative cell-types. I have approached this problem by analysis of one major 
candidate, shady (shd), for a gene critical for the specification of iridophore fate (Kelsh et 
al., 1996, Development 123, 369-389). I have used multiple markers to demonstrate that 
shd mutants show defects in only one neural crest derivative (iridophores). Cell- 
transplantation was used to show that shd acts cell-autonomously in the iridophores. I 
adopted a positional cloning approach to identify the shd locus and mapped the gene to 
LG 17 in collaboration with the Max-Plank-lnstitut fur Entwicklungsbiologie,Tuebingen, 
Germany. I then isolated a series of PAC clones from the same genomic region and 
using PAC microinjection into 2 cell-stage embryos I have shown that shd mutant 
embryos can be significantly rescued by one of these PACs. Sequence analysis of the 
PACs revealed that only one complete gene was encompassed in the PAC that rescued 
the shd phenotype. In situ mRNA expression studies show that this candidate is 
expressed in a subset of neural crest cells from 30 hpf that show the characteristic 
distribution of iridoblasts/iridophores at later stages. That this candidate was indeed the 
shd gene was strongly supported by our demonstration that injection of an appropriate 
morpholino phenocopies the shd iridophore phenotype. cDNA sequence followed by 
phylogenetic analysis revealed that shd is the zebrafish orthologue of the mammalian 
AUK (anaplastic lymphoma kinase) gene. The human ALK gene encodes a receptor 
tyrosine kinase that is involved in human oncogenesis but about which little is known of 
its normal function in development. Finally, we generate testable models of how the 
shd/alk gene might be involved in specification or survival of iridoblasts and suggest 
interactions with other genes necessary for neural crest development.
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shady (shd) was the name given to one of the zebrafish pigmentation loci isolated in the 
Tuebingen mutagenesis screen (Kelsh et al., 1996). Mutants at this locus are characterised by 
a reduced number of reflecting pigment cells (iridophores), hence the name shady. The shd 
complementation group included 12 mutations that formed a clear phenotypic series (Figure 
1.1). In the strongest alleles iridophores were mostly absent. This extreme phenotype lead to 
the inclusion of shd '\r\ a subclass of mutations that could be involved in pigment cell 
specification (Kelsh et al., 1996). The work described in this Thesis, shd molecular and 
phenotypic characterisation (Chapters 4 and 5, respectively) was performed to begin to test 
this prediction.
Figure 1.1 shd mutants form an allelic series. The strongest allele shcP82 has an absence or a 
severe reduction of iridophores (arrows), while other alleles (e.g. ty70) have some iridophores left. 
The iridophores that remain are normal and look like WT iridophores (Adapted from Kelsh et al. 
1996 with permission from The Company of Biologists Ltd.).
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CHAPTER 1
All pigment cell types, including iridophores, derive from the neural crest. Therefore, we will 
introduce the concept of neural crest and explain the complex process of how neural crest 
cells become pigment cells during vertebrate development. For a better understanding of the 
relatively recent research done on zebrafish pigment mutants we will introduce some mouse 
mutants whose molecular characterisation was pivotal in understanding vertebrate pigment 
cell development.
1.1 Neural Crest development
The vertebrate neural crest is a migratory embryonic cell population that segregates from the 
tips of the neural folds just before or shortly after they fuse to give rise to the neural tube. 
Before they emigrate, neural crest cells are an integral part of the neuroepithelium. Neural 
crest cells undergo an epithelial-mesenchymal transformation, thus generating the neural 
crest itself. These cells sit transiently as pre-migratory neural crest cells, before becoming 
motile, enabling migration away from the neural tube. This complex process leads the cells 
through stereotyped pathways until they reach their final destinations (Eisen and Weston,
1993; LeDouarin and Kalcheim, 1999). How neural crest cells are formed in the first place and 
how they separate from the neural tube and undergo an epithelial to mesenchymal 
transformation has been subject of intensive research (Erickson and Perris, 1993; Baker and 
Bronner-Fraser, 1997; Erickson and Reedy, 1998). In contrast to avian, amphibian and murine 
embryos the neural tube from teleosts forms from a ventral thickening of the ectoderm that 
gives rise to a neural keel initially devoid of a central canal (Eisen and Weston, 1993). In 
teleost fish the neural crest is thought to derive directly from the dorsolateral region of the
17
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neural keel that lies in apposition to the non-neural ectoderm. A similar process in fact occurs 
in the caudal region of avian embryos (Eisen and Weston, 1993).
To understand how neural crest is generated it was necessary to be able to distinguish these 
cells from the adjacent ectoderm and the CNS primordium. Slug, a zinc finger transcription 
factor (Nieto et al., 1994) and the cadherin c-Cad-6B (Nakagawa and Takeichi, 1995) were 
the first premigratory neural crest markers to become available. Using slug expression it was 
possible to recognise cells that formed as the result of an epidermal ectoderm and neural 
plate contact both in vivo and in vitro. These cells expressing slug were not seen in explants 
of each separate tissue. As a consequence of this contact between the two tissues other 
markers were induced in the dorsal region of the neural tube such as Wnt-1, Wnt-3a, Pax-3 
and Dorsalin 1 (Dickinson et al., 1995; Liem et al., 1995). Because some of these responses 
were dependent on the age of the explanted tissue, it was concluded that the neural tissue 
has a transient competence to respond to ectodermal signals. This inductive activity of the 
ectoderm was mimicked in vitro by the addition of two distinct members of the TGFp 
(transforming growth factor) gene family, BMP4 and BMP7 (Liem et al., 1995). Thus, it was 
concluded that the generation of the neural crest lineage required active signals from the non- 
neural ectoderm. It was also investigated whether the neural plate was the only tissue 
competent to generate neural crest cells. The results indicated that at least until the closure of 
the neural tube epidermal cells could also form neural crest cells suggesting that there is a bi­
directional transmission of inductive signals between the epidermis and the neural plate 
(Selleck and Bronner-Fraser, 1995). Garcia-Castro et al. (2002) have demonstrated that Wnts 
and BMPs also play roles in neural crest induction in avians as in amphibians and zebrafish. 
Wnts induce neural crest from naive neural plates in vitro without added factors whereas 
BMPs require additives. Therefore these authors believe Wnt molecules are necessary and 
sufficient to induce neural crest cells in avian embryos (Garcia-Castro et al., 2002).
18
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Aybar et al. (2002) review the induction of neural crest cells and report that as a first step, a 
gradient of BMPs is established in the ectoderm that results in the segregation into neural 
plate, neural folds and epidermis at increasing levels of BMP activity. In a second phase, the 
anterior neural folds are transformed into prospective neural crest by posteriorizing signals 
from FGF, Wnts and retinoic acid. To finalise the inductive process cell interactions mediated 
by Notch/Delta signalling are also required (Aybar et al., 2002).
(Aybar and Mayor, 2002) compare the data available on neural crest induction from frog, fish 
and chick and provide a general common model for this process. The timing of neural crest 
induction is difficult to determine but some indication can be obtained from the early markers 
expressed in this tissue, such as snail, slug, foxD3 and zic. Expression of these markers 
indicate that neural crest induction must start soon after the onset of gastrulation in Xenopus 
and zebrafish. Then, the appropriate level of BMPs (which seem to vary between species) is 
achieved via anti-BMP molecules, such as noggin. However, because BMPs alone can not 
induce neural crest (LaBonne and Bronner-Fraser, 1998) it is suggested that Wnts, FGFs, and 
retinoic acid, which are all expressed at the right time and place in all model systems, have a 
posteriorizing effect that patterns the anterior-posterior axis of the neural fold.
Once specified, neural crest cells must delaminate from the neural tube to migrate to their 
destinations. The timing of delamination varies, it happens upon tube closure in avian 
embryos whereas at this time it is already underway in the head of mouse embryos. In frog 
and fish neural crest cells wait for several hours before their migration (Nieto, 2001).
Neural crest cells delaminate from the neuroepithelium in a rostro-caudal wave and migrate 
throughout the embryo using two well defined pathways (dorsoventral and lateral) to give rise 
















Figure 1.2 Schematic representation of the neural crest migration pathways in the avian embryo. 1 
represents the lateral pathway used by melanocytes and 2 indicates the dorsoventral pathway 
along the anterior part of the somites used by all the other derivatives (Adapted from Wolpert et al, 
1998. Principles of Development, Oxford with permission).
How neural crest cells migrate entails dramatic changes in cell-cell and cell-matrix interactions 
(Erickson and Perris, 1993). Some steps were recognised to be crucial for the neural crest 
cells to emigrate from the neural tube: First, they appear to be able to breakdown the basal 
lamina over the dorsal portion of the neural tube (Erickson and Perris, 1993). Second, cell- 
matrix interactions involving extracellular matrix (ECM) macromolecules such as, fibronectin, 
laminin, and collagen are known to play an important role for emigrating cells to be able to 
advance outside the confines of the neural primordium (reviewed by Le Douarin and 
Kalcheim, 1999). Yet, the molecular basis of this process is largely unknown because the
20
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mode of action of the transmembrane receptors (integrins) that bind these ECM molecules is 
not yet clearly understood. Third, changes in cell-cell adhesion were found to take place just 
before the onset of migration of neural crest cells (Newgreen and Gibbins, 1982). These 
changes involved the loss of intercellular junctions that were both dependent and independent 
of calcium signalling (Newgreen and Gooday, 1985). Fourth, changes in the plane of cell 
division were detected in the dorsal neural tube compared to the rest of the neural tube. 
Around 70% of the mitotic spindles in this region were parallel to the surface of the dorsal tube 
epithelium meaning that one of the daughter cells could therefore more easily detach and 
migrate (Erickson and Perris, 1993). To end this list of important steps necessary for migration 
to occur generation of cell motility has to be added. Several proteins have been involved in 
neural crest cell motility, members of the TGFp familly are thought to induce the activation of a 
cascade of genes (cadherins, cytoskeletal components, transcription factors) that are 
necessary for crest cell migration (Liem et at., 1995).
In fact, in addition to its role in neural crest induction, BMP4 is also involved in neural crest 
delamination from the neural tube. While BMP4 expression is homogeneous along the dorsal 
neural tube, that of noggin is progressively downregulated in a caudorostral manner coinciding 
in time and axial level with the initial delamination of crest cells (Sela-Donenfeld and 
Kalcheim, 1999). Various other molecules have been implicated in the epithelial to 
mesenchymal transition, such as the transcription factor Slug which has been shown to be 
involved in both the formation and the migration of neural crest (LaBonne and Bronner-Fraser, 
2000). Downstream targets of Slug, such as cadherins, have been suggested by Nieto (1994). 
Recently, Snail, a close relative of Slug, has been shown to repress E-cadherin expression 
(Cano et al., 2000) making it a good candidate to downregulate N-cadherin or N-CAM 
expression in the neural crest. Downregulation of some adhesion molecules at the expense of 
others had been observed at the time of neural crest migration (e.g Nakagawa and Takeichi,
21
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1995). As with Slug, rhoB is also induced by BMP signalling. This molecule is a small 
GTPase, involved in changes in cell shape through the regulation of actin cytoskeleton and 
cell adhesion. Inhibition of rhoB prevents neural crest delamination (Liu and Jessell, 1998).
A transcription factor involved in the onset of emigration of neural crest from the neural tube is 
PAX-3 (Goulding et al., 1991). The mouse mutant splotch +/" is characterised by a white patch 
in the abdomen (Russel, 1947) and represents a deletion in the gene coding for PAX-3 
(Kessel and Gruss, 1990; Epstein et al., 1991). These mice have defects in neural tube 
closure, and severe reduction of many neural crest derivatives such as pigment cells, 
sympathetic and spinal ganglia, enteric neurons and cardiac structures. Although different 
studies had shown that splotch mutants had a severe defect in emigration of neural crest from 
the neural tube (Moase and Trasler, 1990; Serbedzija and McMahon, 1997), it was the 
generation of interspecies chimeras between mice and chick embryos that actually revealed 
that neural crest cells from splotch neural tubes could emigrate normally, when grafted into 
equivalent positions in chick embryos. In contrast, when the mutant mice neural tubes were 
grafted into chick lateral plate mesoderm, no emigration occurred compared to control wild- 
type graftings (Serbedzija and McMahon, 1997). These results suggested that PAX-3 is 
indeed needed for the interaction between neural crest cells and the somites.
Neural crest was first called ganglion crest, a name that dated from the time of the discovery 
that the spinal ganglia arise from this material (Horstadius, 1950). Other neural crest 
derivatives include a variety of cell types: in the head we find that cranial neural crest cells will 
form the entire facial and hypobranchial skeleton as well as different cell types in the cranial 
ganglia. In the trunk, there are two major pathways of migration: (Figure 1.2) the dorsoventral 
pathway between neural tube and somites, that gives rise to sensory and sympathetic ganglia, 
Schwann cells, and chromaffin cells. The second pathway or lateral pathway, is between the
22
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epidermis and the somites and is only used by melanocytes in avian and mammalian 
embryos. The study of neural crest cell migration has been best studied in avian embryos, 
where the quail-chick chimera technique and the HNK-1/NC1 antibody that detects migrating 
crest cells in whole mount embryos have made this system the first to be well studied (Le 
Douarin et al., 1993; Le Douarin and Kalcheim, 1999).
A recent important finding concerning how chick neural crest cells may choose between the 
two well defined pathways was reported by Santiago and Erickson (2002). These authors 
showed that transmembrane ephrins act as bifunctional guindance cues, first repelling the 
early migrating neural crest cells from the dorsolateral pathway and then stimulating 
melanoblasts to migrate into this pathway. They have shown that melanoblasts have several 
Ephrin B receptors that can be bound by the Ephrin B ligands. However, how neural crest 
cells can be both attracted and repelled by Ephrins is still not known. Other molecules like F- 
spondin and semaphorins are suggested to act in a concerted way with Ephrin B ligands to 
inhibit early migration through the dorsolateral pathway (Santiago and Erickson, 2002).
Zebrafish neural crest is similar to that of other vertebrates but has the advantage of 
consisting of fewer and larger cells that can be easily observed in living embryos (Figure 1.3). 
It is possible to mark neural crest cells in vivo with a fluorescent tracer and follow their 
movements in the living specimen with high-resolution fluorescence microscopy (Eisen and 




Figure 1.3 Zebrafish neural crest cells in a living embryo. 24 hpf neural crest (nc) cells are dorsal 
to the neural tube (nt). Lateral view of dorsal tail with anterior to the left and dorsal to the top. (Mf) 
medial fin; (no) notochord; (mu) muscle cells (with permission from R.N.K.).
Neural crest migration in zebrafish follows the same two pathways that are described for other 
vertebrates: the medial or dorsoventral pathway, between the somites and notochord, and the 
lateral pathway, between the somites and the epidermis. Migration on the medial pathway is 
used by all zebrafish neural crest cell types. Unlike in mammals and birds, many zebrafish 
pigment cell precursors migrate on the medial pathway. The lateral pathway is used 
exclusively by pigment cells like in other vertebrates (Eisen and Weston, 1993).
1.3 Pigment cells derive from neural crest
1.3.1 Pigment cell types
24
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Pigment cells include melanophores and melanocytes which are both brown melanin 
containing cells. The term melanophore is usually employed for ‘lower vertebrates’ (fish, 
amphibians and reptiles) whereas melanocyte is used for homeothermic animals or ‘higher 
vertebrates’ (Le Douarin and Kalcheim, 1999). Although mammals have only melanocytes, 
‘lower vertebrates’ have up to five other cell-types, but only two are seen in embryonic 
zebrafish. Xanthophores and erythrophores are coloured bright yellow, orange or red and use 
carotenoides as the major pigments. They used to be called lipophores because of the fat- 
soluble nature of carotenoids. Pteridines, concentrated in organelles called pterinosomes, also 
play an important role in xanthophore pigmentation. Finally, the third type of pigment cells are 
the iridophores, that form the reflecting units present on the surface of silvery fish (see Figure 
1.4). Vertebrate iridophores are present in the irises of some birds and in the skin of 
amphibians and reptiles but it is in fish that they are more widely spread (Denton and Nicol, 
1966) functioning as biological reflectors in their skin (Land, 1972). In fish, iridophores contain 
guanine platelets each of which is composed by a stack of guanine crystals with intervening 
cytoplasmic spaces (Figurel .5). Thus, the old name for these cells used to be guanophores 
(Horstadius, 1950). The platelets are arranged parallel to each other and are all inclined at the 
same small angle (15 °) to the plane of the scales. The spatial arrangement and properties of 
the guanine crystals are those of ideal light reflectors. When the thickness or the spacing of 
the crystals within a single stack changes so do their spectral reflective properties (Land, 
1972). This effect of changing the structure of the stacks is important because it may explain 
why during procedures such as paraformaldehyde fixation for in situ hybridisation the 
iridophores loose their reflective properties.
25
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Figure 1.4 School of marine fish showing their iridescent silvery bodies as a result of the 
iridophore cells in their skin (Adapted from Doubilet, 1995. light in the sea, New York. With 
permission).
Figure 1.5 Reflectors in fish. Schematic diagram of an electron micrograph section through an 
iridophore from a silvery fish. The hatched regions are the locations of the broken-up guanine 
crystals (redrawn from Kawaguti and Kamishima, 1966 in Land, 1972).
26
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Iridophores are thought to provide fish with important ecological advantages. The first being 
the ability to become almost invisible to predators by acting as mirrors that reflect their 
environment from most points of view. This task is most difficult when the observer is located 
below the fish because the downwelling light is so much brighter than the upwelling light. For 
this reason fish developed silvery bellies (covered with iridophores) that act as a “counter- 
shading” effect (Denton et al., 1972). The second ecological advantage that fish have 
conferred by iridophores, is being able to signal to their neighbours so as to maintain their 
positions within a school. By displaying different patterns of bright and dark surfaces 
depending on the angle of view, such signals can be seen over large distances and provide a 
basic means of communication (Denton and Rowe, 1994).
1.3.2 Origin of pigment cells
The first suggestions that the neural crest might be the source of pigment cells are due to 
Borcea back in 1909 (Horstadius, 1950). Harrison (1910, in Horstadius, 1950) found pigment 
cells in tissue culture from frog spinal cords and suggested that they came from the neural 
crest but it took another 20 years before more experimental work was done (Horstadius, 
1950). Du Shane (1935) was the first to prove that amphibian chromatophores originate from 
the neural crest. By removing the trunk crest, he found that the ablation of dorsal fin, spinal 
ganglia, and Rohon-Beard cells were accompanied by the lack of pigment cells (Figure 1.6). 
Moreover, he found that when grafting pieces of neural folds to the ventral side of an embryo 
or explanting them in vitro, it resulted in the appearance of melanophores.
27
CHAPTER 1
Figure 1.6 Following bilateral excision of trunk neural crest (A) the larva lacks dorsal fin as well as 
chromatophores in the operated region. Redrawn by Horstadius from original by Du Shane, J. Exp.
Zool. 72, 1935.
Implantation of crest from frog to urodele showed that also in anurans not only the 
melanophores, but the iridophores and xanthophores have the same origin (Horstadius,
1950).
In birds, the first experimental evidence for pigment cell origin was found in explants of neural 
folds in chick, as in cultures they produced branched pigment cells, whereas other tissues or 
pieces of embryos deprived of neural crest gave no pigment cells (Doris, 1936 in Horstadius, 
1950). An interesting experiment that revealed the migratory nature of neural crest cells was 
one done by Eastlick in 1939 (in Horstadius, 1950). Eastlick transplanted limb-buds in grafts of 
different size into the coelom or body wall of white chick embryos (Figure 1.7). If the donor 
was of a pigmented breed and the cut (made after a certain stage) was close to the neural 
tube, a pigmented leg developed in a white host. But if the graft was cut further away from the 
neural tube the leg remained unpigmented. In this way the position of the advancing front of 
the migrating neural crest cells could be established.
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Figure 1.7 Chick limb-buds grafted with (left) or without (right) neural crest cells, depending on the 
level of the cut in relation to the front of the advancing crest cells. The leg acquires pigment only if 
the crest cells are included in the graft. Redrawn from Du Shane, Quart. Rev. Biol. 19, 1944 by 
Horstadius, 1950.
In Mammals, only later was there proof of the neural crest origin of melanocytes. Experiments 
by Rawles (1947, 1948) made use of the fact that mouse embryonic tissues transplanted into 
the celomic cavity of chick embryos are viable and develop for several days. Explants 
including the neural crest were taken from black mice and grafted into the celom of 
unpigmented White Leghorn chicks. It was observed that melanocytes invaded the chick 
epidermis whereas in control explants, devoid of neural crest, no pigmentation appeared. By 
transplanting different portions of mouse neural tubes at different stages of development 
Rawles (1947) also revealed that neural tubes from older mice embryos had lost their 




The different types of pigment cells referred to above are characterised by the presence of 
different organelles containing the various pigments. The common origin of pigment cells 
relies on the observation of mosaic pigment cells such as the melanised iridophores of the 
dove iris or the erythrophores of some snakes which contain reflective platelets in addition to 
the usual pterinosomes (Bagnara et al., 1979). These cells contained more than one type of 
pigment which suggested the presence of a neural crest pigment stem cell containing a 
primordial organelle of endoplasmic reticular origin that could differentiate in any of the known 
pigmentary organelles: melanin-containing melanosome; pteridine-containing pterinosome 
and purine-containing reflecting platelet. Bagnara et al. (1979) believed that such a common 
neural crest precursor would only be fully committed towards a definite type of chromatophore 
when it reached its final localisation in the body. Because the chromatophore cell would 
encounter in its environment different substrates and signals that would provide the 
appropriate developmental cues to form melanosomes, pterinosomes or reflecting platelets. 
However, more recent studies from lineage analyses made in vivo do not always support this 
idea. Single neural crest cells from zebrafish originated progeny that consisted of pigment 
cells alone, neural cells alone, and pigment and neural cells mixed clones. Futhermore, 
single-derivative clones of each type were also recorded in great numbers (Raible and Eisen, 
1994; Dutton et al., 2001). Consequently, a clear proof for the requirement of a common 





1.4.1 Some mouse pigmentation mutants
Perhaps the best way to understand the molecular basis of pigmentation is to investigate the 
pigmentation mutations that are present in nature or that have been generated in animal 
model systems. Several mouse mutations affecting coat pigmentation have been described 
and their molecular defects already characterised. We will describe a range of pigment mutant 
phenotypes that provide important background for understanding the related fish pigmentation 
mutant phenotypes. For instance, Dominant spotting (W) and Steel (SI) encode for a receptor 
tyrosine kinase (c-Kit) (Geissler et al., 1988) and its growth factor ligand SF (Steel Factor),
(e.g Anderson et al., 1990), respectively. Mice mutant for these genes have a spotted 
pigmentation pattern, macrocytic anemia and deficiency of primordial germ cells. Mutants for 
the ligand have a more diluted pigmentation pattern in contrast to the sharp spots of the 
receptor mutants. The functional significance of the signalling through c-kit in melanoblasts is 
thought to be proliferation and survival (Yoshida et al., 1996).
The mutants piebald lethal (s') and lethal-spotted (Is) are known to encode a G-coupled 
heptahelical receptor, endothelin receptor B (EDNRB) and its ligand endothelin-3 (EDN3), 
respectively (Yanagisawa, 1994). Targeted mutations of EDNRB and EDN3 reproduced the 
phenotypes of the spontaneous mutants (Baynash et al., 1994; Hosoda et al., 1994). Mice 
mutant for both these genes have decreased melanocytes forming an irregular white spotting 
pattern, and develop megacolon due to a lack of enteric neurons (also neural crest derived) in 
the most distal part of the bowel. The absence of the intrinsic reflexes of the enteric nervous 
system in the terminal gut causes blockage resulting in dilation of the adjacent upstream
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colon, i.e. megacolon. Functional studies on the EDN3/EDNRB signalling pathway have 
shown that it is required for neural crest cell expansion while still in the neural fold, when 
migrating along the dorso-ventral pathway and as they invade the digestive tract. This 
signalling is therefore required for the proliferation of the enteric nervous system precursors to 
colonise the whole gut. In the skin, it is believed that EDN3/EDNRB play a similar role in 
melanoblasts to the one in the gut (Le Douarin and kalcheim, 1999). Interestingly, Le Douarin 
and Kalcheim (1999) reviewed important facts that led to the conclusion that EDN3/EDNRB 
and SF/c-kit might be involved in related but different sequential processes. While the 
signalling through EDNRB is involved in survival of melanoblasts before they expand, the 
signalling through c-kit is more likely to be active after the proliferation of these same 
precursors.
Heterozygous mouse mutants for another gene, Dominant megacolon (Dorn), have 
phenotypes that are reminiscent of those for s and Is homozygous mutants, showing reduced 
number of melanocytes and aganglionosis in the distal part of the g u t. Dorn homozygous 
mice have also other defects in the PNS outside the enteric nervous system (Pavan and 
Tilghman, 1994). Molecular characterisation of Dorn revealed that it encodes the Sox10 
transcription factor (Herbarth et al., 1998; Southard-Smith et al., 1998). Mutations in these 
three genes that generate the terminal aganglionosis of the colon phenotype are models for 
the human conditions of Hirschsprung’s disease and also for the Waardenburg-Shah 
syndrome, when this phenotype is combined with pigmentation defects (Pingault et al., 1998).
One very important gene in pigmentation is the microphthalmia gene (Miff) that encodes a 
member of the bHLH-Zip family of transcription factors (Hodgkinson et al., 1993). Most mutant 
alleles of this gene ablate or severely reduce pigmentation in homozygous mice. Mitf mutants 
often have reduced eye size, early onset deafness, reduced mast and natural killer cell
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numbers, and osteoporosis. Homozygous mice have a white coat because they completely 
lack melanocytes. Thus, this gene seems to be crucial for the development of melanocytes.
Many genes identified in the melanin synthetic pathway were the result of studying mutant 
mice, such as silver and pink-eyed dilution which encode proteins involved in the structure of 
melanosomes; and Albino, brown and slaty which encode enzymes of the melanogenic 
pathway (reviewed by Le Douarin and Kalcheim, 1999).
1.4.2 Zebrafish pigmentation mutants
Many pigmentation mutants were isolated during large scale mutagenesis screen both in 
Tuebingen (Haffter et al., 1996a) and in Boston (Driever et al., 1996) which will be described 
below, but first it is important to stress the value of such mutations in the discovery of key 
genes. Mutations causing a homozygous viable phenotype that is easily recognisable are 
always valuable in genetics and development. Colour is a very visible trait that can be easily 
scored and therefore pigment mutants such as Drosophila with white eyes have had 
enormous impact on the development of Genetics. Over 90 genes affecting zebrafish 
pigmentation have been identified in a large-scale genetic-screen in Tuebingen (Haffter et al., 
1996b; Kelsh et al., 1996; Odenthal et al., 1996). The ready accessibility of the zebrafish 
embryo combined with the large size and prominence of their pigment cells allowed 
comparison of the mutant phenotypes of these genes. This in turn permitted their classification 
according to the kind of defects they cause, and these suggested which functional role they 
may have. Kelsh et al. (1996) identified a sub-group of mutations affecting the number of 
chromatophores present in zebrafish. These mutations are of particular interest because they 
potentially include genes responsible for the earliest processes of pigment cell development:
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specification, proliferation and survival. Defects in these different processes may produce 
similar phenotypes, as it was noticed in mice before, and it is only through the investigation of 
their molecular basis that we can dissect the role of these genes.
1.4.2.1 Generation of mutants
The goal of large-scale saturation screens is to identify genes that define developmental 
pathways. Zebrafish are suitable for such screens because they have a short generation time, 
high fecundity, rapid development and externally fertilised embryos that are translucent 
(Haffter and Nusslein-Volhard, 1996). The transparent eggs allow for easy visual and non- 
invasive detection of embryonic morphological abnormalities. These malformations can easily 
be classified as being Mendelian or non-Mendelian because of the large number of eggs laid 
per clutch. During the mutagenesis procedure males are mutagenised with ethylnitrosourea 
(ENU) and, after the mutations have been fixed, mated to wild-type females. ENU was found 
to be the most efficient chemical mutagen for inducing point mutations that can be recovered 
in an F2 breeding scheme (Mullins et al., 1994). Then the Ft generation is raised and F2 
families are derived from single-pair matings of Ft fish. Around 60-80 larvae per F2 family are 
raised to adulthood. Half of these fish will be heterozygous for any mutation carried by either 
of the two Ft parents. Sibling crosses among F2 fish will then match two carriers of such a 
mutation in a quarter of the matings, and a recessive mutant phenotype will be displayed by 
25% of the F3 embryos.
1.4.2.2 Identification of the mutated genes
After generation and detection of the mutant phenotype by visual inspection it is important to 
investigate further abnormalities that can suggest which developmental pathway has been 
disrupted. Usually a series of molecular markers are used for careful expression studies.
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Often, by phenotypic comparison with mutants present in other model organisms one or more 
candidate genes might be obvious. On the other hand, phenotypic studies might reveal that 
the mutated gene is likely to be a completely novel gene revealing a new developmental 
function. Disruption of such a novel gene can even provide a fish specific phenotype which 
would result in the absence of obvious candidates from the murine system. This last scenario 
usually leads to a positional cloning approach as opposed to a candidate approach for 
isolating the gene in question.
Positional cloning is an unbiased approach that is applicable to any mutation whose 
inheritance can be traced, even if nothing is known about the gene or biochemical pathways 
affected by the mutation. Despite having a considerable genome size (two-thirds of mice and 
human) zebrafish has two advantages for positional cloning projects: the first is the high rate 
of fecundity that allows the analysis of several thousand meioses and fine mapping of a 
mutation to a small interval. The second is the accessibility of the embryo which allows for 
RNA or DNA injection in attempts to rescue the mutant phenotypes and rapid analysis of the 
expression pattern of candidate cDNAs (Talbot and Schier, 1999). In addition, it is also 
possible to phenocopy the mutants phenotype by morpholino injection.
Positional cloning projects include three important steps: the first involves the identification of 
a genetic marker that is near the mutant locus as judged by linkage analysis. The second 
phase starts when the genetic marker identified in the first step is used to isolate clones from 
genomic libraries. These clones might contain the gene if the marker is tightly linked to the 
mutant locus. Otherwise, the process is repeated to carry out a genomic walk until linkage 
analysis demonstrates that the mutant locus is encompassed in a contiguous stretch of 
genomic DNA (referred to as the “contig”). The third phase involves the identification of the 
gene within the contig region. This can be achieved by different procedures, such as
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transgenic rescue of the mutation with progressively smaller regions of the contig or sequence 
analysis of the whole contig (Talbot and Schier, 1999).
1.4.2.3 Some zebrafish pigmentation mutants
According to Kelsh et al. (1996), mutants from the Tuebingen screen that were more likely to 
be involved in the process of specification included colourless (els) which lacked ail three 
pigment cell types, salz and pfeffer {sal, pfe) with a reduced number of xanthophores 
(Odenthal et al., 1996), and shady (shd) with reduced iridophores (Figure 1.8). Since then, all 
these mutants, except shd, have already been characterised molecularly. The results have 
shown that specification seems to be a key role for els (Dutton et al., 2001) but not for pfe, 
later named panther (Parichy et al., 2000b).
Figure 1.8 shd homozygous mutant and wild-type embryo at 6 dpf. shd mutants (upper) have 
very reduced numbers of iridophores all over the eyes, lateral patches and on the dorsal and 
ventral stripes compared with wild-type (below) siblings.
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The pigmentation gene shd is an example of a gene that, when mutated, causes a fish 
specific phenotype: the absence or severe reduction of iridophores (Kelsh et al., 1996). Apart 
from zebrafish this pigment cell type is only present in one other model organism, Xenopus 
laevis. However, iridophore genes have never been studied in the frog model. Thus, so far, 
there are no identified genes that could provide a candidate for the shd locus. Consequently, 
shd would have to be positional cloned. This formed the basis for much of the work described 
in this Thesis (see Chapters 2,3,4).
c/s, on the other hand, had a phenotype highly reminiscent of the Dom homozygous mice 
where several neural crest derivatives are missing (Herbarth et al., 1998; Southard-Smith et 
al., 1998). c/s embryos have fewer melanoblasts as demonstrated by the dct riboprobe 
(Kelsh et al., 2000) and show a drastic reduction in all pigment cell types, enteric neurons and 
glia, and dorsal root ganglia, (Kelsh and Eisen, 2000). For this reason cloning of the c/s gene 
was done by a candidate gene approach which confirmed that c/s encoded a zebrafish sox10 
homologue to mouse Sox10 (Dutton et al., 2001). The current model for the role played by c/s 
in neural crest development proposes that this gene has a very important role in the 
specification of all non-ectomesenchymal fates (Dutton et al., 2001).
Zebrafish sparse mutants (spa) encode the zebrafish c-kit (Parichy et al., 1999) orthologue of 
the mouse C-kit. spa'A embryos have a sparse melanophore appearance because of a 
reduction in melanophore numbers. However, the number of melanoblasts in spa mutants is 
initially normal as revealed by the dct marker (Kelsh et al., 2000). Therefore, spa function is 
involved in proliferation and survival of melanophores. Both the phenotype and the proposed 
function of this gene in fish are thus highly conserved of those in mouse loci Wand SI. 
However, spa/c-kit function in fish is not essential for hematopoiesis or primordial germ cell 
development as it is in mouse (Parichy et al., 1999).
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A zebrafish mutant phenotype that involves both melanophores and iridophores is the one 
shown by nacre (nac) mutants, nac encodes the zebrafish basic-helix-loop-helix/leucine zipper 
transcription factor Mitfa related to the mouse Mitf (Lister et al., 1999). nac mutants lack 
melanophores but interestingly have increased numbers of iridophores (Figure 1.9).
Expression of early melanoblast markers like dct is absent in nac mutants and transplant 
experiments suggest this gene functions cell autonomously in melanophores. Therefore, the 
function of nac is required for the melanophore fate. Transient expression of the wild-type nac 
gene restored melanophore development in nacA mutants suggesting this gene might be 
sufficient to activate the downstream programme that differentiates melanophores (Lister et 
al., 1999). More recently, (Elworthy et al., 2003) have shown that this gene can be directly 
activated by cls/sox10 and that transient expression of wild-type nac is sufficient to rescue 
melanophore development in both els and nac homozygous mutants to the same extent.
Taken together the existing data are compelling in demonstrating a key role of mitfa in 
melanophore fate specification.
Figure 1.9 nac mutants lack melanophores but have increased numbers of iridophores. The 
chromatophores of the retinal pigmented epithelium that are non crest-derived are normal in nac1' 
embryos (with permission from Lister et al., 1999 and The Company of Biologists Ltd.).
Other mutant phenotype that involves both melanophores and iridophores is rose (ros). ros 
mutants encode zebrafish ednrbl, an orthologue of the amniote Ednrb genes, ros mutant
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embryos are indistinguishable from wild-types, but adults lack iridophores and also some 
melanophores. Consequently, the adult stripe pattern is disrupted (Figure 1.10). In spite of the 
lack of an embryonic phenotype this gene is expressed by precursors for all three embryonic 
pigment cell types. In the adult fish ros is required by a subset of melanophores and by all 
iridophores. In contrats to murine Ednrb mutants, there is no enteric phenotype. The proposed 
role for this gene in adult zebrafish is proliferation. The authors suggest that perhaps a 
paralogous gene might be active in the embryonic pigment cells explaining the lack of an 
embryonic phenotype (Parichy et al., 2000a).
Figure 1.10 ros mutant adults lack iridophores and some melanophores (upper) while ros mutant 
embryos (below) have a normal phenotype (from R.N.K. with permission).
39
CHAPTER 1
It is clear from the majority of the mutant phenotypes described here that there are phenotypic 
differences between orthologous loci in mouse and fish. In part this lack of similarity results 
from the fact that fish have more pigment cells types. But surprisingly some differences arise 
from the absence in fish of phenotypes that are present in the murine mutants. One example 
is the lack of microphtalmia (small eyes) in fish nac''' embryos compared to the mouse model 
(Lister et al., 1999). One explanation often given is the sub-functionalization of the zebrafish 
genome (Force et al., 1999). It is believed that teleosts went through an extra whole genome 
duplication event. As a consequence, for many genes in mammals there may be two copies in 
zebrafish (Postlethwait et al., 1999). However, the two genes in zebrafish may be sharing the 
role of a single gene in mammals, and may have new functions as well. Force et al. (1999) 
have suggested that duplicate genes may become preserved during evolution by the 
degenerative loss of complementary gene subfunctions from the duplicate copies. This theory 
is called the duplication, degeneration, complementation model or DDC. Consistent with this 
theory, there is another mitf orthologue in zebrafish: mitfb (Lister et al., 2001). This gene is not 
expressed in neural crest-derived melanoblasts, in contrast to mitfa, but is expressed in the 
retinal pigmented epithelium (normal in nac1' mutants), mitfb is also expressed in other tissues 
different from the mouse Mitf expression pattern.
1.5 Pigment cell fate specification
Understanding how multipotent neural crest cells give rise to such a diverse range of 
derivatives is the object of cell fate specification studies. There are two types of studies that 
try to understand how single neural crest cells can adopt different fates. One is by in vivo 
lineage tracing and the other is by in vitro clonal analysis. These procedures approach the 
question in different ways, in vivo studies will provide perhaps more realistic answers because
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the fate of individual progenitors is being assessed under the same selective environment as 
the intact embryo. The in vitro experiments, on the other hand, are done under more 
permissive environments to allow the progenitor cell to reveal its entire range of 
developmental potentials (Le Douarin and Kalcheim, 1999). Both sets of experiments are very 
informative and complement each other. A cell becomes specified as soon as it shows a 
marker for that particular fate. Markers can be gene expression patterns, migration pathways, 
and final products of differentiation such as pigment.
There are two models for neural crest cell fate restriction: the direct fate restriction model 
(Bronner-Fraser and Fraser, 1989) where postmigratory pluripotent cells are instructed to 
adopt a specific fate by environmental signals. The second model is the progressive fate 
restriction model (Weston, 1982 and Le Douarin et al. 1991) where pluripotent cells undergo a 
process of gradual restriction.
in vitro clonal analysis of single neural crest cells from quail embryos revealed the presence of 
three types of clones: 1) clones of pigmented cells only; 2) clones of unpigmented cells that 
after immunoreactions were identified as sensory and autonomic neurons; 3) mixed clones of 
pigmented and neuronal progeny. These results suggested the existence of tripotent 
(melanogenic, sensory and autonomic), bipotent (sensory and autonomic) and monopotent 
(melanogenic) progenitors that are present at the same time in the trunk neural crest 
population (reviewed by Sieber-Blum, 1990). Other studies failed to show the existence of the 
monopotent melanogenic precursor (Baroffio et al., 1988). Instead, it was shown that 20% of 
clones were indeed composed of a single cell type that was either neuronal, glial, or cartilage. 
About 80% of the clones were derived from multipotent progenitors with daughter cells 
composed of 2-4 different types in various combinations. The significance of these results is 
that they show that although many neural crest cells are pluripotent some progeny apparently
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derive from early-specified precursors. This observation was also reported by (Henion and 
Weston, 1997) when labelling single thoracic neural crest cells growing in culture with a 
lineage tracer.
The discovery of a truly multipotent cell that could have all neural crest cell types among its 
progeny (Baroffio et al., 1991) was the reason for the denomination of “neural crest stem cell” 
in analogy to the stem cells of the hematopoietic system. However, the self-renewal capacity 
intrinsic to the concept of stem cell was not demonstrated at that time. It was later shown in 
mammalian embryos that neural crest cells have stem cell properties (Stemple and Anderson, 
1992) being able to self-renew up to ten generations. But, these neural crest stem cells 
appear only to generate a subset of fates, including autonomic neurons, glia, and smooth 
muscle cells (Kim et al., 2003; Stemple and Anderson, 1992). It is therefore unclear to what 
extent, and at what time, neural crest stem cells are truly multipotent stem cells, although they 
can generate ‘oligopotent’ stem cells, and fate restricted progeny are generated much earlier 
than previously believed.
The in vivo studies using single cell lineage tracing showed that trunk neural crest in birds and 
in xenopus gave rise to multiple types of progenitors thus confirming the existence of a 
multipotent neural crest precursor. A small proportion of clones was also found to contain only 
one derivative. In summary, in vivo studies re-enforced the in vitro findings for these model 
systems (reviewed by Le Douarin and Kalcheim, 1999).
The same type of experiments conducted in zebrafish showed that neural crest appears to be 
greatly lineage-restricted in fish compared to other vertebrates. As a model organism for 
neural crest development zebrafish offers the transparency and accessibility desired for 
tracking cells in this type of studies. Results from cranial and trunk single cell labelling
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experiments show that neural crest cells are more likely to be specified prior to or during 
migration (Raible and Eisen, 1994; Schilling and Kimmel, 1994). The great majority of the 
clones analysed by Raible and Eisen (1994) gave rise to only one type of progeny. This was 
true for all cell types. The combinations of phenotypes in two-derivative clones were never 
specific combinations of two types. For this reason the authors have no evidence to support 
the idea that neural crest cells undergo consistent progressive fate restrictions (Raible and 
Eisen, 1994). An important finding was that in the zebrafish trunk sensory and sympathetic 
cells are derived from early migrating neural crest cells on the ventral pathway whereas later 
migrating cells on the lateral pathway would become pigment cells. Also important was the 
fact that the later the progenitor cells were labelled the higher was the number of clones with 
single-derivatives (Raible and Eisen, 1994). These data suggest that there is some 
time/pathway dependent restriction going on. However, it has been demonstrated (Raible and 
Eisen, 1996) that when early migrating cells are ablated by laser, later migrating neural crest 
cells also have the plasticity to form sensory and sympathetic neurons and compensate for 
the lack of an earlier source of these cells. Taken together, these results indicate that 
zebrafish neural crest cells might be fate-restricted early but are not yet committed. More 
recently, Dutton et al. (2001) conducted a similar study to Raible and Eisen (1994) and have 
shown that most of the clones were again of single-derivatives.
Investigation of zebrafish pigment cells in several pigment mutants has also contributed to 
discussion of cell fate specification. Chromatophores are naturally labelled by the pigment that 
they contain. Thus, melanin labels melanophores, pteridines label xanthophores and purine 
platelets and their reflection properties identify iridophores. Some of these natural markers are 




At present we know that melanophores are specified prior to migration because mitfa, the 
earliest melanophore marker so far isolated was detected in premigratory neural crest cells 
(Lister et al. 1999). Other markers such as melanin, dct and c-kit were seen in migrating cells 
again indicating that melanophores are already specified as such (Kelsh et al., 2000b; Parichy 
et al., 1999). In addition, in els mutants pigment cell fate specification seems to largely fail, yet 
remaining occasional pigment cells occupy a premigratory position suggesting that 
specification of pigment cells may even be required for normal migration (Dutton et al., 2001; 
Kelsh and Eisen, 2000).
The work done on els mutants reveals a genetic distinction between ecto and non- 
ectomesenchymal neural crest fates (Dutton et al., 2001) and suggests that els function may 
lie high up a cascade of events that specify all pigment cells, neurons and glia from the neural 
crest. Therefore Kelsh and Raible (2002) propose a model favouring the idea of progressive 
fate restriction where a non-ectomesenchymal crest cell needs the els gene in addition to a 
set of specific genes for each fate to become fully specified. In this way, they suggest that 
crest cells seem to need the action of Wnt signals to specify pigment cell fates at the expense 
of neural and glial precursors. This was demonstrated by Dorsky et al. (1998) by inhibiting the 
Wnt signalling pathway and observing neuron formation from cells normally fated to generate 
pigment cells. Furthermore, melanophores need the action of the mitfa transcription factor 
(Lister et al., 1999) to adopt the melanophore fate. Recent work shows that the activation of 
the mitfa gene can be done directly by cls/sox10 (Elworthy et al., 2003) and by Wnt signalling 
(Dorsky et al., 2000). In vivo, the action of both is likely required to specify melanophore fate. 




The principle aim of this project was to identify molecularly the gene encoded by the shd 
locus. The reason to engage in such a project was mainly based on the very specific 
phenotype of shd homozygous embryos suggesting shd had a primary role in iridophore 
specification (Kelsh et al, 1996). We expected that identifying the shd gene would provide 
important tests of whether shd is involved in specifying iridophores. In this work we:
1- Localise shd in the zebrafish linkage map (Chapter 2)
2- Identify and isolate a short genomic interval containing the shd locus (Chapter 3)
3- Identify within this interval candidate genes for the shd locus (Chapter 3)
4- Test the best candidate gene by molecular characterisation (Chapter 4)
5- Show that the identified gene is responsible for the shd locus (Chapter 4)
6- Investigate the shd mutant phenotype (Chapter 5)









Genes identified in mutant screens can be cloned in two distinct ways. In some cases, 
candidate genes can be suggested based on studies in other model organisms. This 
approach has been used in many zebrafish studies (e.g. Lister et al., 1999; Moens et al., 
1998; Parichy et al., 2000a; Parichy et al., 1999) and it has also been used for els in our 
lab (Dutton et al., 2001). However, where no candidate genes exist, or where the 
candidates fail to show tight linkage to the mutant phenotypes, positional cloning 
techniques must be used. This approach was used successfully to elucidate the molecular 
basis of Duchenne muscular dystrophy (Hoffman, 1987) and has been used to clone many 
human disease genes (Berger et al., 1992; Boldog et al., 1993; Clark and Goate, 1993; 
Collins, 1990; Collins, 1991; Douar et al., 1994; Goldberg and Collins, 1991; Ranta et al., 
2000). This alternative method has been increasingly used over the last five years to 
identify mutant loci in zebrafish (Brownlie et al., 1998; Zhang et al., 1998); Talbot and 
Schier, 1999; Inoue et al., 1999; Andrews, 2000; Kupperman et al., 2000; Guo et al., 2000; 
Donovan et al., 2000; Rottbauer et al., 2001; Topczewski et al., 2001; Horne-Badovinac et 
al., 2001; Clark et al., 2001; Jessen et al., 2002; Lyons et al., 2002; Poss et al., 2002; 
Parsons et al., 2002; Shafizadeh et al., 2002; Xu et al., 2002). This same approach will be 
necessary for cloning shd because so far, the shd phenotype is characterised by a 
reduction in the number of iridophores alone (Kelsh et al. 1996). Because these pigment 
cells are not found in mammals there were no candidate genes for shd.
Positional cloning is initiated by identifying the broad location of the gene on a 
chromosome by linkage mapping. The sequential narrowing of the candidate genomic 
interval permits identification of the responsible gene whose function then can be studied 
by, for example, protein sequence comparison and gene expression studies.
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Linkage maps are generated by breeding from a parent that carries two different alleles at 
two or more loci. The offspring are then tested for whether they receive either parental or 
recombinant allele combinations. Analyses of this type of data allow one to determine 
whether loci are linked to each other. For linked loci, their relative order and the distances 
that separate them can be estimated from the frequency of recombination events (Silver, 
1995).
Simple sequence length polymorphisms (SSLPs) have become an important genetic tool 
in constructing linkage maps of vertebrates such as the mouse, rat and human (Rauch, 
1997). These markers consist of two primers flanking a dinucleotide repeat, which can be 
highly variable in length and therefore used for genotyping individuals that come from a 
mapping-cross (Knapik et al., 1996). These genetic markers are highly polymorphic 
between the two backgrounds on which zebrafish mapping-crosses are built.
Furthermore,they are codominant and abundant in zebrafish (Rauch, 1997). The SSLP 
map constructed for zebrafish, based on the Boston MGH cross, continues to be refined 
and updated and has been used as a framework in which to integrate higher resolution 
physical maps (Knapik et al., 1996; Knapik et al., 1998; Postlethwait et al., 1998; Gates et 
al., 1999; Geisler et al., 1999; Shimoda et al., 1999; Kelly et al., 2000; Woods et al., 2000; 
Hukriede et al., 2001; lovine and Johnson, 2002; Stickney et al., 2002).
There are now seven mapping panels available, constructed by different labs in the 
zebrafish community: the Boston MGH Cross (MGH) has 3891 markers of which the great 
majority are SSLPs; the Gates et al (GAT) panel has only 464 markers; the Heat Shock 
(HS) panel has 7721 markers of which the majority are ESTs (Expressed Sequenced 
Tags); the Mother of Pearl (MOP) panel has 763 markers of which 257 are genes; the 
Goodfellow T51 panel has 10330 markers of which 4822 are ESTs and finally the LN54 
panel with a total of 5000 markers of which 3417 are ESTs. The seventh mapping panel is 
called ZMAP and is an integrated map of the zebrafish genome which has a total of 23633
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markers. This integrated map used the MGH SSLP based map as a framework for 
positioning all the coding markers. All these panels complement each other and are 
accessible for searches in the ZFin web page (http://zfin.org). These maps can be 
searched individually or in a consolidated version for various types of markers, genes, 
mutants and ESTs. They were generated by two different processes, based upon meiotic 
recombination (called meiotic maps) or by radiation hybrid mapping. Only the Goodfellow 
T51 and the Loeb/NIH/5000/4000 (LN54) panels fall in this last category.
Radiation hybrid mapping involves the fusion of irradiated zebrafish cells with a hamster 
cell line that is either hypoxanthine phosphoribosyl transferase (HPRT) or thymidine kinase 
(TK) deficient. The irradiation procedure randomly breaks the zebrafish genome, and the 
DNA fragments are rescued via the fusion process. Surviving cells are grown in a medium 
which selects for hybrids containing the zebrafish HPRT gene or TK gene. A dose of 3000 
rads produces fragments in a size range required for map continuity and optimal resolution 
for cloning (Kwok et al., 1999). After extracting the DNA from the hybrid clones it is 
possible to use PCR for the ready mapping of any genomic markers by presence or 
absence. This includes genes, ESTs and other markers. The frequency of the radiation 
breakpoints can be translated in mapping distances that are more accurate than those 
provided by the meiotic maps. In this project we have used the MGH mapping panel which 
was, at the time, the diploid meiotic map with more SSLPs mapped. We did not use 
radiation hybrid mapping because as explained earlier there was not a candidate gene or 
EST for the shd locus.
The first stage in mapping a new locus involves genotyping of mutant embryos from a 
mapping-cross with a wide range of SSLP markers to find those which co-segregate with 
the mutant locus. This enables a rough positioning of the gene of interest on the zebrafish 
map and permits the identification of recombinant individuals in the mapping-panel. This 
information will be invaluable for streamlining the second stage, the genotyping of large
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numbers of mutants with all closely linked SSLP markers. If these markers are still too 
distant (more than 1cM) from the mutant locus then other types of genetic markers such as 
amplified frequent length polymorphisms (AFLPs) (Ransom and Zon, 1999) have to be 
generated in the region flanking the locus. These are obtained by selective PCR 
amplification of restriction fragments from a total digest of genomic DNA. Because most 
AFLP fragments correspond to unique positions on the genome they can be exploited as 
landmarks in genetic and physical maps. Another alternative is to use Single-Strand 
Conformation Polymorphisms (SSCPs) (Fornzler et al., 1998; Kelly et al., 2000;
Nechiporuk et al., 1999; Payne et al., 2001) which are polymorphisms found in non-coding 
regions of known genes and partially characterized cDNAs. A polymorphism frequency of 
approximately 50% has been demonstrated between the zebrafish strains used for genetic 
mapping studies (Fornzler et al., 1998).
The aim of the third stage of mapping is to narrow this genetic interval to a critical region, 
which is defined as a physical contig linking the two flanking markers that are no more than 
one recombinant apart from the mutant locus. On average, 1 centiMorgan (cM) in the 
zebrafish genome represents approximately 740 kb in a sex-averaged meiotic map 
(Postlethwait et al., 1999; Shimoda et al., 1999). So the closest linked marker, ideally less 
than 1cM away from the gene locus, is likely to be within reach of a relatively short 
genomic walk. The objective of this stage to bridge the gap between the nearest markers 
and the gene of interest. This involves a group of ever evolving techniques for genomic 
walking (Talbot and Schier, 1999) that detect overlapping sequences of individual clones 
and enable them to be positioned in the correct order. In particular, there are commercially 
available YAC (Yeast Artificial Chromosome), PAC (P1 artificial chromosome) and BAC 
(Bacterial Artificial Chromosome) genomic libraries (available from Research Genetics and 
Genome Systems) that can be screened by hybridisation or by PCR. These libraries 
contain average insert sizes of 240-480; 80-300 and 80-110 Kb of DNA, respectively 
(Amemiya et al., 1999). Therefore, if the distance to the closest marker is say, 1cM then a
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walk of three or four YACs should cover the genetic interval containing the gene of 
interest.
A potential alternative method of delimiting the critical region containing the mutant locus 
involves microinjection rescue assays with genomic clones (Yan et al.,1998; Talbot and 
Schier, 1999). This approach may be very useful for easily scorable early phenotypes, shd 
has a phenotype that is readily scored at 72 hpf. At this stage, using a dissecting scope 
with incident lighting it is possible to identify the presence or absence of even single 
iridophores.
The aim of the work described in this chapter was to find the map position of both 
colourless (els) and shd genes by linkage mapping of mutant embryos. The second 
objective was to limit the genomic region containing the shd locus to a minimum interval of 
no more than 1cM flanked by the two nearest markers.
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2.2 Materials and methods
2.2.1 Mapping-crosses
Large sets of offspring were generated from fish that carry the els and shd alleles. These 
mapping cross families were generated in the laboratory of Pascal Haffter (Max-Plank- 
Institui fur Entwicklungsbiologie,Tubingen, Germany) by crossing strains having maternal 
and paternal chromosome sets from distinct genetic backgrounds (Tuebingen and W iki 1) 
and which thus show the high degrees of polymorphism necessary for easy mapping 
(Rauch, 1997)( Figure 2.1). SSLP mapping on the F2 mutants and wild-type siblings from 
the mapping- crosses was performed using a semi-automated set-up during a visit to 
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75% wild-type
Figure 2.1. shd mapping-cross. Diagram showing how the mapping-cross was generated 
between the homozygous mutant shd/shd and the homozygous wild-type wik11/wik11 (PO). 
These two strains can be easily recognised because they produce different size bands (red) 
when amplified with a polymorphic marker. The progeny of this cross (F1) are all 
heterozygotes and therefore have the same genotype earring both mutant and wild-type 
bands. Crossing the F1 with each other generates the F2 generation. This generation contains 
25% of homozygous mutants, which will be used for mapping, and 75% of wild-type siblings of 
which 50% have a heterozygous genotype and 25% are homozygous for the wik11 allele. 




In order to extract the genomic DNA a total of 48 F2 homozygous mutants and 48 wild type 
siblings were collected from the respective map-crosses, identified and separated from 
their siblings, and kept in methanol a t-70  °C in separate 1.5 ml eppendorf tubes. The 
embryos were then transferred to a 96 well plate (Thermoquick), allowing just one embryo 
in the bottom of each well. The DNA of the individual mutants and siblings was extracted 
with 2.25 ml of a mixture of 1 x TE (Sambrook, 1989) and 250 pi 17mg/ml Proteinase K 
(Sigma). Subsequently, 25 pi of this solution were transferred to each well with a 
multipipette (Finnpipette). The plate was covered with Hybaid film and heated in a Hybaid 
PCR machine at 55 °C for 250 minutes followed by 10 minutes at 75 °C. Finally, the 
genomic DNA extracted from the 48 mutant embryos was pooled in one tube and the 
same was done to the siblings’ DNA.
2.2.2 Bulk segregant analysis
The PCR recipe used in the amplification of all SSLP markers was made up of 15pl of 
PCR mix, which was previously made in large quantities by mixing 6 ml of 10 x PCR buffer 
[10mM Tris pH 8.3 at 25°C (Sigma), 50 mM KCI (Sigma), 1.5 mM MgCI2 (Sigma) and 
0.01% gelatine (Sigma)], which was added to 36 ml distilled water and 120 pi of each 
100mM dNTP (GIBCO), 0.42pl of Taq polymerase 5 Units/pl (GIBCO) and 0.38pl of SSLP 
primers at 10pM (GIBCO). All these reagents were added to 5pl of 3 dpf embryonic 
genomic DNA.
The PCR program performed for amplification with SSLP markers consisted of a prior 
denaturation step of 2 minutes at 95 °C, followed by 34 cycles of 30 seconds at 94°C; 30 
seconds at 60°C; 1 minute at 73 °C followed by 10 minutes final extension at 73°C. The 
amplified products were separated on 4-5 mm thick agarose gels. We used an overall 2% 
agarose gel made by mixing Metaphor (FMC) high quality agarose, with regular agarose
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(Qualex). Gels were electrophoresed for 110 minutes at 100 Volts. We used 1x TBE buffer 
for making gels and running buffer and a type II loading dye (Sambrook, 1989). DNA was 
visualised with a UV transilluminator by prior staining of the gels with 20 pl,10mg/ml, of 
ethidium bromide (Sigma). Gels were recorded using an image analysis system (Sion 
Image) that could consistently record the band intensity produced by the pools of mutants 
and siblings. Any difference between the intensity of the two bands indicated a potential 
linkage to the SSLP marker in question. These markers were then tested on individual 
embryos for confirmation of linkage.
Extraction of DNA from individual embryos was done in the same way as described above 
except that DNA was not pooled in the final step. Instead, individual embryo DNA was kept 
separately in each well, diluted by adding 75 p,l sterile distilled water. These plates were 
named template plates and used for the amplification of one marker at a time. The amount 
of DNA present in each well allowed for up to 20 PCR reactions, i.e. for the genotyping of 
the same individuals with up to 20 different markers. The PCR products were obtained and 
visualised in the same way as mentioned above. To resolve some of the polymorphisms 
pure 2% Metaphore agarose (FMC) was used (see Figure 2.2 for example of how a 
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Figure 2.2 Confirmation of linkage by genotyping individual mutant embryos with different 
SSLP markers. Example of a closely linked marker 1 with the mutant locus and a more distant 
marker 2. The closer the marker is to the mutant locus the fewer recombinant embryos will be 
present. A recombinant mutant embryo will be heterozygous for the mutant and wild-type 
alleles because one or more cross-overs must have occurred between the two loci. So, the 
same mutant embryos when genotyped with marker 1 produce a lower size mutant band and a 
higher size wild-type band and when genotyped with marker 2 generate the opposite situation 
but this time presenting many more heterozygotes due to the increased number of 
recombinants.
Linkage of markers with the mutation in question was evaluated using a computer script 
written in Filemaker Pro 4.1 by Dr. Robert Geisler. Gels were scored by assigning numbers 
to the different bands. Embryos homozygous for the upper band were scored as 1, for the 
lower band as 2 and heterozygotes were scored as 3.The linkages given in cM and the 
respective LOD scores for each marker were then calculated by this script allowing us to 
position the markers in an ordered array in relation to the mutant locus. The LOD score 
was calculated using the following equation (Geisler, R. pers. Comm.)
LOD = Ig [exp (2*n*(ln (1-0)*(1-0) + ln(0*0 -In 0.5)))]
Where:
n = total number of diploid embryos 
0 = recombination fraction
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2.2.3 Fine mapping of the shd locus
To fine map the shd locus large numbers of F2 embryos (~1000) were genotyped using 
the closest markers to the mutant locus. This enables more accurate determination of the 
distance of the markers to the mutant locus. In order to do this we brought F1 embryos of 
the shd map-cross from Tuebingen to Bath. These embryos were raised in our fish facility 
under intensive feeding conditions (4 feedings per day) using a variety of flake food 
(Tetramine) growth food (Tetramine) and hatched artemia. F1 carriers were identified and 
pairs kept separately. F2 progeny from individual F1 pairs were collected weekly, DNA was 
extracted and each individual was genotyped with SSLP markers using the PCR 
conditions described above.
To enable mapping of all new SSLP markers in the region of shd locus, DNA from the 
parental (P0) generation of the map-cross was tested for polymorphisms. DNA was 
generated from tail fin clips and all polymorphic markers were then genotyped on the F2 
embryos and became part of our mapping panel. Tail fin clips were taken from adult fish 
after anaesthesia in 0.04% MESAB using a clean scalpel. Fish were returned immediately 
to fresh water. After recovering they were returned to their original tank. Each tail was 
placed in eppendorf tubes in 1 OOjllI lysis buffer (50mM Tris pH 8.3, 100mM NaCI, 2% SDS, 
5mM EDTA, 200pg/ml proteinase K (Sigma)), and were incubated at 55°C overnight for 
digestion. The next day the DNA was cleaned by adding 5 to 6 ml of phenol / chloroform / 
isoamylalcoholl 25:24:1 mixed thoroughly, spun for 35 minutes at 5000 rpm, and then the 
supernatant was removed with a truncated blue tip. The supernatant was transferred to a 
clean tube and the DNA precipitated by adding 0.3 M NaCI, 2 volumes of cold 100% 
ethanol and spinning for 15 minutes at 5000 rpm. The DNA pellet was washed with 70% 
ethanol and left to air dry for 30 minutes. The pellet was resuspended in TE and the DNA 




2.3.1 Mapping the c/s and shd loci
Both els and shd loci were positioned on the zebrafish linkage map (MGH mapping panel). 
Mapping cross families for these two loci had been generated by crossing the mutants, 
which were firstly generated on a Tuebingen background (TU) (Haffter et al., 1996a), to the 
wild-type strain WIK11. This strain had been previously tested for polymorphisms with a 
large number of SSLPs by (Rauch, 1997) and proven to be the most suitable for 
mapping. Different sets of SSLPs were amplified from pools of genomic DNA from 
mutants and wild-types. After using several sets of markers (each set has 48 different 
markers) the whole genome (2635 cM) has been scanned to a resolution of less than 2 cM 
thus allowing linked markers to be identified.
As explained above, genotyping the homozygous F2 embryos from the respective map- 
crosses permitted to find linkage to a few markers and therefore map the two loci to their 
respective linkage groups. In this way, els was placed on linkage group 3 (not shown here; 
see Dutton et al., 2001) and shd on linkage group 17 (Figure 2.3). In 274 meioses the 
closest markers flanking c/s were z872, 2.4 cM away and z13387, 1.5 cM away. The 
closest flanking markers to the shd locus in 540 meioses were z10985, 0 cM distant and 
z11341, 2.0 cM away. The purpose of mapping these two mutations was very different. 
While c/s was being cloned by a colleague, Angela Pauliny, using a candidate approach, 
shd was going to be positionally cloned. Thus, we needed only a rough map position for 
the c/s locus, so that my colleague could then map her candidate gene onto a radiation
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hybrid map and see if the two map positions coincided. On the other hand, we needed a 
very reliable and precise map position for shd for the positioning cloning to be feasible.
LG 17
cM













Figure 2.3. Diagram showing the results of the first stage of mapping shd. The mutant locus 
was placed on linkage group 17 between the markers z20803 and z11341 comprising an 
interval of 6.3 cM. At this stage the marker z10985 did not show any recombinant with the 
mutant locus and therefore it was impossible to know on which side of the shd locus it lay. The 
centromere was located further south of this set of markers.
2.3.2 Fine mapping of the locus
After waiting for the shd map-cross F1 fish to mature (brought as embryos from Tuebingen 
in February 1999), F1 identified carriers were crossed and large numbers of F2 mutant 
embryos were collected for genotyping with the best SSLP markers found in the first 
mapping stage. A total of 1000 mutant embryos were therefore genotyped with five 
different markers. We will present two examples to illustrate the process of mapping used.
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The marker z10985, the closest marker, had a typical size of 99bp on a Tuebingen 
background and around 111 bp on a W iki 1 background (see Figure 2.4 for an example of 
a gel produced during mapping with this marker).
2 4 6 8 10 12 14 16 18 20 22 24
1 3 5 7 9 11 13 15 17 19 21 23
Figure 2.4. Example of a typical gel showing the mapping of z10985 on 96 individual embryos. 
The first three gels are the result of amplifying z10985 on shd homozygous mutant embryos. 
The last gel was always used for amplifying the same marker on sibling embryos from the 
same cross. All the mutant embryos show the same 99bp band for the marker z10985. There 
is one exception on the third gel showing a clearly mis-sorted embryo amplifying the larger 
band typical from a WIK11 background. This is a sibling embryo homozygous for the WIK11 
band that was picked by mistake and included among the mutants. In the last gel it is possible 
to see several of these embryos homozygous for the W iki 1 allele (e.g.numbers 20, 22 and 23 
from left to right). The majority of the siblings are heterozygotes for both alleles and there are 
two mis-sorted mutant embryos homozygous for the lower band (numbers 14 and 21).
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Several gels like this one were obtained for this marker and only one recombinant was 
found in the total of 1000 mutant embryos genotyped. Therefore the marker z10985 
showed only one recombination event with the shd locus indicating a distance of 0.1 cM, 
which according to Shimoda et al. (1999) translates to around 74kb. By comparison, the 
next closest markers are significantly more distant. Thus, z11341 showed 64 
recombination events on the other side of the shd locus and the marker z20803 scored 70 
recombinants on the same side of the shd locus as z10985. Figure 2.5 shows a typical 
example of a mapping gel for one of these markers. An explanation of how we can tell the 
orientation of each marker in relation to the shd locus is given further below.
Figure 2.5. Example of a typical gel showing the mapping of z11341 on 96 individual embryos. 
The first three gels are the result of amplifying z11341 on shd mutant embryos. The last gel 
shows mapping of the same marker on sibling embryos from the same cross. Most mutant
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embryos show the same 250bp band. However, there are also three recombinant embryos that 
show a lower band around 220bp and also a much higher and weaker band around 600bp. In 
the siblings gel it is possible to see many of these genotypes heterozygous for the Tuebingen 
and W iki 1 alleles due to presence of wild-type heterozygous embryos which have the same 
genotype. The third genotype seen in the siblings gel corresponds to the homozygotes for the 
Wik11 allele, a single band around 220bp.
These two markers indicated an average distance to the mutant locus of around 7cM, i.e. 
approximately 5Mb. This distance was too great to consider any type of genomic walk. The 
remaining markers we had been consistently testing, z7170 and z9831, were even further 
away (see Figure 2.6 for an example of a gel for the mapping of zS831).
2 4 6 8 10 1214 16 18 2022 24
1 3 5 7 9 11 13 15 17 19 21 23
Figure 2.6. Example of a typical gel showing the mapping of z9831 on 96 individual embryos. 
The first three gels are the result of amplifying z9831 on shady homozygous mutant embryos. 
The last gel tests the same marker on sibling embryos from the same cross. Most mutant 
embryos show the same 210bp band typical for the Tuebingen background. However, there 
are 13 mutants showing both this band and the Wik11 band at around 190bp. These 
recombinants are s h d ''' embryos that are heterozygous for this SSLP. Thus, their genotype is 
the same as that of the heterozygous wild-type siblings. The third genotype presented in the
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siblings gel corresponds to the homozygotes for the Wik11 allele, a single band around 190bp.
It is also clear in the siblings gel that there is one mis-sorted embryo at position 22 from left to 
right, this is a mutant embryo homozygous for the Tuebingen allele.
Testing of these more distant, as well as the closest, markers for all 1000 embryos was 
important as a control for mis-sorted embryos. A mis-sorted embryo will typically be 
homozygous for the WIK11 allele, and thus will be easily detected as it will show a single 
different band on the gel. More confusingly, mis-sorted wild-type embryos can be 
heterozygotes for the WIK11 and TU alleles, and thus can be easily confused with a 
recombinant embryo (but homozygous mutant). The only way to detect such mis-sorted 
embryo is by using several markers mapping to the region of the mutant locus. 
Amplification of different markers mapping to the same side of the mutant locus should 
identify the same embryos as recombinants. The number of recombinants is expected to 
be decreased for markers mapping closer to the mutant locus. Heterozygote embryos that 
do not comply with this pattern can be unambiguously identified as mis-sorted wild-type 
embryos, not recombinant shd mutants.
At this stage the DNA from each of the recombinant embryos was physically removed from 
the original template plates and put into separate new plates. One for recombinants distal 
to shd and one for recombinants proximal to shd. These new plates constituted the 
definitive recombinant mapping panels on each side of the shd locus. Instead of 
genotyping every new polymorphic marker on the same 1000 mutant embryos, they would 
only be tested on the recombinant mapping panels. Any new marker that showed fewer 
recombinants than z11341 (64) or z20803 (70) would be closer to the shd locus. We tested 
several further markers and three new markers mapped closer than the previous flanking 
ones. Thus, z15715 mapped on the same side as z11341 but showed only 26 
recombinants and z9818 and z21435 mapped to the same side as z20803 (the same side 
as z10985) but scored 20 and 40 recombinants, respectively. An example of the mapping 
of one of these markers (z9818) using the recombinant panels is presented in Figure 2.7.
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z9818 on z20803 recom binant panel z9818 on z11341 recom binant panel
Figure 2.7. Mapping of the marker z9818 on the two recombinant mutant panels showed 20
embryos recombinant for this marker ( * ). As expected, no recombinants were found on the 
z11341 panel, meaning that the z9818 is on the same side as z20803 in relation to the shd 
locus. Z9818 shows a mutant band around 150bp and a Wik11 band around 210bp
Figure 2.8 summarises the mapping data for these markers. The marker z10985 was still 
much closer than any other marker tested. At that time there were no other polymorphic 
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Figure 2.8. Diagram showing the position of shd in relation to other genes and markers 
mapped to linkage group 17. The insert shows the shd region to indicate the relative positions 
of the zmarkers that were mapped on 1000 individual mutant embryos. The number of 
recombinants between the shd locus and each marker is indicated. 1 recombinant found in 
1000 mutant embryos translates to around 74 kb in a sex averaged map (diagram adapted 
from Postlethwait et al., 1998)
At this stage the shd locus was flanked by markers that limited a genomic interval of about 
2Mb. This distance was still too great to perform a bi-directional genomic walk. We thus 
faced a choice between a) generating new markers and looking for closely linked markers 
on the z11341 side or b) walking from z10985. The distance from z10985 alone was within 
the reach of a very short genomic walk, i.e. 74 kb which was within the standard size of 
one PAC clone. Consequently, the plan was to screen a genomic library with the marker 
z10985, isolate a number of PACs and analyse these by a combined approach including 
restriction analysis, sequencing and microinjection. We hypothesised that one of the 




We have mapped shd on linkage group 17. The shd locus is flanked by two markers: a 
closely linked one and a more distant one. Because between this more distant marker and 
the shd locus we still found 26 recombinants we decided to start a unidirectional walk from 
the other flanking marker with which we had found only one recombinant mutant embryo.
Positioning shd on zebrafish LG 17 raised some interesting questions with regard to 
conserved syntenies. Previous analysis revealed that a group of genes that is syntenic (on 
a single chromosome) in humans tend to have orthologues that are syntenic in zebrafish 
(Postlethwait et al., 1998). The reason it is preferred to compare zebrafish genomics with 
human genomics arises from the fact that in general the zebrafish genome seems to 
correspond more closely to the human genome than the mouse genome. This reflects the 
rapid chromosome evolution among rodents and the rather slow divergence of karyotypes 
in the primate lineage (Postlethwait et al., 1999).
Woods et al. (2000) showed that zebrafish genes on linkage group 17 have their 
orthologues in clustered regions of human chromosomes 2p; 10q; 14q; 20p. Of these 
human clusters the most numerous are chromosome 14q with 10 genes and chromosome 
20p with 5 genes. These syntenic genes include two genes, pax9 and gsc, that flank the 
shd locus (see Figure 2.8). Both these genes are in the 14q human cluster. Thus, we can 
speculate that perhaps that entire zebrafish genomic region, including the shd locus, may 
be syntenic to human chromosome 14q.
However, at present time, with more genes being positioned on the zebrafish maps 
everyday, further investigation showed that zebrafish genes otx l and id2 (both on LG 17
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and even closer to the shd locus) have orthologues on human chromosome 2p13 and 
2p25, respectively (http://zfin.org/cai-bin/view zmapplet.cgi.). Furthermore, Sox11a and 
gdf7 were also mapped on this region (Davidson et al., 1999; de Martino et al., 2000) and 
their human orthologues are found on 2p25 and 2p24-23, respectively 
(http://www.ncbi.nlm.nih.gov). In this way, there are at least four genes confirming the 
synteny between this confined region of zebrafish linkage group 17 and the human 
chromosome 2p13 - 2p25 interval. It is therefore possible to speculate that if there is such 
a human orthologue of the shd gene it will probably lie in this region of the human genome. 
However, at the stage that this mapping phase was completed there were very few genes 
positioned on linkage group 17 and it was impossible to draw such speculation. For this 
reason, a candidate approach by looking at all these human genes and evaluating their 
potential candidacy from their function in development or expression patterns was not 
undertaken. Instead, it was decided to continue with the positional cloning by narrowing 










In order to study fully the function of genes identified by the mutagenesis screens it is 
necessary to positionally clone these genes (Collins, 1992). This task is not trivial and can be 
labour-intensive, requiring an arsenal of both genetic (e.g. different types of genetic markers) 
and genomic tools (e.g. somatic cell/radiation hybrids, genomic libraries). First, we will give a 
brief description of the three types of zebrafish genomic libraries available at this stage of the 
project: the YAC system constructed in yeast artificial chromosome, the BAC system in 
bacterial artificial chromosome, and the PAC system constructed in P1 derived artificial 
chromosome vectors. All these cloning systems have been used successfully in the human 
and mouse genome projects and they are expected to have the same impact in the zebrafish 
positional cloning projects (Amemiya et al., 1999).
The YAC cloning system (Nelson, 1990) uses two vector arms, both containing yeast 
selectable markers and telomere sequences. One of them contains a centromere and a yeast 
autonomously replicating sequence (ARS). The (dephosphorylated) vector arms are ligated to 
the size-selected genomic DNA to be cloned (usually Eco Rl partial digests) and subsequently 
transformed into yeast cells which have had their cell walls enzymatically removed 
(spheroblasts). To ensure that only clones containing both vector arms are propagated, the 
transformed spheroblasts are plated in top agar prepared with selective media. Clones with 
inserts are further detected by a red-white selection. Transformants comprise features 
necessary for mitotic propagation in the yeast cells: namely two telomeres, an ARS, a 
centromere and presumably a genomic insert. This system is highly advantageous in that it is
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capable of propagating extremely large (megabase-sized) fragments. However, the 
disadvantages of this system are many and include the relatively high rate of insert chimerism, 
inherent instability, slow growth rate and overall difficulty in handling. As YACs are linear 
chromosomes, they can only be isolated from the endogenous yeast chromosome by 
separation via pulsed field gel electrophoresis which is a relatively tedious procedure.
The BAC system (Shizuya et al., 1992) is bacterial plasmid-based. The system operates 
under the principle that the Escherichia coli F-factor plasmid replicon is capable of replicating 
DNA molecules as large as the entire E. coli chromosome. The vectors used for BAC cloning 
have been stripped of all accessory components and are essentially an F-factor replicon with 
a chloramphenicol resistance gene (Shizuya et al., 1992). The latest BAC vectors all possess 
a Lac-Z blue-white colour selection system. As with the YAC system, partially digested 
genomic DNA (usually Hind III) is extensively size-selected and ligated to dephosphorylated 
BAC vector (7.5 Kb). Ligation products are then electrotransformed into a E.coli host strain 
that possesses a cell wall defect (DH10B; Life technologies) and recombinants isolated by 
plating on selective media. The BAC system can only propagate inserts up to 300 Kb. 
However, this system is highly advantageous in that BACs are essentially large plasmids and 
can be handled and characterised using simple modifications of routine methods used in all 
molecular genetics laboratories. BACs are also relatively stable and do not exhibit the high 
levels of chimaerism observed in YACs (Amemiya et al., 1999).
The PAC cloning system (loannou et al., 1994; Ota and Amemiya, 1996) is very similar to the 
BAC system, except that is uses a (single copy) P1 bacteriophage replicon and a Kanamycin 
resistance gene. As with the BAC system, size-selected partial digests (usually with Mbol or 
Sau3A) are ligated to a desphosphorylated vector and electrotransformed into DH10B cells. 
The PAC vector (-16Kb) additionally contains a SacBII selection system against noninsert-
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containing clones, whereby only recombinant clones grow vigorously in the presence of 5% 
sucrose. The PAC system can accommodate inserts of up to 300Kb and exhibits essentially 
all the advantages of BACs. In addition, it contains an inducible P1 lytic replicon that permits 
multicopy propagation of PAC plasmids when the clones are grown in the presence of 1mM 
IPTG. The disadvantage of the PAC system with respect to the BAC system is the larger 
vector size.
To date, there are two zebrafish YAC libraries, one BAC library, and one PAC library. All these 
libraries are available (Genome Systems and Research Genetics). All the libraries encompass 
from four to five haploid genome equivalents. The average insert sizes of the four libraries 
range from 470 Kb to 90 Kb and there is roughly a 20x genomic coverage (Amemiya et al., 
1999). The three vector systems are complementary in a sense that different genomic 
sequences may be under or over-represented in each system.
The first aim of the work described in this Chapter was to screen the zebrafish PAC library 
with the marker z10985 in order to isolate a maximum number of PACs that would contain, not 
only this z marker, but also parts of the shd gene or even the complete shd gene. This marker 
was estimated to be around 74 Kb distant from the shd locus and therefore the choice of a 




3.1.2 Identification of clones containing the mutant 
gene by genomic DNA microinjection
Taking a phenotypic rescue approach, at least at an early stage of a positional cloning project, 
is not common. In fact, so far only one project among the published examples of zebrafish 
positional cloning has followed this procedure (Guo et al., 2000). At the time this assay was 
initiated in the current work, there were no published examples of genomic rescue as a means 
to positional clone a gene. Nevertheless, it was known that floating head (flh) mutants could 
be partially rescued by injection of BAC clones containing the wild-type gene (Yan et al.,
1998). Phenotypic rescue was only partial, presumably reflecting the mosaic inheritance and 
expression of the injected transgene. This mosaicism had been documented before for other 
clones injected into one-cell stage embryos (Westerfield et al., 1992). This fact meant that for 
some embryos, with very subtle phenotypes, affecting only a small number of cells, the partial 
rescue might not be detectable. Another unknown factor, at this stage was how long transient 
rescue would be effective. The shd phenotype is not seen reliably until 72 hpf and it was 
unclear whether iridophores could be rescued in a transient assay, nor how much genomic 
DNA it would be necessary to inject to have such a late effect.
These potential problems were perhaps the reason why this assay was not very common. 
Instead, the standard procedure was to create more markers in the ends of identified genomic 
clones for continuing the genomic walk (Talbot and Schier, 1999). This demanded that the 
ends of the genomic clones were sequenced and that specific primers were synthesised and 
then tested for overlap and suitability to serve as Sequenced-Tagged Sites (STSs). This also 
meant that every new STS had to be mapped in the recombinants mapping panel for 
confirmation of linkage and assessment of the progress of the walk. Polymorphisms in STSs
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may be detected with restriction enzymes or by single-strand conformational analysis (Talbot 
and Schier, 1999).
In summary, the alternative to phenotypic rescue with genomic microinjection is laborious. So, 
the second aim of this Chapter was to optimise the PAC injections to enable phenotypic 
rescue of iridophores by trying a number of concentrations of genomic DNA and carefully 
assessing the injected embryos after 72 hpf.
3.1.3 Assembly of a genomic region
Once there are identified genomic clones it is essential to analyse them by pulsed field 
electrophoresis to know their size and to assess the extent of overlapping regions (Amemiya 
et al., 1999; Talbot and Schier, 1999). It is then of major advantage to construct a map with 
these results in order to visualise the genomic contig. In this map of the assembled genomic 
region, it is possible to identify important markers found previously and PAC end-clones by 
hybridisation techniques.
Perhaps the most powerful outcome of a correct assembly of the genomic region containing 
the locus of interest and identification of a PAC that produced transient rescue after 
microinjection was that at this stage it was possible to pinpoint exactly the region containing 
the gene and its regulatory elements required for the rescue. It meant that, in theory, it would 
be possible to sequence only the fragment containing the gene, instead of a large genomic 
stretch. Additionally, it would also be possible to isolate a coding fragment of the gene by 
direct cDNA selection or exon trapping (Amemiya et al., 1999).
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In this way, the third objective of this Chapter was to assemble the genomic region where shd 
lies in and combine that information with the other results obtained so as to identify the critical 
region containing the gene.
3.1.4 Identification of candidate loci within a genomic 
region
There are several approaches to tackle the last stage of a positional cloning project: the 
identification of candidate genes. cDNA libraries can be screened with the large genomic 
clones or a fragment from them that is known to contain the gene of interest. However, this 
approach presents some problems like the repetitive sequences present in untranslated 
sequences of some cDNAs (Talbot and Schier, 1999) and even after resolving this type of 
problem it usually results in identifying several false positives (e.g. Brownlie et al., 1998). 
These will all have to be tested, a process which can be very time consuming. Another 
problem with working with cDNA libraries is that it requires prior knowledge of when the gene 
is active. Nevertheless this approach has been followed earlier by (Brownlie et al., 1998) to 
clone the sauternes gene and by (Zhang et al., 1998b) to clone zebrafish one-eyed pinhead. 
More recently, the zebrafish mutation weissherbst (weh) was positionally cloned by screening 
cDNA libraries with large genomic inserts, weh was identified as ferroportinl, a conserved 
vertebrate iron exporter (Donovan et al., 2000). The positional cloning of the mutant miles 
apart (mil) as a sphingosine-1-phosphate receptor presents another example of successful 
screening of cDNA libraries with PAC inserts (Kupperman et al., 2000).
Another, less problematic, approach is to sequence the whole critical region if this is small 
enough. With the ongoing zebrafish genome sequencing project this is made ever easier
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since the Sanger Centre has prioritised the sequencing of known contigs. This proved 
feasible for the shd region, thus enabling us to analyse the full genome sequence of this area.
Whether we have several candidate cDNAs or a large sequenced region containing the gene 
of interest, it still requires the testing of potential candidates. In the case of candidate cDNAs it 
is possible to perform whole mount in situ hybridisation, a routine method in zebrafish. This is 
likely to be informative unless the gene in question is ubiquitously expressed. On the other 
hand, having a large genomic sequence to analyse may be arduous. Fortunately, there are 
sophisticated computer programmes made available by the UK Human Genome Mapping 
Project Resource Centre (UK HGMP-RC) that aim to identify potential genes in large genomic 
sequences (a more detailed explanation on these programmes is given in the Results section 
of this Chapter).
Candidate genes identified in this ‘virtual’ way have to be confirmed experimentally. In other 
words, the most promising ones have to be cloned and tested by whole mount in situ 
hybridisation and then by either rescuing the mutant phenotype by mRNA or cDNA injection or 
by phenocopying the mutant phenotype by injecting morpholinos. Almost all published 
positional cloning projects have shown mutant rescue by cDNA injection (Brownlie et al.,
1998; Donovan et al., 2000; Guo et al., 2000; Kupperman et al., 2000; Shafizadeh et al.,
2002; Zhang et al., 1998a) and few by using morpholino technology (Parsons et al., 2002).
The one exception to this pattern is gatal for which both mRNA and cDNA failed to rescue the 
phenotype of the vlad tepes mutant. In this particular case injection of a BAC containing the 
gatal gene and assessment of rescue identified gatal as the mutant locus (Lyons et al.,
2002). Ultimately, in the molecular identification of any mutated gene, it will be always 




Thus the last aim of this Chapter was to ‘virtually’ identify one or more candidate genes for the 
shd locus. The combination of all the results from this Chapter helped find the most plausible 
candidate in preparation for definitive testing of that candidate (see Chapter 4).
75
CHAPTER 3
3.2 Materials and methods
3.2.1 Screening P1 artificial chromosome genomic 
libraries
3.2.1.1 DNA-pool-screening procedure
All RZPD libraries can be screened by PCR in a convenient two step procedure. For each 
step sufficient DNA was received for at least 25 rounds of screening. The purified DNA was 
prepared by RZPD using an Automated Nucleic Acid Isolation System and was submitted 
lyophilised in a 96 well format microtiter plate. Initially, the primary pools from the zebrafish 
PAC library 706 created by Chris Amemiya from erythocytes (Amemiya and Zon, 1999) were 
analysed. DNA was resuspended in MilliQ water and 5pl of purified DNA was obtained from 
all clones from 33 microtiter plates, which equals 33x96 clones. The same PCR procedure 
described in Chapter 2 (section 2.2.2) for the mapping of marker z10985 was applied to all the 
clones. Products were run on 1% agarose gels.
Secondary pools consisted of individually pooled microtiter plates from the positive primary 
pool procedure. The secondary pool screening (also performed using the same PCR 
amplification) had to produce at least three positive signals to identify: the positive plate, the 
positive row and the positive column. The combined information of the positive signals 




3.2.2 Rescuing the shady phenotype by genomic 
DNA microinjection
3.2.2.1 Isolation of PAC DNA
The identified clones were ordered from the RZPD Resource Centre and were sent as stabs. 
Glycerol stocks were made as per Sambrook et al., (1989) and kept at -80°C. Colonies were 
grown overnight in the presence of 20mg/ml of Kanamycin. In the next day individual colonies 
were picked and cultured overnight in 300 ml of LB with 20 mg/ml of kanamycin. The QIAGEN 
large-construct Kit (QIAGEN) was used for the purification of PAC DNA according to the 
manufactors’ instructions. This kit is designed to isolate DNA from large constructs such as 
BACs, PACs, and cosmids of up to 250 kb in size. The kit uses a rapid purification procedure 
based on the selectivity of a patented QUIAGEN Anion-Exchange Resin. A digestion step with 
ATP-Dependent Exonuclease enables efficient removal of genomic DNA contamination to 
yield pure genomic DNA free of vector DNA. However, because these large constructs are 
typically present at very low-copy numbers yields can sometimes be low using this column 
based method.
To increase yields the isolation of PAC DNA from 100 ml cultures employing the Plasmid-Safe 
ATP-dependent Dnase enzyme (Epicentre Technologies) was also used. This enzyme digests 
away all DNAs except those that are circularised. The resultant DNA is sufficient for 
subcloning and restriction analysis, and can be scaled up if necessary. The full protocol is 
available at http://med-humaen14.bu.edU/vectors/PACisol-100ml.h. The procedure involved 
inoculating 100 ml of LB-Kanamycin (25 pg/ml) with a 1 ml pre-inoculum of the desired PAC 
clone. A 500 ml erlenmeyer flask was used to grow the culture at 37°C overnight at 300 rpm. 
Next day the culture was spun at 5000 rpm for 5 minutes at 4°C and the supernatant
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discarded completely. The material was resuspended with 8 ml of P1 solution (Sambrook et 
al. (1989) and transferred to a 50 ml SA600 (SS34) screw-top polypropylene tube and 
vortexed briefly to completely suspend the bacteria. 8 ml of the P2 solution (Sambrook et al. 
(1989) was added and gently mixed by swirling the tube. The solution was allowed to sit on 
the bench for 5 minutes, swirling occasionally, before adding the P3 solution and inverting the 
tube a few times to mix. The tube was placed on ice for 10 minutes and then was spun in a 
SA600 rotor for 15 minutes at 12000 rpm at 4°C, supernatant discarded and all traces of 
isopropanol removed. The pellet was washed with 5 ml of 70% ethanol by inverting the tube 
several times, before spinning again at 12000 rpm for 5 minutes and discarding the 
supernatant. The pellet was air-dried briefly until it became translucent and 500 pi of Plasmid- 
safe buffer (Epicentre technologies) was added and swirled several times to resuspend the 
DNA. Then, 5pl of 100 nM of ATP, 5pl of plasmid-safe ATP-dependent Dnase and 1pl of 
Rnase (10 mg/ml) were added and the tube was placed in a 37°C water bath for 3 hours with 
occasional swirling. The DNA was then transferred to a 2 ml eppendorf tube and phenol- 
extracted followed by two phenol-chloroform extractions. DNA was precipitated by adding 50pl 
of 3M NaOAc and 1.2 ml of absolute ETOH. The tube was placed on ice for 10 minutes, then 
spun in a microcentrifuge for another 10 minutes. The supernatant was completely removed 
and 1.8 ml of 70% ETOH was added to wash the pellet by inverting the tube several times and 
then spinning it for 1 minute and removing all traces of ethanol with a pipette. In the end the 
pellet was resuspended in 100 ml TE by leaving the DNA at room temperature over the 
weekend.
Prior to injecting the PAC DNA into zebrafish embryos another cleaning step was introduced 
by using the Microcon-100 Centrifugal Filter Devices (Millipore) according to the manufactors 
instructions. This step was also applied to concentrate the DNA whenever necessary.
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3.2.2.2 Microinjections with PAC DNA
Fish that were identified as carriers for the strong shd fy82/ty82 mutation were inter-crossed the 
day before injection was performed. Eggs laid on the morning of the injections were carefully 
cleaned with embryo medium (5mM NaCI, 0.17mM KCI, 0.33mM CaCI2, 0.33mM MgS04, 10" 
5% methylene blue to suppress fungal growth) and observed under a dissecting microscope 
with the purpose of checking that there were not any abnormalities detectable at this early 
stage. Eggs were then placed in the groove of an injecting petri dish coated in 2% agarose 
according to (Westerfield, 1995). Eggs were trapped and aligned in the groove to hold them 
stable during the injection procedure. Each groove takes about 50 eggs from which only 25% 
were expected to be mutants. The aim was to inject around 400 embryos in order to sample 
100 mutants.
The injections were done using a Nanoject II injector (Drummond) and the needles were made 
of borosilicate glass capillaries GC120F-10 (Clark Electromedical Instruments) that were 
pulled in a Sutter instruments Co. Model P97 puller. The concentration of the PAC DNA was 
checked using a spectrophotometer (Beckman DU530) and diluted in MQ water and 1% 
phenol red to three different final concentrations: 68 pg/nl, 25 pg/nl and 50 pg /nl. The injector 
was set to release approximately 10 nl of liquid; thus each embryo would have received 680, 
250 and 500 pg of DNA, respectively. The injection was done into the yolk between 1 and 2 
cell stages. At these stages the cytoplasmic flow into the cleaving embryonic cells carries the 
PAC DNA into the embryo. This process can be followed by the red colour of the DNA solution 
due to the phenol red.
After injection, around 25 embryos or less were placed in separate petri dishes containing new 
embryo medium. These were checked again for any deformities before they went in the 
incubator at 28°C. The same check was done every day, and the embryo medium was
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replaced with fresh medium whenever necessary until the embryos achieved the 72 hpf 
required to score the shd phenotype.
3.2.3 Assembling the shady genomic region
3.2.3.1 Restriction analysis
After isolating the PAC DNA as described in the section 3.2.2.1, 600 ng of each PAC were 
digested with both Not I and Sal I restriction enzymes (Promega) together and independently. 
Not I is a 8 base-pair rare cutter and Sal I recognises 6 base-pair sequences. Each 20 pi 
digestion had 2 pi of enzyme (4 Units) and 2 pi of 10 x buffer D from Promega. The digestions 
were incubated at 37°C for two hours and then analysed by Pulsed Field Gel Electrophoresis 
(PFGE) using a CHEF-DRII (Clamped Homogeneous Electric Fields) (Biorad). Gels were 
made of 1% Fast lane agarose (Flowgen), run at 150 Volts for 27 hours in 0.5x TBE buffer 
with cooling to 15°C. A high molecular weight marker (Gibco BRL) was used in order to 
identify bands from 8.3 to 48.5 Kb. Around 300 ng of the marker was heated up to 65°C prior 
to loading the gels. Gels were post-stained with ethidium bromide until the bands were clearly 
seen in the printed picture (Sony video graphic printer). The same digests were also run on 
standard 0.8% agarose gel electrophoresis to detect bands smaller than 8 kb. These were run 
overnight at 20 volts for optimal resolution.
3.2.3.2. Non-radioactive hybridisation and detection of genomic DNA
Southern blots of the pulsed field gels produced were made according to Sambrook et al. 
(1989). In order to make a non-radioactive probe containing the z10985 marker a fragment of 
304 bp containing the z10985 marker was amplified from genomic DNA and run on a 0.7%
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agarose gel. The 304 bp band which had around 2pg of DNA was excised and diluted in MQ 
water. A ratio of 3 ml of water per gram of gel was used. Approximately 1 jug of DNA was used 
in the labelling reaction. It was decided to employ the DIG High Prime DNA Labelling and 
Detection Starter Kit II (Roche) for the non-radioactive DNA labelling procedure. This Kit uses 
digoxigenin (DIG), a steroid hapten, to label DNA probes for hybridisation and subsequent 
chemiluminescence detection by enzyme immunoassay. The probes were generated with 
DIG-High Prime according to the random primed labelling technique. DIG High Prime is a 
specially developed reaction mixture containing digoxigenin-dUTP, and all reagents, including 
enzyme necessary for random primed labelling, premixed in an optimised 5 x concentrated 
reaction buffer. The use of a special form of DIG-11-dUTP enables easier and more efficient 
stripping of blots for rehybridisation with a second DIG-labelled probe. The hybridised probes 
are immunodetected with anti-digoxigenin-AP, Fab fragments and are then visualised with the 
chemiluminescence substrate CSPD, ready-to-use. Enzymatic dephosphorylation of CSPD by 
alkaline phosphatase leads to a light emission at a maximum wavelength of 477 nm which can 
be recorded with Lumi-lmager or on X-ray films. I have used X-ray film with exposure times in 
the range of 5 to 30 minutes and developed the film in a X-ograph Compact X2. The 
procedure for using this non-radioactive Kit was followed as described in the instruction 
manual (Roche cat.No. 1585614).
3.2.3.3 End-cloning and sequencing of PAC inserts
This method is based on the fact that there are no Xba I sites in the PAC vector. We can 
therefore cleave the PAC clone with Xba I and clone the linearised vector attached to each 
end into suitable vectors; e.g. pUC19. We used the vector pGEM-4Z (Promega) (see Figure 
3.1 and 3.2). To select for the inserts containing the PAC-ends both kanamycin and ampicillin
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Figure 3.2. Diagram of the mixed vector containing both PAC-ends. The enzymes Not I and Xba I 
will release the PAC-ends for their size characterisation.
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The procedure involved digesting 50-100 ng of PAC clone and 100 ng of pGEM-4Z with Xba I 
for 30 minutes at 37°C. The digestion was heat-inactivated at 65°C for 20 minutes and purified 
using Microcon-100 (Millipore) to remove salts. A standard ligation step took place in the 
same tube. Around 20 pi of the purified digestion was incubated with 2.5 pi of ligase buffer,
1 pi of T4 ligase (Gibco/BRL) and 1.5 pi of MQ water for two hours at room temperature. 
Ligated vectors were electroporated into DH10B cells, expressed for one hour in 2 XYT 
medium and plated onto LB-agar plates with kanamycin (25 pg/ml) and ampicillin (50 pg/ml). 
This dual selection was necessary to select those clones that had both PAC ends and pGEM- 
4Z. The plates were left growing over night and on the next day appropriate clones were 
picked to grow minipreps for DNA sequencing. DNA isolation followed the protocol described 
earlier in section 3.2.2.1 using Plasmid-Safe ATP-dependent Dnase enzyme (Epicentre 
Technologies), with the exception that this time 2 ml cultures were used.
A 20pl restriction digestion including: 2pl Xba I (Promega), 2pl Not I (Promega), 2pl buffer D 
(Promega), 5pl DNA and 9pl MQ was made in order to check the sizes of each PAC-end. 
PAC-end sequencing could not be done using T7 and SP6 because these primers are present 
in both the PAC vector and the pGEM-4Z. Instead, M13-forward and M13-reverse primers 
were used since these are present in the pGEM-4Z vector but not in the PAC vector. Between 
300-500ng of plasmid and 1 pi of 10pM primer in a total of 6pl were sent for sequencing.
3.2.4 Identification of candidate loci for shd
The UK Human Genome Mapping Project - Resource Centre (UK HGMP-RC) makes 
available a tool named NIX (Nucleotide Identify X) which is intended to aid the identification of 
interesting regions in genomic or transcribed nucleic acid sequences. There are many useful
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computer tools that can be used for this; however, none of them is completely accurate and it 
is useful to be able to compare the results from many programs that use different methods 
and have different strengths and weaknesses. NIX integrates many of these programs 
(including GRAIL, Fex, Hexon, MZEF, Genemark, Genefinder, Fgene, BLAST (against many 
databases), Polyah, RepeatMasker and tRNAscan) runs them on a sequence and displays 
their results side by side, thus identifying features detected by multiple programs. Rather than 
giving the user total control over how the programs are run by providing them with many 
poorly-understood choices, the NIX system selects reasonable defaults for all the programs, 
based on whether the sequence is genomic or transcribed, its species of origin and its size. 
This makes a vastly simplified interface for running a dozen or so programs on the specified 





3.3.1 Screening P1 artificial chromosome genomic 
libraries
Pooled PAC libraries from the RZPD resource centre were screened by PCR using the marker 
z10985. According to the data obtained from linkage mapping (see Chapter 2) this marker 
showed a very tight linkage to the shd locus and the prediction was made that it should be 
only around 70 kb away from shd. This distance is within the range of one or two PAC clones 
and therefore we decided to screen this type of genomic library.
The primary screen results are presented in Figure 3.3. From the 33 pools screened, which 
represented 33 x 96 clones, 10 pools were positive for the presence of the z10985 marker 
(10, 11, 12, 13, 14, 19, 21, 22, 23, 33). From these, 8 pools were selected to carry on to the 
next screening step based on the fact that they reproducibly produced stronger, brighter and 




Figure 3.3. Primary PAC-pool screening procedure. 1% agarose gel showing the products of the 
primary screening with the marker z10985 (304bp). Primary pools tested are indicated above each 
lane. A water control was included in the last lane.
The secondary screening of these 8 pools of clones identified three plates that produced the 
consistent three bands necessary for the identification of the plate, row and column of the final 
clone. Figure 3.4 presents one example of such a gel.
Figure 3.4. Secondary PAC-pool screening procedure. 1% agarose gel showing the products of 
the secondary screening on one of the plates that produced only 3 positive bands (5, 24 and 38) 
as required for identifying the final PAC clone. A water control was included in this experiment (W).
The identified clones were clone BUSMP706P14181Q2, which we will call PAC1 from now on; 
clone BUSMP706N10265Q2 which we renamed PAC2 and clone BUSMP706016107Q2, 
which was renamed PAC3. All these three clones were from the same zebrafish PAC library 
706, the vector is pCYPAC-6 and the host E.coli DH10B.
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3.3.2 Rescuing the shady phenotype by genomic 
DNA microinjection
Injecting the three PACs into early developing mutant zebrafish embryos was used as a 
means to rescue the mutant phenotype and identify the critical region containing the shd locus 
(see Introduction). The results from these experiments are all summarised in the following 
three tables. The DNA concentrations inferior to 50 pg/nl were not considered for calculating 
the rescue rates. Only concentrations equal or superior to 50 pg/nl were efficient in producing 
rescue of the shd phenotype that could be scored at 72 hpf.
Table 1. PAC1 genomic DNA injection into 1-2 cell stage shd fy82 zebrafish mutant embryos does 


















1 68 58 58 13 0
2 68 146 109 30 0
3 50 88 70 25 0
4 50 105 76 23 0
TOTAL >= 50 397 213 91 0
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Table 2. PAC2 genomic DNA injection into 1-2 cell stage shd ty82 zebrafish mutant embryos does 


















1 50 500 205 38 0
2 50 150 78 26 0
3 50 150 122 26 0
4 55 160 148 30 0
TOTAL >= 50 960 553 120 0



















1 68 13 13 2 0(0)
2 25 129 113 25 0(0)
3 50 153 104 34 6(17.6)
4 50 256 102 37 9 (24.3)
5 60 300 271 69 4 (5.8)
TOTAL >= 50 851 603 167 19(11.4)
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As an example of the extent of rescue obtained in experiments 3,4 and 5 from Table 3, Figure 
3.5 shows some rescued embryos compared to their wild-type siblings. These rescued 
phenotypes are clearly outside of the range of iridophore phenotypes seen in shd fy82 
homozygotes. The strong shd allele ty82 is characterised by having virtually no iridophores. 
The only exceptions I have encountered during the 4 years of this project were the presence 
of one tiny iridophore on the interior side of the eye, in a lateral patch, or in the dorsal stripe. 
Rescued phenotypes ranged from several individual iridophores to spots made of several 
individual iridophore cells or patches made of an even larger number of individual iridophore 
cells. Therefore it was concluded that these mutant fish were indeed partially rescued in 
respect to the iridophore lineage. Sometimes one eye or one lateral patch could look 





Figure 3.5. Phenotypic rescue of sh d ,y82 7 ty82 mutants after PAC3 injections, (a) 72 hpf wild-type 
embryo; (b) same age shd ty82/ty82 mutant embryo showing partial rescue of some iridophore spots 
in the eye and lateral patch after genomic injection with PAC3; shd ty82/ 15,82 mutant embryo without 
rescued iridophores. These three embryos were siblings, (d) sh d ty827 ty82 mutant embryo rescued 
on the right side eye and lateral patch only (arrows), (e) detail of the rescued right side eye and (f) 
non rescued left side eye of the same embryo, (g) wild-type embryo showing part of dorsal stripe 
(top arrows), lateral patch region and part of ventral stripe with normal iridophore pattern (lower 
arrows), (h) sibling shd 15,82717 2 mutant embryo showing partial rescue of lateral patch and three 
ventral stripe iridophores only.
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3.3.3 Assembling the shady genomic region
In parallel to the PAC DNA injections referred to in this Chapter, we assessed how the three 
PACs overlapped, since they all shared the common marker z10985. In order to do that, 
restriction analysis using some rare cutter restriction enzymes was performed. The resulting 
fragments were run on pulsed field gel electrophoresis (PFGE) and to complement this 
analysis a probe containing the marker z10985 was synthesised and hybridised to the 
Southern blots of these PFGE products. The cloning and sequencing of some of the PAC 
ends also helped to position the three PACs correctly. At this stage the Sanger Centre started 
the zebrafish genomic project and was prioritising the sequencing of genomic contigs. It was 
therefore decided to send them the three PACs for shotgun sequencing. In this way, It was 
hoped that the bulk of information generated by the restriction analysis and PAC-end 
sequencing could be confirmed by the complete PAC sequences.
3.3.3.1 Restriction analysis
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Figure 3.6. Pulsed Field Gel Electrophoresis of the Not I and Sal I digestion of PAC1, 2 and 3. It is 
clear that many bands have the same sizes for PACs 1 and 2. As an example, Sal I bands of 
around 25Kb and Not I/Sal I bands of the same size appear to be shared between PACs 1 and 2. 
All PACs share a 16Kb Not I band that corresponds to the PAC vector. (M) high molecular weight 
marker.
To detect some smaller fragments that might have run off the gel aliquots of the same digests 
were run on a 1% agarose gel. These results are presented in Figure 3.7 and show a number 
of fragments that were not visible in the PFGE results. In particular PACs 2 and 3 seem to 
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Figure 3.7. a) Not I and Sal I digestion of PAC1, 2 and 3 run on 1% agarose gel electrophoresis to 
detect fragments smaller than 10 Kb. (M) 1kb ladder, b) PAC3 digestion with Not I to visualise 
fragments smaller than 2Kb run on 1% agarose gel.
The interpretation of the size of each fragment showed in the Figures 3.6 and 3.7 is 
summarised in Table 4.
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Table 4. Summary of the fragment sizes from the gel products of the restriction digests with Not I 
and Sal I presented in Figures 3.6 and 3.7 Similar size bands between PACs have the same 
colour
Not I (kb) Sal I (kb) Not I / Sal I (kb)
PAC1 >50; 35; 16 38.5; 27.5; 19.3; 15; 11; 
5.5
27.5; 24.7; 19.3; 16; 15; 10; 5.5
PAC2 >48.5; 
<48.5?; 16
29.9; 27.5; 19.3; 18?;11; 
4.5
29.9; 27.5; 19.3; 16; 10; 4.5; 2.8
PAC3 >50; 24.7; 16; 
2; 0.75
>50; 22; 17.5; 10; 8.6; 4.5; 
3.2; 2.7
>50; 22; 16; 10; 8.6; 4.5; 2.7; 
1.8; 1.6
The total size of PAC1 according to the sum of all the Sal I fragments is 118.3 Kb which is 
only slightly smaller than the size given by the addition of all the Not I/Sal I fragments 119.5 
Kb. The same exercise for PAC2 indicates a much larger discrepancy between the total size 
calculated with the Sal I fragments (92.2 Kb) and the size given by the double digest (110 kb). 
In fact this discrepancy might be telling us that there is another Sal I fragment of around 18 Kb 
that has not separated from the 19.3 Kb fragment well enough for us to detect it. Consistent 
with this, the Sal I 19.3 Kb band is wider than the others suggesting that this might be the 
case. The same discrepancy happens with the sum of Not I fragments from PAC2. The wide 
>48.5 Kb fragment must be a double band formed by two fragments of slightly different sizes 
that did not separate well enough after electrophoresis. In relation to PAC3 the difference 
between the addition of Sal I fragments (118.5 Kb) and the double digest fragments (117.2) is 
very small, indicating that our estimate sizes are probably nearly correct. These estimates 
were assuming the larger fragments are 50 Kb however, these can be larger. Attempts to use 
a molecular marker that allowed estimation of fragments larger than 48.5 Kb were not
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successful. To enable construction of a restriction enzyme map, this digestion data was 
supplemented with Southern blot analysis and non-radioactive hybridisation presented in the 
next section.
3.3.3.2 Non-radioactive hybridisation and detection of genomic DNA
Hybridising a probe containing the marker z10985 (after excluding a region with a stretch of 
CA repeats) to a membrane obtained from the gel present on Figure 3.6 should tell us which 
bands contained this marker. After identifying the overlapping bands anchored by z10985 we 
expected to be able to make better predictions on which bands are also likely to contain the 















Figure 3.8. X-ray film with hybridisation of the probe containing the marker z10985 without CA 
repeats to the Southern blot of the gel presented in Figure 3.6.
 PA C 2 —   P A C S —
N S N/S M N S N/S
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Overlaying the x-ray film (Figure 3.8) to the original gel (Figure 3.6) allowed identification of 
the bands containing the marker z10985 (see Table 5).
Table 5. Identification of the Not I and Sal I restriction fragments that contain the marker z10985.
Not I Sal I Not I / Sal I
PAC1 35 Kb 38.5 Kb 24.7 Kb
PAC2 >48.5 Kb 29.9 Kb 29.9 Kb
PAC3 >50 Kb 22 Kb 22 Kb
Using all the mapping data available, plus knowledge of the cloning sites in the PAC vector 
(Not I present at both ends of insert and Sal I only at SP6 end) it was possible to suggest a 
map of the region covered by the three PACs (Figure 3.9). It is perhaps worth noticing that the 
vector backbone is 16 Kb long. This fragment is isolated when cutting with Not I but it is only 
cut at one end when Sal I is being used on its own. So, for instance in PAC 1 the last Sal I 
fragment on the right end side has around 40.7 Kb (24.7 plus 16) which I estimated as 38.5 
Kb in Table 4. In PAC 2 there is a sal I fragment of 18.8 Kb produced by the vector backbone 
plus the last 2.8 Kb mixed fragment. For PAC 3 it is possible to assume that the 18 kb Sal I 
fragment (estimated as 17.5 Kb in Table 4) is probably the result of the vector backbone plus 
the 1.8 Kb end fragment (see Figure 3.9).
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Figure 3.9. Map of the genomic region containing the three PAC inserts identified with the marker z10985. The fragments that hybridised to the probe 




This map is the only one consistent with all the data. The only ambiguity concerns the 
precise order of the Sal I fragments to the right of the 4.5 Kb Sal I fragment in PAC3. The 
sizes for PACs 1 and 2 are unambiguous. The order of PAC3 fragments right of the zone 
of overlap with PACs 1 and 2 was indeterminate, but became clear after sequencing of the 
contig.
3.3.3.3 End-cloning and sequencing of PAC inserts
The sizes of the cloned PAC-ends were checked with both Xba I and Not I restriction 
enzymes. It was expected to see four bands in each digest: two correspond to the PAC 
and PGEM-4Z vector backbones (16 kb and 2.7 Kb, respectively) and the other two bands 
for each of the PAC ends. However, the mapping data obtained in the previous section 
showed multiple Not I sites near one of the ends of PAC3. It was therefore possible that 
more than two bands might be found for PAC3 end-clones resulting from Not I sites 
contained in the PAC-end clone.
Gel electrophoresis of the Not l/Xba I restriction digests identified the size of the end- 
clones for each PAC (Figure 3.10). As expected PACs 1 and 2 had 4 fragments each and 
PAC3 had 6, from which 2 were Not I fragments. Table 6 summarises these fragment 
sizes and accounts for the Not I fragments present in PAC3.
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PAC1................ PAC 2-------- --PAC3- 1 Kb Hmdiil
Figure 3.10. PAC-end clones. 3 minipreps for PAC1, 4 to PAC2 and 2 for PAC3 were doubly 
digested with Not I and Xba I to identify the size of the PAC-end clones. PAC vector is 16Kb 
and PGem-4Z is 2.7Kb. 1KB ladders are flanking the gel and a Hind III ladder is shown on the 
right side of the gel.
Table 6. PAC end-clones. Fragment sizes produced by the Not I/ Xba I digestions shown on 
the Figure 3.10 (above). Not I fragments for PAC3 are shown in the gel from Figure 3.7b.
Xba I / Not I 
fragments 
(Kb)





PAC 3 5.5; 4.3 2; 0.75
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At this stage we had expected to identify unambiguously the right and left ends of each 
PAC on the restriction enzyme map presented in Figure 3.9 by making probes with each of 
the PAC end-clone fragments. This would be an independent confirmation of the genomic 
map that was presented before. However, in practice we chose an alternative strategy : 
the opportunity to have the contig sequenced by the zebrafish genome sequencing project 
was an attractive option. Thus, the PAC end-clones were sequenced for comparison with 
the Sanger Centre sequences. The end clones were sequenced with M13 primers. 
However, only the M13 Forward primer worked, since there is an unreported M13 reverse 
primer sequence in the middle of the PAC vector backbone. From directly sequencing 
PAC2 with T7 primer some sequence was obtained from the other end of PAC2. 
Comparisons between these PAC-end sequences with those released by the Sanger 
Centre are presented in the next section where a new map of the shd genomic region 
integrates all the sequencing data.
3.3.4. Identification of candidate loci for shd
As soon as the draft sequences for the three PACs became available from the Sanger 
Centre they were analysed with the NIX package for identification of potential coding 
sequences. The first PAC sequence to be completed was PAC3. This was fortunate 
because PAC3 injection rescued shd mutants and hence contained the shd locus. The 
Sanger Centre gave the following accession numbers to the three PAC sequences: PAC1 
AL592543; PAC2 AL672149 and PAC3 AL596022. These are available in the genome 
database and have sizes of 99495Kb; 15645Kb and 121941 Kb, respectively.
Clicking on the boxes/genes given in the NIX output (Figures 3.11-3.13) reveals details of 
the features identified. Here we summarise the most reliable features identified on each 
PAC. The output for PAC1 (Figure 3.11) indicated that it contains a novel gene similar to
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IVD (HUMAN P26440 Isovaleryl-CoA dehydrogenase, mitochondrial precursor (EC 
1.3.99.10) and a fragment of a novel gene similar to ITPKA (inositol 1,4,5-trisphosphate 3- 
kinase A) also known as IP3K. According to the Swissprot database the 5’ end of IP3K 
was situated at the end of the sequence counting from the upper strand (above the 
sequence line in thick green). The IVD predicted gene was localised around 63856-77362 
bp but it was on the opposite strand (below the sequence line). The EMBL database 
indicated that PAC1 and PAC3 overlapped from 85557 bp until the end of the PAC1 clone. 
This overlap included the IP3K predicted 5’ fragment which spread from around 90230- 
93334 bp according to the BLAST programs. The promoter region of this gene was 
estimated to start at position 78778 bp and the first exon at 80030 to 80476 (according to 
Genscan software).
The results released for PAC2 sequence (Figure 3.12) indicated the presence of a 
potential gene in the upper strand (above sequence line). The BLAST results showed this 
gene to be similar to human 1D- Myo-lnositol Trisphosphate 3-Kinase A (EC 2.7.1.127), 
also known as Inositol 1,4,5-Trisphosphate 3-Kinase, IP3K or IP3-kinase, the same gene 
as the identified fragment in PAC1. NIX identified four exons from this gene over which 
most programs agreed. Three exons were internal and one was predicted to be terminal. 
The first one spanned the sequence from 3924-4128 bp and had a probability of 0.968 of 
being correct. The second one was between 5889-5987 bp and had a probability of 0.665. 
The third one was between 8088-8159 bp with a 0.506 probability and the terminal one 
spread from 11846-12052 bp and had a probability of 0.651.
The PAC3 sequence (Figure 3.13) was predicted to contain two potential genes, one over 
a shorter region on the lower strand (below the sequence line) and another over a very 
large region on the upper strand (above the sequence line). The gene predicted on the 
lower strand was very similar to human 1D- Myo-lnositol Trisphosphate 3-Kinase A (EC 
2.7.1.127) and was also on the overlapping regions of the other two PACs. Once again,
CHAPTER 3
because several programs detected this gene it is considered a good prediction. The 
larger gene predicted on the upper strand of the sequence was similar to two human 
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Figure 3.11. NIX output for the analysis of PAC1 sequence. The programs run in this package 
are listed on the left side. They are grouped by colour according to similar purposes. The blue 
colour codes for programs that look for potential genes. The different shades of blue indicate 
the quality of the prediction. The more intense the blue the better the prediction. The 
rectangular boxes indicate potential exons linked by lines if belonging to the same predicted 
gene. If different programs agree in predicting one given exon it makes it a very good 
prediction. Clicking on the boxes on-line will give the raw output produced by each program. 
Clicking on the lines will give information on the start and end positions of that predicted gene. 
The green colour is given for the BLAST programs Swissprot and TREMBL. It indicates that 
the coding regions predicted by the programs in blue are actually similar to sequences already 
present in the databases. The genes identified in this way are indicated in black. It is possible 
to access the raw BLAST results or a graphical view of the BLAST matches. Other BLAST 
programs in yellow, red and black include different EMBL databases such as mRNA, EST, 
HTG (High Throughput Genome Sequences). There are also BLASTs for the STS EMBL 
database, E. coli database, and a vector database. The sequence orientation is the same as 
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Figure 3.12. NIX output for the analysis of PAC2 sequence. Programs on the left are grouped 
by colour depending on their purpose. Rectangular boxes/sticks that are vertically aligned 
mean that different programs agree over that particular feature. See legend from Figure 3.11 
for a detailed description of the colour code. The sequence orientation is the same as used in 
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Figure 3.13. NIX output for the analysis of PAC3 sequence. Programs on the left are grouped 
by colour depending on their purpose. Rectangular boxes/sticks that are vertically aligned 
mean that different programs agree over that particular feature. See legend from Figure 21 for 
a detailed description of the colour code. The sequence orientation is the opposite to the one 




BLASTs between two sequences (http://www.ncbi.nlm.nih.gov/blast/bl2seq/bl2.html) were 
performed to confirm the overlapping regions between PACs, localise the PAC-end 
sequences (see section 3.3.3.3), and most importantly to confirm where the marker 
z10985 (accession number: G39855) mapped.
Based on all these results it was possible to construct a map showing how the three PACs 
overlapped based on the sequencing results (Figure 3.14). The first feature that stood out 
from this new analysis was the size of PAC2. The Sanger Centre PAC2 sequence was 
much shorter than the insert size deduced by restriction enzyme analysis in section 3.3.3.2 
in this Chapter. The estimated size of PAC2 based on restriction fragment analysis with 
Not I and Sal I was around 94000 bp compared to 15645 bp of released sequence. Apart 
from this aspect both maps are highly consistent, both in terms of the sequences obtained 
and the observed/predicted restriction fragments.
As expected, the PAC end-sequences available mapped to the ends of the PACs next to a 
Xba I site (see section 3.2.3. for explanation). Their positions further confirmed the overlap 
between the PACs (see Figure 3.14). It is important to notice that the left end-sequence of 
PAC2 mapped to the positions 31345-31971 bp of PAC1 supporting the idea that the 
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Figure 3.14. Map of the shd genomic region containing the three PACs based on NIX analysis and end-sequencing results. The red colour marks the 
position of the marker z10985. Orange triangles sign the positions of the end-sequences and their correspondent positions on the other PACs are also in 
orange numbers. The blue dotted line represents the region of PAC2 that was absent from the Sanger Centre data. The rectangular shapes represent 
exons of predicted genes, IP3K (green) and ALK/LTK (pink). The arrows show the orientation and beginning of the predicted transcription site. Numbers
indicate genomic positions in base pairs (bp).
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Since only PAC3 injection could rescue the shd '1' phenotype (see section 3.3.2) we 
focused on the two genes predicted to be in this clone. Whether PAC3 contained the full 
IP3K gene is ambiguous because the first exon was not detected as such by any NIX 
program except the HMMgene package. This ambiguity is exemplified by considering the 
prediction of the Fgenes and HMMgene softwares. The IP3K predicted gene contained 
either six or seven exons spread from 101479-117276 bp (Fgenes) or from 97541-120209 
bp (HMMgene). The probability given for each of the exons and their boundaries also 
varied between programs. Similarly, the BLAST results were not very robust either; the 
prediction was only marginal and referred to a fragment that ranged from 97547-117276 
bp.
In contrast, the presence of a full-length ALK/LTK gene on PAC3 was more robustly 
predicted although the quality of these predictions again varied for each predicted exon. 
Nevertheless, most programs seemed to agree that the gene has around 20 exons 
covering a genomic region starting around 32614 bp and ending at 89061-90032 bp.
There were identical BLAST results from Swissprot and EMBL databases recognising a 
good similarity to the ALK and LTK human genes. The genomic region identified by these 
databases spread from 41203-89804 bp meaning that the predicted gene probably has a 




We chose to use PAC injections of mutant embryos as a screen to narrow down the 
genomic region of interest. At the time there were no published examples of this approach, 
so one concern was whether we could obtain broad distribution of such a large construct in 
the embryo. There were at least two factors to take into account; the first being the mosaic 
distribution of the injected genomic DNA in relation to the size of the target population of 
cells. The second factor was the concentration of the genomic DNA with respect to the 
number of cell divisions that happen from early blastomere until the iridoblast formation.
After a few trials the volume injected in this work was around 10 nl per embryo at a 
concentration of 50pg/nl which results in 500 pg of genomic DNA per embryo. This 
concentration seemed to be the minimum required to produce rescue of iridophore cells at 
72 hpf. floating head (flh) mutants (Yan et al., 1998) were also rescued with genomic DNA 
injections but the authors do not mention the volume injected into each embryo, 
nevertheless the concentration that worked better was also 50pg/nl and the percentages of 
rescued embryos are comparable. The fact that the flh phenotype is visible at 22 hpf 
compared to the much later time (72 hpf) for scoring shd mutants may account for their 
slightly better results. In another study where genomic microinjections were used to rescue 
mutant phenotypes the concentrations used ranged from 40-60 pg/nl (no mention of 
volume injected again) and the phenotype was scored at 48 hpf (Guo et al., 2000). This 
last study did not provide percentages of rescue either. Finally, there was one other work 
(Lyons et al., 2002) where embryos were injected with only 100 pg of BAC DNA. This 
amount was enough to rescue the bloodless phenotype of vlad tepes at 21 hpf (Lyons et 
al., 2002). Perhaps this can be explained by the number of blood cells at 21 hpf being 
much higher than the number of iridophore cells at 72 hpf.
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The two genomic maps presented in this Chapter were generated by applying two 
completely independent approaches, restriction fragment analysis and sequencing, and 
gave very similar results. This result strongly validates the genomic analysis of this region. 
The sizes of the PAC clones were slightly overestimated by the restriction analysis 
approach, but the only major disagreement in size refers to PAC2. It is believed that the 
reason for the huge discrepancy in size of the PAC2 insert was probably a deletion that 
occurred in the clone used for sequencing. The facts that (1) the marker z10985 is not 
present in the PAC2 sequence and (2) the left PAC2 end-sequence overlaps with a region 
around position 31 Kb of PAC1 (see Figure 3.14) strongly support this argument. Taking 
this left end as the start of PAC2 the correct insert size would be close to 80 Kb or 96 Kb 
including the vector. This size is within the predicted size range of 92 -110 Kb proposed 
from the restriction analysis alone.
Combining the results from the genomic rescue with PAC3 with the data from the genomic 
maps it is possible to identify a high probability region within which the shd locus is likely to 
lie. PAC2 did not rescue the shd mutant phenotype therefore arguing strongly against 
IP3K as a candidate. However, conceivably, PAC3 might have a functional IP3K gene, 
whilst that in PACsl and 2 is truncated. This, however, seems unlikely because NIX 
packages were unable to find a high probability initial exon or promoter region for IP3K in 
PAC3. Such a region was only present in PAC1 starting around position 78778 bp.
In contrast, the other strongly predicted gene within the critical region was a much better 
candidate. This gene encodes a receptor tyrosine kinase (RTK) similar to both mammalian 
ALK and LTK. Further support for the proposition that this RTK might be shd arises from 
consideration o f : a) gene size; b) synteny; c) gene function. In Chapter 2 we concluded 
that the marker z10985 and the shd locus lay about 74Kb apart. Whilst the marker lies 
within IP3K, the 5’end of the ALK gene lies around 80 Kb away (see map on Figure 3.14).
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In the Discussion of Chapter 2 it was argued that there was good synteny between the 
region where shd maps on LG 17 and a fragment of human chromosome 2p13 - 2p25. It 
happens that human ALK lies within this region (position 2p23) in support of its candidacy. 
LTK maps to human chromosome 15q15.1-15q21.1. So far there are only two zebrafish 
genes on LG 17 that have potential orthologues in human Chromosome 15. However, one 
of these is IVD, a gene predicted to be in PAC1 and therefore very close to the shd critical 
region. Consequently, syntenic arguments support the identity of the PAC3 RTK as an 
orthologue of either human ALK or human LTK. These arguments, however, also apply to 
IP3K as this gene maps to the same human chromosome as LTK (15q15.1-15q21.1). We, 
therefore believe that this region of LG 17 has genes that are syntenic with human 
chrmosomes 2 and 15, which does not help us find the right candidate for the shd locus.
Both ALK and LTK belong to the insulin receptor subfamily of receptor tyrosine kinases 
and have 57% amino acid identity and 71% similarity (Morris et al., 1997). This family 
includes other RTKs with well known developmental functions, such as the Insulin growth 
factor receptor I (Igf1 r), mainly involved in embryonic and post-embryonic growth 
e.g.(Maitre et al., 1995; Pera et al., 2001) but also with an anti-apoptotic effect in 
tumorigenesis (Kuroda et al., 1998).
ALK was first identified as a fusion product with the Nucleophosmin gene in the 
t(2;5)(p23;q35) translocation in anaplastic large cell lymphoma (ALCL) (Morris et al.,
1994). Therefore the majority of the work done on ALK explores the role this gene plays in 
cancer (e.g. Agarwal et al., 2002; Au and Liang, 2002; Bai et al., 2000; Bridge et al., 2001; 
Cook et al., 2001; Duyster et al., 2001; Evens and Gartenhaus, 2003; Gascoyne et al., 
1999; Greenland et al., 2001; Hernandez et al., 2002; Pulford et al., 2001; Zamo et al., 
2002). Not much is known about the normal function of ALK except that its murine 
transcripts are confined to the nervous system and include several thalamic and 
hypothalamic nuclei; the trigeminal, facial, and acoustic cranial ganglia; the anterior horns
i l l
CHAPTER 3
of the spinal cord in the region of the developing motor neurons; the sympathetic chain; 
and the ganglion cells of the gut (Morris et al., 1997). It is noteworthy that many of these 
tissues actually belong to the peripheral nervous system and contain cells derived from the 
embryonic neural crest. However, there are no reports of ALK expression in melanocytes, 
the only type of pigment cell present in mammals.
The LTK gene, also known as protein tyrosine kinase-1 or TYK1, was first isolated from a 
mouse pre-B lymphocyte cDNA library and Northern analysis revealed expression of the 
gene in thymus, spleen and kidney (Ben-Neriah and Bauskin, 1988). The human LTK 
gene product was identified in placenta and hematopoetic cell lines (Kozutsumi et al., 
1993). Toyoshima et al (Toyoshima et al., 1993) cloned a set of cDNAs representing 
differently spliced human LTK mRNAs. These cDNAs predicted a truncated receptor 
protein that lacked the tyrosine kinase domain and a soluble receptor protein that had 
neither a transmembrane nor a tyrosine kinase domain. A cDNA clone containing the 
complete open reading frame demonstrated that the extracellular domain of the receptor 
was larger than previously predicted by Ben-Neriah (1988). Thus, the LTK gene produces 
not only the putative receptor tyrosine kinase for an unknown ligand but also multiple 
protein products that may have different functions. Recently, however, it has been 
suggested that LTK may function in a survival signalling pathway (Honda et al., 1999; 
Ueno et al., 1995; Ueno et al., 1996).
Although it is possible to state, based on the results from this Chapter, that the RTK similar 
to both ALK and LTK is the most likely candidate for the shd locus present in PAC3. It will 
be crucial to test this prediction by doing laboratory work on these two candidate genes. 










In the previous Chapter an ALK/LTK-related Receptor Tyrosine Kinase (RTK) was 
introduced as a candidate for the shd gene product. These structurally similar RTKs 
belong to the insulin receptor superfamily of RTKs (also known as type II RTKs). Together, 
based on their primary structure, they form a novel subfamily of the Insulin receptor family 
of RTKs (Iwahara et al., 1997; Robinson et al., 2000). A wide range of processes involving 
intercellular communication are mediated by RTKs and their signalling pathways. The 
growing list of processes regulated by these receptors across the phylogenetic tree is very 
broad including the induction of cell fates, guidance of cell and axon migration, cell 
proliferation, differentiation and survival (Loren et al., 2001).
RTKs are composed of three domains: an extracellular ligand-binding domain, a single 
membrane-spanning domain and a cytoplasmic catalytic domain displaying the highest 
level of conservation (Yarden and Ullrich, 1988). Ligand binding to the extracellular domain 
induces activation of the kinase on the cytoplasmic side, which initiates the intracellular 
signalling. The activated RTKs phosphorylate themselves and the cytoplasmic substrates, 
leading to activation of a number of downstream signalling molecules, and ultimately 
inducing changes in gene expression and the phenotypic state of the cell (Fantl et al.,
1993; Van der Geer et al.,1994). Phosphorylation of distinct tyrosine residues of the 
activated receptor creates binding sites for Src homology 2 (SH2) and phosphotyrosine 
binding (PTB) domain-containing proteins. Molecules recruited via these binding motifs are 
either enzymes that are activated by subsequent tyrosine phosphorylation, such as Src 
and phospholipase Cy, or adaptor molecules that link the RTK activation to downstream 
signalling pathways. One important adaptor protein complex is the Shc-Grb2-Sos complex 
that couples RTKs via Ras to the extracellular regulated kinase (ERK) /mitogenic-activated
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protein (MAP) kinase pathway which is crucial for RTK-induced cell proliferation (Zwick et 
al., 2001).
RTKs are not only key regulators in normal cellular processes but are also critically 
involved in the development and progression of human cancers and other hyper- 
proliferative diseases when they become constitutively activated. This can happen by 
several processes including deletions or mutations within the extracellular region or 
alterations of the catalytic domain, especially the ATP-binding motif. Mutations in the 
transmembrane domain have also been shown to lead to ligand-independent kinase 
activation (Zwick et al., 2001).
ALK (Anaplastic Lymphoma Kinase) owes its name to the type of human cancer where it 
was first identified (Morris et al., 1994). A translocation fused the ALK catalytic domain to 
the Nucleophosmin (NPM) gene which resulted in a chimeric constitutively activated 
tyrosine kinase that is expressed in a deregulated and ectopic manner, both in terms of 
cell type (lymphoid) and cellular compartment (nucleus and cytoplasm) (Ladanyi, 2000). 
Since then other types of chimeric oncoproteins involving ALK have been found such as, 
TPM (tropomyosin) 3 and 4 -ALK present in inflammatory myofibroblastic tumor (IMT) 
(Ladanyi, 2000). Fusion of the ALK gene to the clathrin heavy chain gene, CLTC, was 
found more recently in IMT (Bridge et al., 2001) and TRK-fused gene (TFG)-ALK was 
detected in other anaplastic lymphomas (Hernandez et al., 2002). Altogether, there have 
been reports of eight different ALK chimeric fusions that generate oncoproteins present in 
either IMT or anaplastic lymphomas (Bridge et al., 2001). In addition to this list it seems 
that ALK alone also has the potential to be involved in the genesis of highly malignant 
cancers of the brain such as glioblastoma multiforme (Powers et al., 2002). The full-length 
mammalian ALK has been shown to be expressed in the developing nervous system and 
therefore by virtue of its expression pattern is implicated in nervous system physiology 
(Morris et al., 1997).
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Because the normal function of ALK remains unknown the downstream signalling 
molecules identified so far were all in cancer situations. The mitogenic effect of NPM-ALK 
has been attributed to the activation of the PLCy pathway (Ladanyi, 2000). On the other 
hand the anti-apoptotic effect of the same fusion protein seems to utilise the PI3- 
kinase/Akt pathway as a result of the binding of the growth factor pleiotrophin (Ladanyi, 
2000). This seems also to be the case in glioblastomas where the pleiotrophin-ALK 
signalling axis has been reported to have a rate -limiting factor in their growth (Powers et 
al., 2002). Stoica et al. (2002) has recently identified Midkine, a pleiotrophin homologue, as 
a growth, survival, and angiogenic factor during tumourigenesis that signals through the 
ALK receptor. The signalling transduction pathways involving Midkine-ALK were the anti- 
apoptotic PI3-kinase/Akt and the MAP-kinase pathways. Midkine was reported to bind to 
the ALK ligand binding domain with lower affinity than pleiotrophin in cultured cell lines 
(Stoica et al., 2002).
The orphan receptor LTK (Leukocyte Tyrosine Kinase) was the alternative candidate 
orthologue for the shd gene. Literature reports on LTK are scarce, perhaps because its 
clinical relevance is not as crucial as the ALK oncogene. LTK appears to utilise two main 
substrates; insulin receptor substrate 1 (IRS-1) and She. She mediates the interaction 
between Grb2 and Sos through tyrosine 862 at the carboxyl-terminal domain of LTK. IRS-1 
phosphorylation, on the other hand, is done at tyrosine 485 at the juxtamembrane domain 
of LTK. Both of these tyrosines are located in the NPXY motifs that were identified as the 
consensus sequence of binding sites for the phosphotyrosine binding domains (PBT) of 
She and IRS-1. While the phosphorylation of both these tyrosines activates the Ras 
pathway generating mitogenic signals involved in cell proliferation, the phosphorylation of 
tyrosine 485, crucial for IRS-1 activation, generates a cell survival signal (Ueno et al.,
1997; Ueno et al., 1996). In summary, both ALK and LTK have the potential to mediate cell 




Other RTKs have been identified in zebrafish pigment cell proliferation and survival 
(Parichy et al., 2000b; Parichy et al., 1999). The zebrafish c-kit gene (encoded by the 
pigment pattern locus sparse) has a role in embryonic melanophore migration and survival. 
Fms, its closest known homologue (encoded by the pigment pattern locus panther/pfeffei) 
has been implicated in the maintenance (survival) of cells of the xanthophore lineage and 
therefore indirectly involved in the formation of the correct pattern of melanophore stripes 
in the adult zebrafish. Both these genes encode type III RTKs which belong to the platelet- 
derived growth factor receptor group (PDGFR) and are characterised for their extracellular 
Ig- like domains. On the other hand, both ALK and LTK belong to the type II RTKs or the 
insulin RTK subfamily. In this group we see very different structures of the receptors 
mature forms, although each is initially translated as a single polypeptide produced from a 
single gene locus. For example, the insulin and the insulin-like growth factor-1 receptors 
possess a disulfide-linked heterotetrameric a2 (32 structure, the MET and RON RTKs exist 
as a(5 disulfide-linked heterodimers, and the mature TRK RTKs (TRK-a, -B, and -C) are 
present in the cell membrane as monomeric proteins (Barbacid, 1993; Gaudino et al.,
1994; Fantl et al., 1993). Like the TRK RTKs, ALK and LTK are both monomeric proteins 
(Morris et al., 1997).
In this Chapter we utilise expression analysis on wild-type and shd mutant embryos and 
antisense technology using morpholino oligos to demonstrate molecularly that the shd 
gene corresponds to an ALK homologue as predicted in the previous Chapter by genomic 
gene finding analyses. We discuss whether shd is a common ancestor of ALK and LTK 
and we start focusing on the likely role of shd in the iridophore lineage.
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4.2 Materials and Methods
4.2.1 Isolation of the complete ALK/LTK cDNA
4.2.1.1 Fish husbandry
Wild-type and mutant embryos were obtained from the zebrafish facility at the University of 
Bath, Department of Biology and Biochemistry. Crosses were set up as described in 
Westerfield (1995), eggs were collected from successful matings on the following morning. 
After rinsing, eggs were transferred to a Petri-dish containing embryo medium (5mM NaCI, 
0.17mM KCI, 0.33mM CaCI2, 0.33mM MgS04, 10‘5% methylene blue to suppress fungal 
growth). The embryos were raised at 28.5°C and staged according to Kimmel et al. (1995). 
Embryos to be live mounted or sorted were anesthetized in a 0.2% solution of 3- 
aminobenzoic acid ethyl ester (“Tricaine”, Sigma) prior to analysis.
4.2.1.2 Primer design
Based on the results from Chapter 3 it was decided to design primers that amplified a 
region around 1 Kb of the predicted ALK/LTK. This product would be cloned and 
sequenced and it would then be used to make an in situ riboprobe. The transcripts would 
reveal whether there was any neural crest expression pattern. According to our results 
from the cell autonomy study presented in Chapter 5 shd gene function was predicted to 
be cell autonomous and therefore we were expecting to see expression of the shd gene in 
iridoblasts or their precursors. When designing primers only exons that were given high 
probability by most programs included in the NIX package were considered. One important 
consideration was that the amplified region should not contain the tyrosine kinase catalytic
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domain of the RTK gene. To avoid this conserved region the whole of the zebrafish 
predicted ALK/LTK cDNA sequence was compared to both human ALK and LTK genes 
using the BLAST application (www.ncbi.nlm.nih.gov/blast/bl2seq/bl2.html). After excluding 
these regions and finding high probability exons, primers were designed with the use of 
two programs. First, suitable primer pairs for PCR amplifications were suggested by 
Primer3 (http://waldo.wi.mit.edu/cqi-bin/primer/primer3.cqi/primer3 www.cqi). Primer pairs, 
each containing at least 1-2 GC clamps at the 3’end were then analysed for hairpins, 
dimers, crossdimers and melting temperature (Tm) with a second program, NetPrimer 
(http://www.premierbiosoft.com/netprimer/netprimer.html). Only primers with a rating of at 
least 80 (out of 100; NetPrimer) were selected. Primers were ordered from INVITROGEN 
Lifetechnologies with standard purification and 50 nmol synthesis scale. The primers 
obtained for the amplification of 1 Kb fragment from the predicted zebrafish ALK/LTK were 
the following:
Forward shdl: GTGACAGTGCCTACCGAAACA 
Reverse shdl: ATGATGGTGGACGAGCGAAT
4.2.1.3 Isolation of total RNA using Tri Reagent
Approximately 200 wild-type embryos at 24, 28 and 48.5 hpf were dechorionated using 
watchmaker forceps, killed by an overdose of the anesthetic Tricaine and homogenised 
thoroughly in 1 ml Tri Reagent (Sigma). Tri Reagent is mixture of guanidine thiocyanate 
and phenol in a mono-phase solution that effectively dissolves DNA,RNA and protein on 
homogenisation or lysis of tissue samples. After adding chloroform and centrifuging, the 
mixture separates into three phases: an aqueous phase containing the RNA, the 
interphase containing DNA and an organic phase containing proteins. These components 
can then be isolated after separating the phases.
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For the isolation of RNA the homogenates were spun at 13000rpm for 10 minutes at 4°C, 
the supernatant was removed to a fresh tube and the sample allowed to stand for 5 
minutes at room temperature. 0.2ml chloroform was added, the tube shaken vigorously 
and left to stand for 2-15 minutes at room temperature. After centrifugation at 13000rpm 
for 15 minutes at 4°C the aqueous phase containing RNA was transferred to a fresh tube, 
1/10 volume of isopropanol was added, the tube was inverted a few times and allowed to 
stand at room temperature for 5 minutes. The sample was spun again at 13000rpm for 10 
minutes at 4°C and an equal volume of isopropanol added to the transferred supernatant. 
After the tube was inverted again and left to stand for 5-10 minutes at room temperature 
the precipitated total RNA was pelleted at 13000rpm for 10 minutes at 4°C. The 
supernatant was removed, the pellet washed with 1ml 75% ethanol by vortexing and the 
sample respun at 13000rpm for 5 minutes at 4°C. After removal of all the ethanol, the 
pellet was dried at room temperature for approximately 5 minutes and redissolved in 30pJ 
of fresh milliQ water. The RNA was frozen at -80°C until necessary. The quality of the total 
RNA preparation was assessed by using a spectrophotometer (Beckman DU530) (OD 
260nm/280nm should be around 2.0 for pure RNA). The concentration of the total RNA 
was calculated on the basis that an OD (260nm) =1 translates in a concentration of 40 
ng/ml of RNA.
4.2.1.4 Reverse transcription using random hexamers
1-5|ig of total RNA was combined with 250jnl g random hexamers (Promega) and the 
volume made up to 12|xl with fresh milliQ water. The sample was heated to 70°C for 10 
minutes, chilled on ice, then 4jnl of 5x reaction buffer (Gibco BRL), 2jil 0.1M DTT and 1̂ 1 
10mM dNTPs mix were added. After mixing the reaction, samples were incubated at 25°C 
for 2 minutes and 1 | L i l  (200U) Superscript II (Gibco BRL) was added. Tubes were 
incubated for another 10 minutes at 25°C. All reactions were transferred to 42°C for 50
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minutes followed by 15 minutes at 70°C to inactivate the reverse transcriptase. Then 2U 
RNAse H (Promega) was added and reactions incubated at 37°C for 20 minutes. The 
quality of the cDNA was primarily tested with primers known to work well on other 
previously synthesised cDNAs.
4.2.1.5 Polymerase Chain Reaction (PCR)
For all different PCR reactions, PCR conditions (MgCI2, dNTP and primer concentrations) 
were optimised with a scheme of 12 reactions varying all parameters at the same time.
The PCR reaction that worked for the primers forward and reverse shd 1 was composed of 
1 jul of cDNA, 4jal of 10x buffer (Thermoprime), 4jnl Mgcl2 at 20mM, 4|J dNTPs mix (Gibco) 
at 2.5mM, 4fjJ of primers at 1pM, 0.8|xl of Taq (Thermoprime), and 22.2 jLtl of MilliQ water. 
The PCR program that was used for this amplification was a touchdown programme with 
the first 10 cycles ramping from 65°C to 55°C in 10 seconds and then 30 cycles at 55°C. 
Denaturation step was at 92°C for 10 seconds and extension at 72°C for 4 minutes. This 
amplification was used for four cDNA time points; 24, 28, 48.5 and 63 hpf. The last time- 
point cDNA was kindly donated by S. Elworthy in the lab.
4.2.1.6 Cloning of PCR products directly into TOPO vectors
The PCR product obtained with the 48.5 hpf cDNA was cloned into TOPO TA vector 
(Invitrogen). The map is available at www.invitrogen.com. The cloning procedure followed 
the kit instructions. A cloning reaction was composed of 4jnl of fresh PCR product, 1 jllI of 
salt solution and 1pl of vector. These 6 jllI were mixed gently and left at RT for 30 minutes. 
Then the cloning reaction was kept on ice until the one shot chemical transformation that 
followed. Bacteria were thawed on ice and 2fil of the cloning reaction were added to the 
bacteria tube and mixed briefly. These were incubated for 5-30 minutes on ice after which
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the bacteria cells were heat shocked for 30 seconds at 42°C, without shaking, and 
returned to ice.
Meanwhile the SOC medium (2% Tryptone, 0.5% yeast extract, 10mM NaCI, 2.5 mM KCI, 
10mM MgCI2, 10mMMgSO4, 20mM glucose) was thawed until room temperature was 
reached and selective Ampicillin LB plates were warmed at 37°C for 30 minutes. 250jJ of 
SOC medium at RT were added to the tube containing the bacteria with the cloning 
reaction. This transformation tube was then shaked for 1 hour at 37°C at 200rpm. 20 and 
50jllI from each transformation were spread on two pre-warmed selective plates and 
incubated over night at 37°C. Colonies were streaked the next day and grown in 5ml of 
selective LB for further analysis. Minipreps were made with Wizard plus Kit (Promega) 
according to the Kit instructions. 50jil restriction digestions were done with EcoRI to 
release the inserts and check for their sizes on a 1% agarose gel.
4.2.1.7 Automated sequencing using BigDye terminator chemistry
The sequencing of plasmid inserts was carried out by Dr. Paul Jones (Sequencing Core 
Facility, University of Bath) on an ABI DNA sequencer using BigDye terminator chemistry. 
For sequencing, typically 300-500ng plasmids were combined with 10pmoles of primer or, 
alternatively, 3-1 Ong PCR product (approximately 500bp) with 5pmoles of primer in 6jjJ 
total volume. The resulting sequence files were viewed with the Chromas viewing 
programme. Sequences were then blasted against the NCBI databases to compare the 
cDNA clones with those predicted by the NIX package.
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4.2.1.8 In situ hybridisation with zebrafish 1200 bp clone
4.2.1.8.1 Preparation of Dig labelled RNA in situ probe
After checking the orientation of the insert approximately 10pig of plasmid containing the 
1200 bp clone of interest was linearised with 50U of restriction enzyme Spe I (Promega) in 
a total volume of 100^1. An aliquot of the reaction was loaded on a 1% agarose gel to 
check for complete digestion. The remaining sample was purified using the QIAquick PCR 
Purification Kit (Qiagen) and the concentration of the purified linearised plasmid estimated 
by comparison to a quantitative ladder. Probes were synthesised using the Dig RNA 
Labelling Kit (Boehringer/Roche) as described below.
In a 20|ul reaction 1-2|ig of linearised plasmid was combined with 1pJ 20x Dig-NTP 
labelling mixture, 2jxl 10x transcription buffer, 1 jul RNAse inhibitor and 2jul RNA 
polymerase. T7 RNA polymerase was used to create an antisense RNA probe. After 
incubation at 37°C for 2 hours, 1̂ .1 aliquot was kept at -20°C. 1 jllI RNAse-free DNAse was 
added to the remaining reaction. The sample was incubated at 37°C for 15 minutes, then 
15jil 5M Ammonium acetate (Ambion), 75(il absolute ethanol and 1.5^1 seeDNA 
(Amersham) were added. The RNA was precipitated on ice briefly, spun at 13000 rpm for 
15 minutes at 4°C, the pellet washed with 500jnl 70% ethanol, air dried for 1 minute after 
carefully removing all traces of ethanol and redissolved in 20jil fresh milliQ water. Again, a 
1 fil aliquot was removed and compared to the one kept earlier before DNAse treatment on 
a 1% agarose gel. Before storing the RNA probe at -80°C 80pil formamide (Sigma) was 
added. As a starting point for in situ hybridisation 1̂ 1 of probe was diluted in 200pil of 
hybridisation mix (50ml hyb mix contains 25ml formamide, 12.5ml 20xSSC, 0.5ml 5mg/ml 




4.2.1.8.2 In situ hybridisation on whole mount zebrafish embryos
Digoxigenin labelled RNA was detected with alkaline phosphatase conjugated anti-Dig 
antibody. To visualise labelled transcripts NBT/BCIP (Boehringer/Roche) was used as 
colour substrate in the alkaline phosphatase reaction.
Embryos from a cross between shd ty82/+ carriers were used at the following stages: 22, 24, 
30, 48,72 hpf. Staging was done according to Kimmel et al. (1995) and embryos were 
always dechorionated if they were older than 24hpf, anesthetised and fixed in 4% 
paraformaldehyde / PBS (0.8% NaCI, 0.02% KCI, 0.02M P04pH7.3) for at least 24 hours 
at 4°C. Embryos older than 24hpf were incubated in a 0.003% phenyl-2-thiourea (PTU) 
solution to inhibit melanin sinthesis prior to fixation (Westerfield, 1995). This step 
prevented melanisation of melanophores which would obscure the detection of transcripts.
Embryos were dehydrated by washing 3x5 minutes in methanol, 1x10 minutes in methanol 
and then stored at -20°C for a minimum of 2 hours or until needed. Embryos were 
rehydrated by washing 5 minutes in 75% methanol/25% PBS, 5 minutes in 50% 
methanol/50% PBS, 5 minutes in 25% methanol/75% PBS and finally 4x5 minutes in PBT 
(0.1% Tween20 in PBS).
To improve the penetration of the probe, embryos between 18-somite and 22-somite 
stages were digested in a solution containing 10pg/ml proteinase K in PBT for 5 minutes, 
24hpf embryos were treated for 15 minutes, 30hpf-48hpf embryos for 30 minutes and 
embryos up to 72hpf for 1 hour. Embryos were then refixed in 4% paraformaldehyde/ PBS 




Embryos were hybridised in a minimum of 200pl of a 1:200 dilution of the probe and 
incubated at 65°C overnight. The probe was saved and stored at -20°C for re-use. To 
wash away non-specifically bound probe, embryos were first rinsed in hybridisation mix 
(HM), followed by 10 minute washes at 65°C with each of 75% HM/25% 2xSSC, 50% 
HM/50% 2xSSC, 25% HM/75% 2xSSC and 2xSSC in turn. Two high stringency washes at 
65°C in 0.2xSSC for 30 minutes each were performed, followed by 10 minute washes at 
room temperature in each of 75% 0.2xSSC/ 25% PBT, 50% 0.2xSSC/50% PBT, 25% 
0.2xSSC/75% PBT and PBT.
Blocking of the embryos was done at room temperature in PBT/2% sheep serum/2mg/ml 
BSA for 2-5 hours and incubation with the appropriate antibody (anti-Dig diluted 1:5000 in 
block solution) overnight at 4°C. The antiserum was discarded and the embryos rinsed 
once in PBT, then washed 6x15 minutes in PBT and 3x5 minutes in NBT/BCIP buffer 
(100mM TrisHCI pH 9.5, 50mM MgCI2, 100mM NaCI, 0.1% Tween20 in milliQ water). 
NBT/BCIP stain solution was freshly prepared by dissolving one NBT/BCIP tablet 
(Boehringer/Roche) in 10ml milliQ water. Embryos were stained in the dark for up to 48 
hours and the reaction then stopped by washing the embryos in PBT several times. To 
improve the optical clarity of stained embryos they were transferred to 50% glycerol/50% 
PBS overnight or a few hours prior to inspection under an MZ12 dissecting microscope 
(Leica). For a more detailed analysis and for documentation the Eclipse E800 microscope 
(Nikon) with DIC optics was used.
4.2.1.9 RACE-PCR
RACE-PCR (Rapid Amplification of cDNA Ends-Polymerase Chain Reaction) was carried 
out using the Clontech SMART (Switching Mechanism At 5’ end of RNA Transcript) RACE 
cDNA Amplification Kit. This method was used in order to amplify the zebrafish ALK/LTK- 
like cDNA ends. It was planned that by designing new primers in these ends, a Long
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Distance PCR could then be performed to amplify the reminder of the cDNA. (primers are 
indicated in alignment 1 of the Appendix).
First, 5’RACE cDNA and 3’RACE cDNA were synthesised by combining 1 jug of total RNA 
from 48.5 hpf wild-type embryos with 1pl 5’-CDS primer or 3’-CDS primer respectively and 
1pl SMART II (5’RACE cDNA reaction only). Supplied sterile water was added to a final 
volume of 5pil, the reactions incubated at 70°C for 2 minutes and cooled on ice for 2 
minutes. After spinning the tubes briefly to collect the contents, 2pl 5x First-Strand buffer, 
1̂ 1 20mM DTT, 1pl 10mM dNTP mix and 1pl (200u) Superscript II (Gibco BRL) reverse 
transcriptase were added. Reactions were incubated at 42°C for 90 minutes, diluted with 
1 OOjlxI Tricine-EDTA buffer supplied with the kit and heat treated at 72°C for 7 minutes.
RACE PCR reactions were set up by combining 2.5pl 5’RACE or 3’RACE cDNA with 5pl 
10x UPM (universal primer mix), 1pl 10pM 5GSP (5’gene specific primer) or 3GSP (3’ 
gene specific primer), 5jnl 10x Reaction Buffer, 1pl 10mM dNTP mix, 1pl 50x Advantage 2 
Polymerase Mix (Clontech) and 34.5pl PCR-grade water. The gene specific primers that 
succeeded were designed based on the initial and terminal predicted exon sequences by 
the NIX package. Other, more internal, primers were used without success. It was 
therefore decided to try to amplify smaller fragments closer to the ends of the cDNA (for 






These were meeting the best requirements to use the SMART technology with Tm> 65°C, 
number of nucleotides between 23 and 28 and 50-70% GC content. A MJ Research PTC- 
DNA Engine PCR machine was used. Reactions were subjected to 5 cycles of 94°C for 10 
seconds, 72°C for 3 minutes, then 5 cycles of 94°C for 10 seconds, 70°C for 10 seconds, 
72°C for 3 minutes, then 30 cycles of 94°C for 10 seconds, 68°C for 10 seconds, 72°C for 
3 minutes followed by a final extension step at 72°C for 10 minutes. 5fil of each reaction 
were run out on a 1% agarose/ethidium bromide gel and examined using an ultraviolet 
light source.
To test for product specificity nested 3’ RACE PCR reactions were carried out by diluting 
5p.l of the primary PCR products into 245jil of Tricine-EDTA buffer. PCR reactions were set 
up as before, but replacing the 2.5fxl cDNA with 5pl of the diluted primary PCR product and 
1pl 10pM 3GSP with 1jul 10|iM N3GSP. N3GSP sequence was as follows:
N3GSP: CCCCACCTCCATCTGCTGCACCCTCA
The nested PCR reaction was subjected to 25 cycles of 94°C for 10 seconds, 68°C for 10 
seconds and 72°C for 3 minutes followed by a final extension of 72°C for 10 minutes. As 
before, 5pl of reaction were run out on a 1% agarose/ethidium bromide gel (TBE) and 
examined on an ultraviolet light source.
Cloning and sequencing of the RACE-PCR products was done in the same way as 
described for the 1200bp fragment (see section 4.2.1.6 and 4.2.1.7). Because the 3’RACE 
products were more than one, the stronger products were purified using the QIAquick Gel 
Extraction Kit (Qiagen) according to the Kit instructions.
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4.2.1.10 Long Distance PCR
Primers were designed within the RACE fragments obtained in the previous section. One 
specific primer was designed in the 5’RACE fragment (5’LD) and different specific primers 
were designed in each of the three 3’RACE fragments obtained (3’LD1, 3’LD2, 3’LD3). All 
primers were chosen with the help of software Primer3 followed by Netprimer as 





The system elected for performing Long Distance PCR (LDPCR) was the Herculase 
Enhanced DNA Polymerase (Stratagene). Other attempts were made using the Expand 
High Fidelity PCR System (Roche) without good results. Herculase enhanced DNA 
polymerase provided high fidelity amplification over more than 6Kb. It consists 
predominantly of Pfu DNA polymerase, combined with PfuTurbo PCR enhancing factor 
and a small amount of Taq 2000 DNA polymerase. This Stratagene mixture allows 
amplification of genomic targets up to 37Kb while maintaining a lower error rate. PCR 
parameter optimisation was done according to the instruction manual the guidelines of 
which proved to be crucial.
The PCR reaction that was used successfully for the three required products was made of: 
40.6|il of MilliQ water, 5\i\ of 10x Herculase buffer, 0.4pJ of 25mM dNTPs mix, 1|il of 5’ 
RACE ready cDNA, 2.5fil of 10fiM primer mix and 0.5jllI of (5U/jul) Herculase DNA
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polymerase. The reagents were added on ice in this precise order. The 50pl reactions 
were then amplified in a MJ Research PTC-DNA Engine PCR machine using the following 
cycles: 2 minutes at 95°C, followed by 10 cycles of 30 seconds at 95°C, 30 seconds at 
50°C and 5 minutes at 72°C. Another 20 cycles were then performed with 30 seconds at 
95°C, 30 seconds at 50°C and 9 minutes at 72°C. PCR products were directly cloned into 
Zero Blunt TOPO PCR Cloning Kit (Invitrogen) as described in section 4.2.1.6. The reason 
for using this different vector was because the Pfu polymerases included in the Herculase 
solution make blunt end PCR products and therefore a suitable vector had to be used for 
cloning.
For the analysis of positive clones 12 colonies were grown overnight in LB containing 
50fig/ml Kanamycin. Again plasmid minipreps using the Wizard Plus SV Miniprep DNA 
Purification System (Promega) were performed according to the Kit instructions. 
Sequencing of the three LD PCR products was done commercially by Oswel DNA 
Sequencing. Oswel synthesised all the sequencing primers on both strands of DNA. These 
are indicated in the wild-type sequences presented in the Appendix.
The three wild-type consensus sequences released by Oswel were compared to each 
other using the multiple sequence alignment package Clustalw available at EMBL-EBI 
(European Bioinformatics Institute (www.ebi.ac.uk/clustaw/). Open reading frames (ORFs) 
were analysed using the HGMP-RC package ‘Getorf. The amino acid sequences were 
also aligned using Clustalw. Identification of intron/exon boundaries was made by 
comparing these cDNA sequences with the PAC3 genomic sequence. The pairwise Blast 
(BLAST 2 sequences) was used for this purpose.
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4.2.2 Morpholino gene knockdown of zebrafish 
ALKJLTK- like gene
Morpholinos are antisense oligos, typically 18 to 25 bases in length, designed to bind to a 
complementary sequence, referred to as the target sequence in a selected mRNA. This 
binding, if targeted to a translation start site, prevents translation of that specific mRNA 
(Ekker and Larson, 2001). As a consequence, the protein product coded by that particular 
mRNA is not made. Because morpholinos are stable, specific and non-toxic they are ideal 
for studies in embryos. Morpholinos can be easily delivered by microinjection into zebrafish 
1-2 cell stage embryos (Ekker and Larson, 2001). In this work one morpholino was 
synthesised (Gene tools) against the beginning of the coding sequence for the mRNA 
encoded by the zebrafish ALK/LTK-like gene. The morpholino was ordered on line at the 
web site www.qene-tools.com and was designed by Gene tools free Oligo Design service. 
The first 25 bases of the coding sequence and as much 5’untranslated sequence as 
available were provided as well as the true AUG translational start site. The purchased 
morpholino had the following sequence:
AGTTTGTCGAGTAATATAATCCATG.
On its arrival the morpholino was resuspended in 1x Danieau buffer ( 58mMNaCI, 0.7mM 
KCI, 0.4 mM MgS04, 0.6 mM Ca(N03)2, 5.0 mM HEPES pH 7.6) to make a stock 
concentration of 25pg/pl that was aliquoted and stored at 4°C. Microinjections were 
performed on 1-2 ceil stage wild-type embryos. The procedure and equipment used were 
the same as described for the PAC genomic microinjections on Chapter 3 section 3.2.2.2.
A range of decreasing dilutions of the stock solution was injected together with 10% 
phenol red. These resulted in the following increasing amounts per embryo: 1.15ng;
2.30ng; 4.60ng; 9.2ng; 18.4ng; and 36.8ng. Embryos were kept at 28.5°C until 72 hpf and 
were analysed under a MZ12 dissecting microscope (Leica) with incident light to observe
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the number of iridophores. For Documentation a SPOT camera (Diagnostic instruments, 
inc.) was used.
4.2.3 Identification of the molecular lesions 
responsible for the different shd mutant 
phenotypes
RNA was extracted in the same way as described for the wild-type embryos in section 
4.2.1.3. Around 100 homozygous mutants for the shd alleles ty9, ty82 and trd were 
collected and kept alive until 72 hpf. At this stage they were easily identified and separated 
from their wild-type siblings and the RNA extraction took place. Filter tips were always 
used so that no contamination between mutants could take place.
The procedures used were exactly the same as those described for wild-type embryos, 
unless otherwise stated. 5’RACE ready cDNA (Clontech) had to be synthesised from each 
of the three mutant alleles so that the same LD PCR could work (see section 4.2.1.9) The 
primers used for the LD PCR with the three different mutant cDNAs were 5’LD combined 
with either 3’LD1 or 3’LD2 (see section 4.2.1.10 for sequences). Automated sequencing 
was performed directly on PCR products [typically 3-1 Ong PCR product (approximately 
500bp) with 5pmoles of primer in 6pl total volume] after cleaning them with QIAquick PCR 
Purification Kit (Qiagen). An extra wash with 35% guanidine hydrochloride was included to 
remove primer dimers longer than 20bp.
Sequences were analysed using Bioedit software and the link to Clustalw to produce a 
consensus sequence for each mutant DNA. These were compared to the wild-type 




4.3.1 Isolation of the complete zebrafish
likegene
4.3.1.1 The 1200 bp fragment
We began by cloning a fragment suitable for asking whether ALK/LTK was expressed in 
the neural crest. We knew from cell autonomy studies (see Chapter 5) that the candidate 
gene for shd was expected to be expressed in the neural crest. Secondarily, the cDNA 
sequence would allow us to analyse the orthology of the RTK gene.
PCR using primers forward and reverse shd 1 was optimised (Figure 4.1) and conditions 
applied in the reaction in lane 11 were considered the best.
cDNA
control 1 2  3 4
Figure 4.1. PCR optimisation with the primers forward and reverse s h d l The 1200bp 
fragment was clear in reaction 11. PCR conditions for reaction 11 were described in the 
Methods. A positive control (sox10 204bp fragment) was included in order to check the cDNA 
synthesis had been successful
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Using these optimised conditions, PCR was performed on cDNA prepared from embryos 
of four different ages. This showed that the fragment was present at all stages but 
amplification was best at 48.5 and 63 hpf (Figure 4.2).
24 28 48.5 63 Negative
hpf hpf hpf hpf control
1200bp
Figure 4.2. 1200bp fragment amplified from embryonic cDNA prepared from: 24, 28, 48.5, and 
63hpf wild-type embryos. A negative control shows specificity of the amplified band.
Cloning of the 1200bp fragment amplified from the 48.5 hpf cDNA into a TOPO TA vector 
resulted in five positive inserts from 12 colonies (Figure 4.3).
j1200bp
Figure 4.3. Result of EcoRI digestion of TOPO TA plasmid minipreps. Only five clones 
contained the expected 1200bp insert: clone number 1, 2, 7, 10 and 12.
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Sequencing of the 1200bp fragment using the T7 sequencing primer generated sequence 
that allowed a translated BLAST search (Figure 4.4). This confirmed the high sequence 
similarity with ALK/LTK mammalian translated sequences.
C o l o r  K e y  f o r  R l i g n n e n t  S c o r e s
50-80 80-200 >=200
0 50 100 150 200 250 300 350 400 450
Figure 4.4. Translated BLAST result for the 5’ 500bp of the 1200bp fragment. The best 
homology in red, not surprisingly, was with the zebrafish PAC3 genomic clone. The next ten 
best homologies in pink were with mouse ALK tyrosine kinase receptor precursor; human ALK 
tyrosine kinase receptor precursor; human ALK receptor, human LTK receptor precursor; 
human LTK receptor; mouse LTK receptor precursor; human non-catalytic LTK splice form; 
mouse LTK receptor; mouse protein tyrosine kinase; and rat LTK. The green trace is for rat 
ALK.
In conclusion, these results were encouraging and strongly supported the NIX predictions. 
A fragment of a zebrafish ALK/LTK-like gene had been cloned. The localisation of the full 




4.3.1.2 Expression pattern of the 1200bp transcript
Confirmation of the clone identity led to the next question: what was the expression pattern 
conferred by a riboprobe made from this clone. To generate the riboprobe the plasmid 
containing the insert was first digested with Spe I. As expected this resulted in linearisation 
of the 5139bp clone (3939bp from the vector plus 1200bp from the insert) (Figure 4.5).
■
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Figure 4.5. Making a riboprobe with the 1200bp fragment from the zebrafish ALK-LTK -  like 
gene. 1% agarose gel showing the result of digesting TOPO TA vector (3939 bp) and the 1200 
bp insert (= 5139 bp) with Spe I.
The 1200 bp riboprobe was used in a whole mount in situ hybridisation time course study, 
(see Figures 4.6 and 4.7). At 22 hpf it was possible to distinguish 25% of the embryos from 
the rest on the basis of the expression pattern in the head region (Figure 4.6 a-b). We 
therefore assumed these embryos were shd '1'. Basically no expression or very reduced 
expression was detected in these shd mutant embryos when compared to their wild-type 
siblings. The expressing cells above the yolk sac and yolk elongation (Figure 4.6 c) were 
also almost absent in 25% of the embryos (Figure 4.6.d). Again we assume these were the 
shd 'A embryos resulting from an heterozygous cross. At this stage we did not assess in 
what tissues might the expressing cells be. A more detailed study, involving sectioning the
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embryos is necessary. At 24 hpf these differences were also very obvious in the eyes 
(Figures 4.6 e and f). Small clusters of expression were easily seen in the iris of wild-types 
eyes resembling the iridophore later pattern whilst almost no staining was detected in shd 
mutants (25% of total number of embryos). At 30 hpf (Figure 4.7) transcripts were seen in 
the dorsal and ventral stripes of wild-types embryos at the right distance and number to be 
identified as iridoblasts (Figure 4.7 a, c). Again shd ''' mutants had virtually no expression 
(Figure 4.7 b, d). This pattern was maintained until 48 hpf when the eye expression in wild- 
types was perhaps most striking (Figure 4.7 e). At 72 hpf it looked as though the 






Figure 4.6. Whole mount in situ hybridisation with a zebrafish ALK/LTK-like riboprobe.(a) 
Expression at 22 hpf in the head of a wild-type embryo and (b) its absence in a shd^8 mutant.
(c) Expression at 22 hpf in a ventral stripe in the midbrain-hindbrain region in a wild-type and
(d) its very reduced levels in a shd1782 mutant, (e) Expression in the iris of a 24 hpf wild-type 
compared to (f) much reduced levels of expression in a shd**82 mutant of the same age.
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Figure 4.7. (a-f) Whole mount in situ hybridisation with a zebrafish ALK/LTK riboprobe. (a) 
Expression at 30 hpf is located in cells of the ventral stripe and (c) dorsal stripe of wild-type 
embryos. (b,d) These expression patterns are mostly absent in shd1782 mutants, respectively,
(e) Expression in the eye of a 48 hpf wild-type embryo and (f) its absence in a s h d 2 embryo 
of the same age.
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4.3.1.3 The full zebrafish ALK/LTK cDNA
As the 1200bp sequence confirmed the identity of the expected RTK it was decided to 
clone the full length gene by performing RACE PCRs followed by Long distance-PCR. The 
RACE products generated were of different sizes: 700bp for the 5’RACE, and three 
different products of 800bp, 1250bp and 1500bp for the 3’RACE amplification (Figure 4.8 
a). These 3’RACE products were confirmed with nested RACE PCR (Figure 4.8 b). Other 










Figure 4.8. RACE PCR products (a) 5’ and 3’ RACE PCR products (b) 3’RACE products 
confirmed with nested PCR. The stronger bands in b correspond to the 3’RACE bands shown 
in a The 5’RACE product is around 700 bp and the 3’RACE products are around 800, 1250 
and 1500 bp long. Marker lanes show 1kb and 100bp ladders (Promega).
Analysis of the 5’RACE clones by restriction digestion with EcoRI showed that nearly all of 
them had the right insert around 700bp (Figure 4.9). The same procedure for the 3’RACE 
clones was not so successful, in particular for the 1500bp insert which was difficult to clone 
by gel purification (see Methods). However, a shotgun cloning of the PCR reaction was 
successful in cloning this fragment (Figure 4.10).
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Figure 4.9. Cloning of 5’RACE products. Restriction digests of 5'RACE clones with EcoRI. 
Only clone number 4 did not contain the expected 700bp insert. Marker lanes show 1 kb ladder 





Figure 4.10. Cloning of the 3’RACE products. Restriction digest of the 3’RACE clones with 
EcoRI. (a) Clones from 1-3 resulted from the purification of a 1200bp band, only clone number 
2 had the expected insert of 1200bp. Clones from 4-9 were generated from an isolated 800bp 
band. Clones number 5, 8, and 9 had the right size insert around 800bp.(b) Shotgun clones of 
the same PCR product. Clone number 2 had around a 1500bp insert. Clones number 3 and 4 
had 800bp size inserts and clones 5 and 6 had 1200bp inserts. Marker lanes show 1 kb ladders 
flanking the gels and a 100bp ladder on the right side of both gels
The purpose of the RACE PCR was to obtain sequence from both ends of the cDNA and 
use it to design new PCR primers that would be used in a LD-PCR aiming to amplify the 
transcript between the RACE products. As a result of the 3’RACE PCR three consistent 
products were obtained (Figure 4.10) leading to the design of three specific primers from 
each of the 3’RACE products and consequently to three LD-PCRs (all with the same 5’ 
primer). A shorter one, around 5Kb, from the 3’primer originated with the shorter 3’RACE 
product, a medium one, around 5.5Kb, from the primer designed with the 1250bp 3’RACE
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product, and a slightly larger one with the third primer originated from the 1500bp 3’RACE 
product (Figure 4.11). Cloning results in Figure 4.12.
Figure 4.11. Long Distance PCR (LD-PCR) aiming to amplify near full-length cDNAs from the 
zebrafish ALK/LTK-like gene. Three products were obtained when using the three different 
specific 3’primers designed based on the three 3’RACE sequences Product 1 was around 5Kb 
and products 2 and 3 were around 5.5Kb. Marker lanes show a 1Kb ladder on each side of the 
gel.
Figure 4.12. Cloning of the three LD-PCR products. Clones were digested with EcoRI to 
evaluate the insert sizes, (a) clone 1 (lane 1) had the right insert size around 5 Kb. Clone 2 
(lanes 10-15) only lanes 11-13 had the right insert sizes around 5.5 Kb. Clone 3 (lanes 2-9) did 
not have any right insert sizes, (b) Clone 3 (lanes 1-22) only lane 12 had the right insert size. 
Clone 1 (lanes 23-29) only lane 27 shows the right insert size. Markers show 1Kb ladders.
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Once all three bands were cloned and the DNA was fully sequenced it was possible to 
compare them to each other. The alignment produced for the three nucleotide sequences 
shows that they are very similar (see Appendix alignment 1). Clones 2 and 3 are identical 
but clone 1 has a 78bp insertion, beginning at position 2520bp, compared with clones 2 
and 3. This results in a 26 amino acid insertion. The predicted ORF is otherwise, exactly 
the same. The start codon was assigned based on the morpholino results presented in the 
next section. The sequence shows two in-frame Methionin codons making the putative 
start site ambiguous. A morpholino designed to the first putative start site proved 
successful and therefore led us to believe that the ATG at position 83 was the right start 
codon. In this way, the zebrafish ALK/LTK-like gene open reading frame predicts a 1530 
(clone 1) and 1504 (clones 2 and 3) amino acid protein. The sizes of the 3’UTRs from 
these three identical cDNAs are slightly different because clones 2 and 3 are truncated 
versions of clone 1 (see alignment 1 in the Appendix).
Comparison of the three cDNA sequences with the genomic sequence from PAC3 (Table
4.1 and Figure A1 in the Appendix) showed that the cDNA from clones 2 and 3 spread 
through the same 28 exons of genomic sequence (see Table 4.1). The only difference was 
that clone 2 was longer than clone 3 as already mentioned. In this way it was concluded 
that clones 2 and 3 probably represent the same transcript. In relation to clone 1 it was 
shown that the extra 78 nucleotides resulted in a larger exon 18 when compared to clones 
2/3. Clone 1 also had an extra exon in the end separated by an intron of 32bp (see Table
4.1 and Figure A1). This last exon 29 did not contain any coding sequence but was the 
result of a longer 3’UTR unique to clone 1, absent in the other clones, perhaps due to 
truncation. Based on these results we believe we have cloned 2 different transcripts of the 
same gene: one longer one represented by clone 1 and a shorter version represented by 
clones 2 and 3.
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Table 4.1. Genomic distribution of cDNA clones 1, 2 and 3








1 (all clones) 4466-4579 *24-137 113 28197
2 (all clones) 32776-32870 136-230 94 2763
3 (all clones) 35633-35784 230-381 151 1890
4 (all clones) 37674-37901 379-606 227 3292
5 (all clones) 41193-41337 604-748 144 432
6 (all clones) 41769-41911 746-888 142 3662
7 (all clones) 45573-45723 888-1038 150 2987
8 (all clones) 48710-48812 1036-1137 101 639
9 (all clones) 49451-49614 1135-1299 164 2036
10 (all clones) 51650-51745 1299-1394 95 5472
11 (all clones) 57217-57293 1393-1469 76 481
12 (all clones) 57774-57953 1466-1645 179 4364
13 (all clones) 62317-62467 1645-1795 150 173
14 (all clones) 62640-62771 1796-1927 131 260
15 (all clones) 63031-63190 1927-2086 159 2625
16 (all clones) 65815-66002 2083-2270 187 2189
17 (all clones) 68191-68291 2266-2366 100 4068
18 (clonel) 72359-72705 2365-2711 346 5438
18 (clones2&3) 72359-72513 2365-2633 268 5630
19 (clonel) 78143-78330 2712-2899 187 1298
19 (clones2&3) 2634-2821 187
20 (clonel) 79628-79720 2897-2989 92 82
20 (clones2&3) 2819-2911 92
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21 (clonel) 79802-79868 2988-3054 66 5645
21 (clones2&3) 2910-2976 66
22 (clonel) 85513-85644 3053-3184 131 865
22 (clones2&3) 2975-3106 131
23 (clonel) 86509-86607 3185-3283 98 170
23 (clone2&3) 3107-3205 98
24 (clonel) 86777-86873 3280-3376 96 78
24 (clones2&3) 3202-3298 96
25 (clonel) 86951-87057 3374-3479 105 194
25 (clones2&3) 3296-3401 105
26 (clone 1) 87251-87386 3477-3612 135 343
26 (clones2&3) 3399-3534 135
27 (clonel) 87729-87820 3613-3704 91 1238
27 (clones2&3) 3535-3626 91
28 (clone 1) 89058-90848 3701-5492 1791 32
28 (clone2) 89058-90823 3623-5389 1766
29 (clonel) 90880-90930 5564-5614 50
*sequence 1-23 bp belongs to vector (see Alignment 1 in Appendix)
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4.3.2 Morpholino gene knockdown of zebrafish 
ALK/LTK-like gene phenocopies the shd 
phenotype
Morpholinos are oligonucleotides of a specific morpholine backbone chemistry that when 
targeted to the translation start site result in efficient inhibition of protein translation (Ekker 
and Larson, 2001). The choice of the right start codon is therefore crucial for the 
morpholino to work. When designing the zebrafish ALK/LTK-like morpholino a careful 
search based on sequence comparisons with other organisms was performed in order to 
select the right start codon. The morpholino location in relation to the start codon can be 
found in the Appendix (alignment 1). Results from the morpholino injections are 
summarised in Table 4.2
Table 4.2 Summary results of the morpholino injections at different concentrations
Concentration
(ng/embryo)
No. injected embryos % morphants % abnormalities % mortality
1.15 140 4.2 10
-
2.30 178 1.2 9 9
4.60 163 2.3 16.5 22
9.2 260 65.5 5 30.7
18.4 255 82.7 8.6 9
36.8 38 84.8 27.2 13
When the data was analysed per batch of eggs injected as opposed to total number of 
eggs injected it was possible to show the variability associated with each batch. Such
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variability could have resulted from the quality of the eggs, the skill of the injector on each 
particular batch , or even the quality of the needle being used. The results of treating the 
data this way are presented in Figure 4.13.
•  % morphants 
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Figure 4.13. ALK/LTK morpholino injection phenocopied the shd phenotype. Graphic 
representation showing how the different concentrations of morpholino injected affected the 
percentage of abnormalities, mortality and successful morphants generated. A curve fit 
following a Boltzmann function [y ^ A M s j/ l+ e ^ 0̂  +A2] (Chi2=146.25874 and R2=0.98889) 
was applied to the % of morphants generated.
The analysis of these data led to two important conclusions: The first one being that the 
optimum concentration needed to phenocopy the shd mutant phenotype at 72 hpf was 
high (18.4 ng/embryo) and second that even such a high concentration had little 
associated non-specific abnormality or mortality, and was therefore considered ideal for 
this specific morpholino. The curve fitted according to the Bolzmann function indicated a 
concentration of 8.8 ng/embryo was needed to obtain half the number of morphants. This
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model is typical of a concentration dependent event and shows that the number of 
morphants generated increases very fast (slope of 0.89327) with concentrations between 5 
and 15 ng/embryo and that around 15 ng/embryo this number reaches a steady state 
meaning that a higher concentration will not result in more morphants being generated.
The graphic also seems to indicate that the % of mortality and abnormalities are not 
concentration dependent. These parameters are probably more affected by the injection 
procedure and the damage it can cause to the eggs. Figure 4.14 shows the phenocopied 
wild-type embryos compared to uninjected wild-types.
Figure 4.14. A morpholino designed to the zebrafish ALK/LTK-like gene phenocopies the shd 
phenotype. Injections were performed into 1-cell stage wild-type embryos, (a) Uninjected wild- 
type embryo (top) at 4 days post fertilization (dpf) and morphant of the same age (bottom), (b) 
Dorsal view of the head and dorsal stripe of a 4 dpf wild-type embryo and (c) of a morphant of 
the same age. The concentration of morpholino injected was 18.4ng/embryo. Phenocopied 
embryos showed no iridophores or a very reduced number of iridophores and were often 
indistinguishable from homozygotes for the strong shd mutant allele ty82.
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4.3.3. Identification of the molecular lesions 
responsible for the different phenotypes
Conclusive evidence that a certain gene has been mutated is given by showing the altered 
sequence of mutated alleles of that gene. Therefore we attempted to amplify the cDNA 
from shd mutants ty82, ty9 and trd by performing the same LD-PCR used for the wild-type 
embryos (see Materials and Methods). The three bands, one for each of the mutant alleles 
were consistent but not very bright which made direct sequencing difficult due to low 
concentration of DNA (Figure 4.15 shows an exceptional LD-PCR). Cloning of these 
products did not work in the available period of time probably due to poor amplification and 
DNA loss during band purification.
ty9 ty82 trd  Negative 
control
Figure 4.15. LD-PCR performed on shd mutants alleles ty9, ty82 and trd. A negative control 
was included in the last lane to test for contamination. Marker lane shows a 1 Kb ladder.
Nevertheless, some sequence was obtained from the PCR product of the ty9 mutant allele. 
Comparison of sequences from both strands with the correspondent wild-type region 
identified only one potential point mutation. A T to G nucleotide change would be predicted 
to result in replacing a Valine with a Glycine at the transmembrane domain residue 833. 
However, subsequent analysis of other wild-type clones showed that this occurred
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frequently and was therefore a normal polymorphism and not due to the mutagenesis. This 
aminoacid replacement seems to be specific to zebrafish since this Val 833 is conserved 




In this Chapter we have 1) confirmed that there is a zebrafish gene of the type II RTK 
subfamily in PAC3 that is similar to both mammalian ALK and LTK as predicted in Chapter 
3; 2) shown that the zebrafish ALK/LTK homologue is expressed in neural crest; 3) 
identified its’ genomic/cDNA structure and 4) provided evidence that it is indeed encoded 
at the shd locus.
Although the predictions for the genomic/cDNA structure given in Chapter 3 were very 
good they were not 100% correct. Most software included in NIX predicted a zebrafish 
gene with 20 exons that covered a PAC3 genomic region from around 32614 bp to 89061- 
90032bp. It was shown in the current Chapter that there were 29 exons and these spread 
from 4466bp to 90930bp of the PAC3 sequence.
Comparison of the two zebrafish ALK/LTK translated sequences and those available from 
other organisms in the SwissProt database showed that the zebrafish RTK predicted ORF 
is more identical to an ALK protein than to an LTK (E=0.0 for all blasts). The similarity to 
ALK proteins is found on all the domains over 1443 residues. LTKs do not have MAM 
domains and therefore the similarity to zebrafish RTK is based on the remaining domains 
spread over 759 residues.
The main region of conservation, conserved even in Drosophila ALK, corresponds to the 
tyrosine kinase catalytic domain between residues 865-1201 of the zebrafish clone 2/3. 
Based on this region the zebrafish RTK shows 10% more similarity to human LTK than to 
human ALK. This catalytic region included the consensus ATP binding sequence GxGxxG 
followed by the AxK residues downstream (for localisation of conserved domains see
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alignment 2 in the Appendix). This domain was also confirmed by the NCBI Conserved 
Domain Search Database (www.ncbi.nlm.nih.gov/Structure/cdd/wrpsb.cgi) with an E value 
of E=4e-94.
Other conserved domains identified were the two MAM domains at residues 53-218 and 
277-431 (E values of E=6e-06 and E=1e-20, respectively). MAM domains comprise about 
160 amino acids found in extracellular domains of many receptors likely to have an 
adhesive function relevant in cell/cell interactions (Beckmann and Bork, 1993; Jiang et al., 
1993). The MAM domain is named after meprins, A-5 protein and receptor protein tyrosine 
phosphatase mu. Such a domain is found in mammalian ALK and Drosophila ALK but not 
in LTK (Loren et al., 2001).
A domain that is found in both proteins ALK and LTK and is also in this zebrafish RTK is 
the LDLa domain (Low Density Lipoprotein Receptor Domain class A) which is known to 
play a central role in mammalian cholesterol metabolism (Daly et al., 1995; Fass et al., 
1997). In zebrafish it is located between residues 240 and 264 (E=7e-4) just before the 
second MAM domain. A schematic diagram clarifies these structural similarities between 
zebrafish ALK/LTK, Drosophila ALK, human ALK and human LTK (Figure 4.16). An 
hydrophobic transmembrane domain comprising 26 residues was identified by comparing 










Zebrafish Drosophila Human Human
ALK/LTK ALK ALK LTK
Figure 4.16. Structural similarity between zebrafish ALK/LTK, Drosophila ALK, human ALK 
and human LTK. Structural conservation includes the presence of an intracellular Protein 
Tyrosine Kinase (PTK) domain, a transmembrane domain (T.M.) and a glycine rich 
extracellular domain (G-rich). ALK proteins also share MAM domains that are not present in 
LTK. A low density lipoprotein class A (LDLa) domain is shared between zebrafish and the 
ALK proteins (adapted from Loren et al., 2001).
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Based on the presence of MAM domains in the zebrafish protein it is suggested that the 
identity of zebrafish RTK is an ALK orthologue as opposed to a LTK orthologue. This 
argument was also given by Loren et al. (2001) when they named Drosophila ALK as 
such. Translation of zebrafish shd/ALK, as we shall refer to it from now on, shows two 
MAM domains similar to those found in mouse ALK and unlike human ALK where we can 
only find one such domain (www.ncbi.nlm.nih.gov/Structure/cdd/wrpsb.cqi).
The question remains on whether the zebrafish shd/ALK identified in this work is the true 
ancestor of mammalian ALK and perhaps also of LTK. This and other questions such as 
whether zebrafish shd/ALK is closer to human, mouse or Drosophila ALKs were 
addressed by a comprehensive phylogenetic study done in collaboration with Prof. 
Laurence Hurst (University of Bath, Dep. Biology and Biochemistry).
Using the nucleotide and translated sequences for both clones (with and without the 78 
nucleotides) he submitted them for comparison with homologous sequences in a 
phylogenetic analysis, using the following seven sequences: AF236106 (Drosophila 
melanogaster ALK), U62540 (Human ALK), NM_007439 (Mouse Aik), AB073169 (partial 
rat Aik), NM_002344 (Human LTK), M90470 (Mouse Ltk) and, XM_230479 (rat Ltk). 
Results are presented in Figure 4.17. A very conservative approach was taken by 

















Figure 4.17. Phylogenetic analysis of the zebrafish RTK. Nucleotide and translated sequences 
from the zebrafish (Danio rerio) protein tyrosine kinase domain (PTK) were compared to the 
same domains from sequences AF236106 (Drosophila melanogaster ALK), U62540 (Human 
ALK), NM_007439 (Mouse Aik), AB073169 (partial rat ALK), NM_002344 (Human LTK), 
M90470 (Mouse Ltk), and XM_230479 (rat LTK). The coding sequences were extracted by 
reference to the annotations in the GenBank files using gbparse 
(http://sunflower.bio.indiana.edu/~wfischer/Perl Scripts/). Alignment was performed using 
ClustalX on the translated sequences (Thompson et al. 1997). The nucleotide alignment was 
reconstructed from the protein alignments using AA2NUC.tcl (a tel script written by Laurence 
Hurst, available on request). The nucleotide alignment was filtered by Gblocks (Castresana 
2000) under the codon mode in default settings to eliminate ambiguous alignments The 
phylogeny was estimated using a Bayesian method (Huelsenbeck & Ronquist 2001). One 
million generations were simulated resulting in 10,000 trees. The general time reversible model 
was assumed, with site specific rates with sites partitioned by codon. The last 5000 of the 
10000 all have approximately the same likelihood and represent the 5000 most likely 
topologies. From these a 50% majority rule consensus tree was reconstructed. The figures on 




The phylogeny strongly supports that zebrafish clones are ALK homologues. Indeed 
looking at the protein alignment, we looked at two figures: 1) how many times we find both 
clones the same as both ALks but different from both Ltks; 2) how many times we find both 
clones the same as both Ltks but different from both Aiks. The answer to the former 
question is 37 and to the latter is just 6. Therefore our clones are much more similar (at 
least in this PTK region) to ALK. We can thus confirm that this zebrafish RTK is an 
orthologue of mammalian ALKs.
So far both the mapping and the molecular data supported the hypothesis that the gene 
identified as zebrafish ALK was encoded by the shd locus. As an independent experiment 
to further test this hypothesis we injected a specific morpholino targeting the zebrafish 
ALK-like gene. It was predicted that by blocking the translation of this protein in wild-type 
embryos these would phenocopy the shd mutants and would therefore lack the majority of 
the iridophores.
With the morpholino we observed a high rate of phenocopied embryos. Although high 
levels of morpholino were used (18.4ng/embryo) abnormalities remained low suggesting a 
specific targeting. We believe the requirement for a high dose can be explained by the 
relatively late function of shd. Thus, most mutant phenocopy studies have used much 
lower concentrations of morpholino because genes functioning earlier in development 
were being targeted (e.g. Karlen and Rebagliati, 2001). Others have also injected high 
doses (15ng) with good results as late as 4 dpf (Miller and Kimmel, 2001). Perhaps the 
best comparison with the results presented here is the morpholino phenocopy of 
colourless, another pigment mutant that lacks all three types of pigment cells including 
iridophores (Dutton et al., 2001). These authors found that they could only achieve strong 
phenocopies with high doses of morpholino (optimal dose 16.5ng) (Dutton et al., 2001). 
Unfortunately this scoring was based on melanophores and did not include the other 
pigment cells. Nevertheless, if they needed such a high concentration for scoring a
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pigment phenotype at 27 hpf then it is understandable that for a 72hpf phenotype such as 
shd 18.4ng might be necessary.
Because genomic rescue (Chapter 3), mRNA expression studies and morpholino knock 
down studies were all successfully performed a cDNA rescue approach was not 
undertaken. Supporting this decision was data in the literature suggesting that very long 
cDNAs (6055bp) may present a problem for heat-shock rescue experiments (Parsons et 
al., 2002). Using a non-endogenous promoter also presented a problem in the past 
(Lyons et al., 2002). As a last confirmation that the shd locus is encoded by the zebrafish 
ALK-like gene we intended to identify the mutant lesions but could not do these 
experiments in the available period of time. However these last experiments will be 
performed in the near future for the purpose of publication.
The most interesting question that emerges from the results presented in the current 
Chapter concern the relationship between the gene identified here and its putative 
mammalian homologues. Whilst the mammalian ALK is expressed in both the embryonic 
and neonatal CNS and PNS (Iwahara et al., 1997), the human LTK gene product was 
identified mostly in placenta and hematopoietic cell lines (Kozutsumi et al., 1993). In 
addition, mouse LTK mRNAs were detected in adult, but not embryonic brain, and 
lymphoid cells (Snijders et al., 1993). Zebrafish ALK showed specific expression in the 
embryonic iridophore lineage and, at around 22 hpf, in the brain as well as in a ventral 
elongated region above the yolk sac and yolk extension. Consequently, the only similarity 
in the expression patterns is in embryonic CNS between mammalian ALK and zebrafish 
ALK. On the other hand, the region of expression above the yolk needs to be properly 
identified because it could be part of the gut or the excretory system. As mammalian ALK 
transcripts have been reported in the enteric nervous system (Iwahara et al., 1997) and 
mamalian LTK in the kidney (Ben-Neriah and Bauskin, 1988) we need a more careful
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determination of the exact tissue distribution of the zebrafish transcripts to permit accurate 
comparison with mammalian genes.
It has been shown that the growth factor pleiotrophin (PTN) and its homologue Midkine 
(MK) are both ligands for the mammalian ALK promoting growth, survival, and acting as 
angiogenic factors during tumorigenesis (Stoica et al., 2001; Stoica et al., 2002). Blocking 
of the ALK receptor with an ALK monoclonal antibody targeted to the ligand binding 
domain, within one of the mouse MAM domains, showed that MK and PTN could no longer 
bind to ALK. Furthermore, MK or PTN induced colony formation of SW-13 cells was 
inhibited supporting the idea that these growth factors are true functional ligands for the 
ALK receptor (Stoica et al., 2002).
Two zebrafish heparin binding growth factors, midkines a and b, (mdka and mdkb) have 
been identified as well as a EST for zebrafish pleiotrophin (ptn) (Winkler and Moon, 2001; 
Winkler et al., 2003). mdkb was previously known as mdk2 (Winkler and Moon, 2001) and 
it has been shown that mdkb participates in posterior neurogenesis and that its ectopic 
expression enhances neural crest fates at the lateral edges of the caudal neural plate. On 
the other hand, mdka is involved in floor plate development (Winkler et al., 2003). So far 
there are no studies done on zebrafish ptn only on its phylogenetic relationship to both 
midkines that showed the separation between these genes arose before the divergence of 
the fish and tetrapod lineages at least 450 million years ago. Thus, it was concluded that 
mdka and mdkb were not fish versions of PTN (Winkler et al., 2003).
In contrast to the ubiquitous expression of mammalian MK, zebrafish mdka and mdkb are 
expressed in restricted, mostly non-overlapping, areas during embryonic development. 
Thus, mdka is expressed in the paraxial mesoderm and somites, central neural tube and 
brain whereas mdkb is expressed in regions of the dorsal CNS (Winkler et al., 2003).
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From both mRNA expression and overexpression studies (Winkler and Moon, 2001) mdkb 
is the most likely candidate ligand to zebrafish shd /ALK. In order to test mdkb candidacy it 
would be of major interest to look at mdkb later expression pattern and investigate whether 
expression in the neural crest cell environment persists and remains active alongside with 
shd /ALK. If appropriate expression is observed it could be speculated that perhaps the 
same anti-apoptotic pathway (IP3-kinase/Akt) activated by the mammalian 
Pleiotrophin/Midkine binding to ALK (Stoica et al., 2002) is responsible for the survival of 
iridophore precursors. Then in the absence of shd /ALK function iridoblasts die.The last 
hypothesis would point to shd/ALK having a role in the survival of iridophores. Although 
cell death was not tested for, the in situ time course did not reveal expression in shd ''' 
mutants at any tested time point. Perhaps because shd/ALK function is needed to maintain 
its own expression in a positive feedback loop. Thus, iridoblasts might never develop at all 
in a sh<fA embryo, suggesting an earlier role for shd/ALK conceivably in specification. 
Alternatively, iridoblasts might be specified but their fate is not maintained.
Deeper understanding into the potential role of shd/ALK in the pigment cell lineage will be 
given in the next Chapters after presenting the expression pattern of different genes in shd 








The shd complementation group included 12 mutations that formed a clear phenotypic 
series (tc205; te295; te300; tf238c; th219; ti263c; t}229e; tm46a; tp218; ty9; ty70 and ty82) 
(Kelsh et al., 1996). Mutants in the strongest alleles (e.g. ty82 and te295) have no more 
than a few iridophores if any, with remaining iridophores usually on the interior side of the 
eye only. Mutants for the weaker alleles (e.g. ty70ar\6 th219) show an approximately 50% 
reduction of iridophores in the lateral patches but a much weaker reduction in iridophore 
number elsewhere (see Figure 5.1 for location of body stripes and patches).
Figure 5.1. Wild-type Iridophore body pattern. Live embryo (5 dpf) photographed with incident 
light (top) and schematic drawing (bottom) for better identification of iridophore cells in blue. 
The yellow cast is given by xanthophores. Dorsal stripe with black melanophores and shiny (or 
blue) iridophores (down facing arrowheads). Shiny (or blue) patches of iridophores are visible 
in the eye and in the lateral patch as well as in the yolk sac stripe (arrows). Iridophores are 
also present in the ventral stripe (arrowheads facing up) alternating with melanophores.
All the other intermediate phenotypes show some iridophores in the eyes and lateral 
patches but relatively few in the yolk sac stripe.Thus, shd\Nas classified as having one
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pigment cell type reduced, essentially absent in strong alleles (Kelsh et al., 1996). Some 
weak alleles are homozygous viable and develop into adults with usually no obvious adult 
phenotype. Only one allele (shdte295) shows an adult phenotype; homozygotes show a 
reduction of both iridophores and melanophores in the adult and for this reason it is 
possible that its phenotype is due to a separate, closely linked mutation (Haffter et al., 
1996b).
The shd phenotype fulfilled the criteria for mutations causing defects in chromatophore 
specification. These were expected to cause very severe pigment phenotypes, affecting 
one or more chromatophore types, and for strong alleles to show a total absence of that 
cell-type(s) (Kelsh et al., 1996).
With no more available information on the shd phenotype at the beginning of this project. I 
began to investigate the general aspects of this mutant phenotype alongside the main 
objective which was the positional cloning of the shd gene. These phenotypic aspects of 
the study were significant for guiding the cloning project and most importantly provide a 
biological and functional framework to the whole project.
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5.2 Materials and Methods
5.2.1 Whole mount in situ hybridisation
The procedure followed for mRNA in situ hybridisation on all mount zebrafish embryos was 
already described fully in Chapter 4 section 4.2.1.8. The probes for the following genes 
were used: zebrafish shd/ALK synthesised in this work, roselednrbl (Parichy et al.,
2000a), nac/mitf (Lister et al., 1999), dopachrome tautomerase (dct) (Kelsh et al., 2000b), 
fkd6/foxd3 (Odenthal and Nusslein-Volhard, 1998).
5.2.2 Antibody staining of dorsal root ganglia and 
enteric ganglia
Antibody staining with anti-Hu, mAb 16A11 (Marusich et al., 1994) was performed on 
tissue cryosections, whole mount embryos and dissected guts.
5.2.2.1 Tissue cryosections
Agar embedding for cryostat sectioning of fixed embryos was done by melting an aliquot of 
agar-sucrose solution (1.5% agar, 5% sucrose) and cooling it to 40°C. Animals were 
transferred with a drop of fix buffer to a flexible plastic well mould. Excess liquid was 
removed and the agar-sucrose was added to cover the embryos. Using fine needles the 
embryos were oriented properly and the agar was set aside until it was solidified (5-10 
minutes). Blocks were removed from the mould and trimmed with a razor blade according 
to the desired plane of sectioning. 2-3mm of agar were left around the tissue and 3-4mm 
below it to allow a surface where it would be frozen to the cryostat chuck. The trimmed 
agar blocks containing the animals were placed into a 30% sucrose solution and stored at
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4°C until all blocks had sunk (few hours) indicating impregnation. A slightly raised platform 
was made by freezing a layer of OCT compound (Tissue Tek Miles) to the cryostat chuck. 
A drop of OCT was added to the platform and the agar blocks positioned and lowered 
slowly into a container of liquid nitrogen. Even freezing was necessary to avoid cracking 
the blocks. These were equilibrated to the cryostat temperature before sectioning.
Sections 10-40pm thick were cut with this procedure and dried on a 26°C hot plate.
For the antibody staining procedure an Immedge pen (Vector) was used to form a 
hydrophobic barrier around the slide. Sections were rinsed briefly in PBS (tablets from 
Oxoid), and pre-incubated in PBDTX containing 2.5% of sheep serum for at least 30 
minutes at room temperature. PBDTX contains: 1g BSA (Sigma), 1 ml DMSO (Sigma),
0.5ml 10% Triton X-100 (Sigma) and distilled water to make a total volume of 100ml. The 
pre-incubation solution was removed and the primary antibody (1:3000), mouse anti-Hu, 
was added in PBDTX containing 2.5% of sheep serum for 2 hours at room temperature or 
over night at 4°C. Sections were then rinsed 3 times in PBS for 10-15 minutes each wash 
and subsequently the secondary biotinylated antibody (1:200), goat anti-mouse (Roche), 
was added in PBDTX containing 2.5% of sheep serum for 1 hour at room temperature or 
overnight at 4°C. This was also rinsed 3 times in PBS for 10-15 minutes each wash.
Vectastain Elite ABC reagent (Vector) was diluted by adding 20pl reagent A per ml to 
PBDTX, followed by 20pl reagent B, mixed and let to stand for 30 minutes at room 
temperature. The diluted reagent was added to the sections for 1 hour at room 
temperature or overnight at 4°C after which it was washed 3 times in PBS for 10-15 
minutes. 3,3’-Diaminobenzidine (DAB) substrate, from the DAB substrate kit for peroxidase 
(Vector), was diluted in PBSX (14jnl/ml) and the sections incubated for 15 minutes. Then,
7pi hydrogen peroxide (Sigma) were added per 1ml diluted DAB solution. The reaction 
(usually very quick) was closely monitored under a dissecting scope and stain
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development stopped by rinsing several times with PBS. Slides were coversliped in 50% 
glycerol: PBS solution and analysed under a Eclipse E800 microscope (Nikon).
5.2.2.2 Dissected guts and whole mount embryos
Whole mount embryos up to 60hpf or dissected guts of older embryos were stained using 
this slightly different protocol. Embryos to be antibody stained were dechorionated and 
fixed in 4% paraformaldehyde/PBS overnight at 4°C and then kept in PBSX (0.5% Triton-X 
(Sigma) in PBS) at 4°C until needed. They were washed 2x5 minutes with PBSX, 4x30 
minutes in milliQ water, incubated in acetone for 7 minutes at -20°C and blocked for at 
least one hour in PBSDX (50ml 2xPBS pH7.3, 1g BSA (Sigma), 1ml DMSO (Sigma), 0.5ml 
10% Triton X-100 and milliQ water up to 100ml) containing 15pl/ml horse serum (Sigma) 
block. Primary antibody, anti-Hu was diluted 1:5000 in PBSDX containing 15jil/ml horse 
serum and the embryos incubated overnight at 4°C. On the following day embryos were 
washed 4x30 minutes in PBSDX, the biotinylated secondary horse anti-mouse/rabbit 
antibody diluted 1:5000 in PBSDX with 15^1/ml horse serum and the embryos incubated 
overnight at 4°C.
The antibody was discarded, the embryos washed 4x30 minutes in PBSDX, incubated 45 
minutes in the diluted ABC reagent (Vectastain ABC Elite kit), washed 3x30 minutes in 
PBSDX and 30 minutes in PBSX. The DAB substrate was diluted in PBSX (14jil/ml) and 
the embryos incubated for 15 minutes. After transferring the embryos to a glass well plate 
7pl hydrogen peroxide (Sigma) were added per 1 ml diluted DAB solution. The coloured 
precipitate was developed in the dark for 5 minutes up to a few hours. For long incubations 
it was necessary to add more hydrogen peroxide approximately every 10 to 15 minutes. 
The coloured precepitate development was finally stopped by rinsing the embryos several 
times in PBSX and embryos were kept at 4°C.
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5.2.2.2.1 Using a fluorescent secondary antibody
This protocol was used for whole mount embryos older than 60hpf since the sensitivity of 
detection of structures deep within the tissue is greater with the fluorescent detection than 
with the DAB substrate.
Embryos were washed 3x5 minutes at room temperature in PBSX, 3x1 hour in milliQ 
water, pre-incubated in 0.75ml block [0.5% Triton X-100, 1% DMSO, 5% horse serum in 
PBSX] and incubated at room temperature overnight with the primary anti-Hu mouse 
antibody diluted 1:1000 in 0.75ml block. The antibody was discarded, embryos rinsed in 
PBSX as described in the previous protocol, washed for 3x1 hour in PBSX and incubated 
at room temperature overnight with the secondary antibody, Alexa Fluor 546 rabbit anti 
mouse IgG (Molecular probes, Oregon), diluted 1:800 in 0.75ml block. Again, the antibody 
was discarded, embryos rinsed in PBSX, washed for 3x30 minutes in PBSX, transferred 
into 50% glycerol/PBS and incubated for 15 minutes. Embryos were analysed with an 
Eclipse E800 microscope (Nikon) using fluorescence microscopy (TRITC filter).
5.2.3 Transplant experiments
WT into shd chimaeras were obtained as follows: rhodamine conjugated biotinylated 
dextran dye (Molecular Probes) was injected into the yolk of 2 cell stage wild-type embryos 
(0:45 hpf) using a Drumond Nanoinjector and a dissecting scope. Embryos were then 
allowed to develop until 30% epiboly stage (5:50 hpf) according to (Kimmel et al., 1995). 
At this stage wild-type cells were transferred to an unlabeled shield stage host (6 hpf).
Each slide had one donor and three hosts mounted on cold methylcellulose. Hosts were 
derived from shd*1' x shd crosses and thus were a mixture of WT, shd and shd ''' 
embryos. Donor cells were placed into host embryos in the approximate position of the 
neural crest as judged from the fate map at the same developmental stage (Kimmel et
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al., 1995). The total number of surviving embryos at 72 hpf was recorded. As expected, 
approximately 25% of hosts proved to be shd "A. These shd '1'embryos were examined 
under fluorescent light for the presence of rhodamine labelled cells and thus scored as 
chimaeras. Chimaeric shd '1'embryos we examined for the presence of reflecting 
iridophores under incident light. All rhodamine labelled iridophores were scored using a 
rhodamine filter block on an Elite E800 (Nikon) microscope. All other cell types in the 
chimaeric shd 'embryos were also scored for rhodamine label.
In addition to the rhodamine labelling, confirmation of the donor cell origin was performed 
by detection of biotin using an anti-biotin secondary antibody following the protocol 
described below. This confirmation was needed because iridophores are auto fluorescent 
under the same channel as rhodamine and sometimes this distinction can be difficult.
The following detection procedure was applied to all chimaeric mutant embryos. Embryos 
were fixed in 4% paraformaldehyde/PBS overnight at 4°C or for 1-2 hours at room 
temperature. Washed 3x 5minutes with 0.1M phosphate buffer at room temperature. 
[Phosphate buffer: 80ml 0.1M Na2HP04; 20ml 0.1M NaH2P04, pH 7.3] and then 4x30 
minutes with distilled water at room temperature. Embryos were cooled at -20°C for 7 
minutes in cold acetone and susequently washed for 5 minutes with 0.1M phosphate 
buffer at room temperature. Background peroxidase activity in blood cells was quenched 
by incubating the embryos for 30 minutes in methanol with 5% hydrogen peroxide. 
Embryos were washed 3x 5 minutes with 1% PBDTX and incubated for 2 hours with 
Ready to Use (RTU) Vectastain ABC (Vector). They were then washed for 3x 15 minutes 
with 1% PBDTX and pre-incubate with DAB (14pl per ml PBS/0.1% Triton X-100) for 15 
minutes at room temperature. 7|il H20 2 were added per ml DAB solution and mixed well. 
Stain development was stopped when desired by washing several times with PBSX and 




5.3.1 Iridophores in wild-type and shd'/m embryos
To understand the shd phenotype it is important to describe in some detail the wild-type 
early larval iridophore pattern. In wild-type embryos the iridophores are positioned among 
the melanophores making it difficult to photograph them. Hence, we have used sandy 
(sdy) homozygous embryos which lack the melanin pigment but are otherwise normal 
(Kelsh et al., 1996) to allow us to fully visualise the wild-type iridophore pattern both with 
incident and transmitted light.
The embryonic iridophore pattern is complete by 5 dpf (Kelsh et al, 1996). Iridophores are 
discernible in the chorion lying over the retinal epithelium melanophores as early as 3 dpf. 
In 3 dpf sdy embryos it is possible to see iridophores with transmitted light. They form a 
spotted pattern over the eyes, densest around the iris where they form a continuous ring 
(Figure 5.2a). Iridophores are also present in three of the four embryonic stripes. At 3 dpf 
they can be seen in the dorsal, ventral and yolk sac stripes. These are respectively, dorsal 
to the neural tube, dorsal to the gut and ventral to the yolk. In the dorsal stripe they 
aggregate in a large patch on the top of the head and as a row of discrete spots along the 
trunk to the tip of the tail (Figure 5.2c). These spots are usually made of a few cells 
together and they are spaced fairly evenly. Occasionally, by 3 dpf onwards they can be 
fused forming a thin continuos stripe of iridophores. In the ventral stripe iridophores form 
large patches, one on each side of the embryo, over the yolk sac, known as the lateral 
patches (Figure 5.2b). These become narrower towards the back of the embryo and are 
replaced by the characteristic double spotted stripe of iridophores that run until the tip of 
the tail where they meet the dorsal stripe. Iridophores can also be found as a flat sheet 
covering the region under the yolk sac and yolk sac elongation. Here they are not spotted
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or patchy, in contrast, they appear as a thin reflective layer of cells in tight association with 
the yolk sac stripe melanophores. Iridophores are characteristically compact and round or 
oval in shape. However, some migratory differentiated iridophores are seen (e.g. over the 
yolk patches melanophores) and these have the typical elongated or branched shape of a 
migratory neural crest cell. Under transmitted light or with DIC optics they appear 
reminiscent of unpolished gold stones (Figure 5.2d). When incident light is used 
iridophores look like shiny iridescent patches or spots and their shape and texture is not 
always detectable because its hindered by their great reflectivity.
In a shd ''' embryo the number of iridophores varies from very reduced to completely 
absent depending on the strength of the allele being analysed. Consequently, the patterns 
we have just described are very compromised. The patches or spots seen in wild-types, if 
not absent, are usually smaller (have less individual cells). However, the cells that are 
present appear normal in shape and brightness. In this project we have looked at three of 
the shd alleles: ty82, ty9 and, terminally dull (trd) identified in a later screen (David Raibles’ 
laboratory, Seattle). ty82 is the strongest allele and only very rarely are one or two 
iridophores seen in embryos homozygous for this mutation (Figure 5.2 k,m). These are 
usually on the interior side of the eye or in a yolk patch. This mutation is lethal because the 
mutants never develop a swim bladder. In contrast, the ty9 homozygotes are viable. Their 
embryonic iridophore pattern is compromised but they often have smaller patches of cells 
in the eyes (Figure 5.2 e,f,g) or on the lateral patches and can have incomplete spot 
patterns in the dorsal and ventral stripes. These mutants develop a swim bladder and, 
most interestingly around the transition from larvae to adult stage (4 weeks after 
fertilisation) seem to recover a normal iridophore pattern (figure 5.2h) and develop into 
normal looking adults. The trd homozygous mutants, as hinted by their name, also die 
without forming a swim bladder. These mutants have a phenotype that lies somewhere in 
between ty9 and ty82, perhaps more similar to the ty82 phenotype (Figure 5.2 i).
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Figure 5.2 Embryonic iridophore phenotype, (a-d) sdy homozygous embryos at 72 hpf. (a) 
Iridophores can be seen in the retina around the iris with transmitted light, (b) dorsal view of 
the head focusing on reflective iridophores in the eyes and lateral paches above the yolk sac. 
(c) iridophores on the dorsal stripe under transmitted light, (d) higher magnification of the 
dorsal stripe showing the oval/round shape and texture of individual cells.(e,f,g) ty9 
homozygous embryos at 72 hpf. Different strength eye phenotypes that can be found in these 
mutants, (h) ty9 homozygous mutant embryo 20 dpf at transition stage from larvae to adult 
showing recovered iridophore pattern.(i) trd homozygous mutant embryo (bottom) and wild- 
type sibling (top) at 72 hpf. (k) ty82 homozygous mutant embryo showing complete lack of 
iridophores in the eye and lateral pach compared to its wild-type sibling (j). (m) ty82 
homozygous mutant embryo without iridophores in the dorsal stripe compared to its wild-type 
sibling at 72 hpf (I), orientation is as in other Figures.
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5.3.2 Marker genes for the Neural Crest pigment 
lineages
5.3.2.1 Identification of e d n r b l  as a marker for the iridophore 
lineage
rose mutants have wild-type early larval pigment patterns but fail to develop normal 
numbers of melanophores and lack iridophores in the adult (Parichy et al., 2000a). ednrbl 
is the gene responsible for the rose mutant phenotype and encodes a G-protein-coupled 
receptor with seven transmembrane domains (Parichy et al., 2000a) (see Chapter 1 for 
Figure of this phenotype). In order to test whether ednrbl was expressed in embryonic 
melanophores and iridophores in spite of the lack of a rose embryonic phenotype, we 
performed a time course in situ hybridisation. We identified the ednrbl gene as a marker 
for iridoblasts (48 hpf) and iridophores (72hpf). However, before 48hpf this gene seems to 
be expressed in the other pigment lineages as well and therefore it is not suitable as a 
early iridophore lineage marker (Parichy et al., 2000a).
Using mRNA in situ hybridisation we examined expression of ednrbl in shd'1' and wild- 
type embryos between 12 and 72 hpf (Figure 5.3). Lack of ednrbl expression in shd '1' was 
very dramatic at 72 hpf. At this stage iridophores are readily visible under incident light and 
their absence in shd '1' was obvious (Figure 5.3 g,h). At this same time-point the 
expression of ednrbl followed the same pattern as iridophores. In wild-type embryos 
labelled cells were detected in the correct locations and patterns for iridophores; these 
were completely absent from shd ''' embryos (Figure 5.3 i,j). Labelled presumed 
iridophores could thus clearly be seen in a 72 hpf sdy ''' embryo without the melanin 
pigment obscuring pattern (Figure 5.3 k) and in transversal histological sections of wild- 
type embryos (Figure 5.3 I). The reduced expression of ednrbl in shd '1' embryos could be 
traced earlier to 24 hpf in a region dorsal to the eye when compared to wild-type siblings 
(Figure 5.3 c,d). At 30 hpf there were distinct expression patterns around the otic vesicle
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and again shd '1' embryos had less labelled cells than their wild-type siblings (Figure 5.3 
e ,f) . At these early stages mutants were identified on the basis of a difference in 
phenotype seen in 25% of the embryos resulting from a heterozygous cross. No 
differences were found between mutants and wild-types at 12 and 18 hpf (Figure 5.3 a,b).
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Figure 5.3 ednrbl expression in embryonic and early larval development, ednrbl is not 
expressed in 12 nor 18 hpf zebrafish embryos, respectively (a,b). At 24 hpf shd A show lower 
levels of expression of ednrbl around the eye region (d) when compared to wild-type siblings 
(c). The same is seen at 30 hpf around the otic vesicle of shd A (f) and wild-type (e). At 72 hpf 
the iridophores are readily visible among the melanophores of the dorsal stripe using incident 
light (g). shd ''' do not have iridophores but have normal melanophore pattern (h). ednrbl 
expression localises to cells (purple) that are in the right position to be iridophores (i) these are 
absent in shd (j). Presumed iridophores labelled with ednrbl in a 72 hpf sdy ''' without 
melanin pigment for better visualisation of the iridophore pattern in the dorsal stripe (k). 




5.3.2.2 Are the melanophore and xanthophore lineages affected in 
shcfA embryos?
shd '1' embryos do not show any abnormalities in melanophore or xanthophore pattern or 
shape. In order to confirm that these other pigment lineages were unaffected in shd ''' 
embryos we used two molecular markers, one for the melanophore lineage, dopachrome 
tautomerase (dct) (Kelsh et al., 2000b) and an other for the xanthophore lineage, GTP- 
cyclohydrolase I {gch) (Parichy et al., 2000b). Melanophores are labelled naturally by their 
melanin pigment from 27 hpf. dct is a marker for melanobiasts and melanophores because 
it was shown to label undifferentiated cells (5 hours before melanisation) as well as 
differentiated cells (melanised) (Kelsh et al., 2000b). Comparison of dct expression 
pattern in shcf1' and wild-type siblings shows that there are no detectable differences (data 
not shown). It was therefore concluded that both melanobiasts and melanophores seem to 
be unaffected in shd'1' in terms of number, pattern and shape.
The xanthophore lineage marker gch converts guanosine triphosphate to 
tetrahydrobiopterin (BH4), a precursor to pteridine pigments. BH4 also is a co-factor for 
phenylalanine hydroxylase, which converts phenylalanine to tyrosine (a precursor to 
melanin), and regulates the activity of tyrosinase, which converts tyrosine to melanin 
intermediate, dopa. Thus, gch should be expressed by xanthoblasts and possibly 
melanobiasts (Parichy et al., 2000b). The time points chosen for the in situ hybridisation 
with this probe were 30, 49, 54 and 77 hpf (on PTU treated embryos for better 
visualisation). Again the expression pattern of this marker on shd '1' showed no distinction 
from wild-type siblings.
In order to test if gch was expressed by iridoblasts we used the zebrafish shd/ALK probe 
(see Chapter 4) in parallel to compare the expression patterns at 30 and 49 hpf. Although, 
double in situ hybridisations were not performed it was clear from the very distinct 
expression patterns that xanthoblasts and iridoblasts do not share expression of these
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markers. The dorsal stripe pattern of iridoblasts, described earlier as spots of round/oval 
cells positioned on top and along a single dorsal line, is not comparable to the extremely 
branched pattern of gch+ cells. Furthermore, gch expressing cells are positioned 
surrounding but not intermixed with the positions where iridoblasts are seen (Figure 5.4 a) 
The dorsal branched pattern extends ventrally throughout the trunk and tail and is not 
confined to stripes as iridoblasts do (Figure 5.4 b). Again the expression of gch in the eye 
(Figure 5.4 c) is very different from the shd/ALK expression at 48-49 hpf. gch+ cells are 
branched in shape not round, they are often very large with thin projections, never form a 
spotted pattern, and do not surround the iris as iridoblasts do (for the shd/ALK expression 
pattern see Chapter 4).
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Figure 5.4 gch expression pattern in shd+/' and shd '1' embryos is the same, (a) dorsal view of 
the trunk of a 30 hpf showing the extremely branched pattern of gch+ cells, (b) trunk lateral 
view of a 30 hpf embryo showing that gch+ cells do not assemble in any dotted-stripe pattern 
in contrast they extend their projections all over the body, (c) eye of a 49 hpf embryo showing 




5.3.2.4 f o x D 3  as a marker for iridoblasts
FoxD3 belongs to the winged-helix or forkhead class of transcription factors and has been 
identified as a marker for pre-migratory neural crest, floorplate, somites and tailbud 
(Odenthal and Nuesslein-Volhard, 1998). More recently Kelsh et al. (2000) identified it in 
neural crest-derived glia in the cranial ganglia and along the posterior lateral line nerve. 
More interestingly, J. Lister (personal communication) identified expression of foxD3 in 
iridophores and has evidence that this transcription factor might be involved early in 
iridophore lineage specification. To test this hypothesis we decided to perform some 
preliminary foxD3 expression studies on shd '1' to test whether this gene (1) might have a 
role in the iridophore lineage and (2) in particular, at what stage of development foxD3 was 
acting: upstream or downstream of shd/ALK?
Results from preliminary expression studies done at 30 and 49 hpf showed no differences 
between shd mutants and wild-type siblings. However, a subset of foxD3+ cells were 
positioned in the right locations to be identified as potential iridoblasts both at 30 and 49 
hpf. At 49 hpf we observe strong foxD3 expression in the cranial ganglia associated glia, 
lateral line glia (Figure 5.5a) and in cells identified as iridoblasts because of their position 
and spacing on the dorsal and ventral stripes (arrows in Figure 5.5b). This expression 
pattern strongly resembles the one obtained with shd/ALK riboprobe (see Chapter 4) and 
suggests that foxD3 may indeed play a role in the iridophore lineage.
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Figure 5.5 foxD3 has an intriguing expression pattern in all embryos from an heterozygous shd 
cross at 49 hpf. (a) foxD3+ cells in cranial ganglia and lateral line associated glia are still 
present at 49 hpf. (b) lateral view of the trunk showing foxD3+ cells on the dorsal and ventral 
stripes (arrows) positioned in a pattern reminiscent of that of iridoblasts when labelled with 
shd/ALK.
At 30 hpf foxD3 expression is seen in the glia associated with the cranial ganglia (Figure 
5.6a arrowheads), in the glia associated with the lateral line nerve (thin arrows) and also in 
some cells that are in the position of iridoblasts above the yolk sac elongation (single 
arrow). On the medial pathway (Figure 5.6b) foxD3+ cells are seen throughout the trunk 
but only a subset of these are closer to potential iridoblast positions above the yolk (arrows 
in Figure 5.6b) and on the dorsal stripe. Some of these cells could also be melanophores 
based on their branched shape but more likely, these cells can be medially migrating 
neural crest cells that are not yet fate restricted. Other cells, on a more superficial focal 
plane, positioned above the yolk sac and yolk sac elongation are potential iridoblasts 
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Figure 5.6 foxD3 expression in all embryos resulting from a heterozygous shd cross at 30 hpf. 
(a) foxD3 expression is seen in the region of the cranial ganglia (arrowheads), lateral line nerve 
(thin arrows) and in potential iridoblasts (broad arrow) on a superficial focal plane, (b) foxD3+ 
cells on the medial pathway are spread throughout the trunk but only a subset of these are 
closer to iridoblast positions (arrows), (c) Superficial focal plane showing foxD3+ cells on 
lateral line nerve and in potential iridoblasts on the ventral stripe above the yolk sac (arrows).
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5.3.3 Genes that might interact with shd/ALK
5.3.3.1 n a c r e lm i t f a
nacre homozygous mutants (nac'1') are characterised by their lack of melanophores and 
their precursors throughout development. In contrast, these mutants were reported to have 
an increase in iridophore number (Lister et a!., 1999). The nacre gene was identified as 
encoding a basic helix-loop-helix/leucine zipper transcription factor related to 
microphthalmia (Mitf), a gene known to be required for development of eye and neural 
crest-derived pigment cells in the mouse. In order to investigate iridophore development in 
nac'1' we used the iridoblast and iridophore markers ednrbl and shd/ALK on nac'1' 
embryos. We asked whether nac1' embryos have more iridoblast precursors.
Surprisingly, both ednrbl and shd/ALK riboprobes showed delayed expression in 
iridoblasts in nac1' embryos. Thus, at 48 hpf nac1' embryos did not express ednrbl (Figure 
5.7b) whilst, as noted before, their wild-type siblings already did (Figure 5.7a). At 56 hpf 
the expression in nac1' embryos was still very faint compared to their wild-type siblings 
(Figure 5.7c,d). Only at 72 hpf were the levels of ednrbl expression considered equivalent 
between nac v' and siblings (Figure 5.7e,f). It is worth stressing that these embryos were 
processed and developed in parallel in the same tube throughout the protocol. Similar 
observations were made with the expression of shd/ALK at 30 hpf. While wild-type 
embryos showed iridoblast probe expression in both dorsal (Figure 5.7g) and ventral 
(Figure 5.7h) stripes, expression was completely absent in nac'1L embryos (Figure 5.6i). 
However, by 48 hpf shd/ALK expression in iridoblasts was identical in both nac ''' and 
nac+l' embryos (data not shown). In summary, ednrbl expression, usually detectable very 
clearly at 48 hpf in nac'1' is still faint at 56 hpf and shd/ALK, usually very strong at 30 hpf 
was only detected at 48 hpf in nac'1' (but is possible that it could be visible sometime earlier 
between 30 and 48 hpf).
179
CHAPTER 5
Figure 5.7. Expression of iridoblast markers in nac1' embryos is delayed, (a) ednrbl 
expression at 48 hpf in wild-type and (b) its absence in nac '7' siblings, (c) ednrbl expression at 
56 hpf in wild-type and (d) very faint expression in nac 7' siblings, (f) Normal levels of ednrbl 
expression in nac 7' embryos were only detected at 72 hpf compared to their wild-type siblings 
(e). shd/ALK expression in iridoblasts on the dorsal (g) and ventral (h) stripe of a wild-type PTU 
treated 30 hpf embryo compared to a nac 7' embryo of the same age (i) (note that (h) is more 
anterior to (g) and (i) is comparable to (h).
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To further investigate the relationship between shd and nac function we created nac/7shcf/' 
double mutants. The resulting phenotype was additive (data not shown). The double 
mutants lacked all melanophores as well as all iridophores at 72 hpf. This genetic result 
suggests that these mutations affect distinct and independent populations of pigment cells. 
Thus, nacA iridophores require shd/ALK function to form and shd melanophores need 
the naclmitfa function to develop.
5.3.3.2 c o lo u r le s s / s o x 1 0
els homozygous mutants have severe defects in most crest-derived cell types, including all 
three types of pigment cells, neurons and glia from the PNS. It has been shown that all 
three types of pigment cell are affected by els mutations cell-autonomously (Kelsh and 
Eisen, 2000). The c/s gene encodes a zebrafish sox10 transcription factor and has been 
suggested to have a primary role in specification of non-ectomesenchymal crest 
derivatives (Dutton et al., 2001). In this way, it is proposed that els is upstream of genes 
with critical roles in specific fates. Such a role has been demonstrated for melanophores 
(Elworthy et al., 2003) where nac/mitfa is activated by cls/sox10. It is therefore conceivable 
that such a similar relationship (perhaps not so direct) might occur between cls/sox10 and 
shd/ALK in iridophores. To test this idea we examined shd/ALK expression in els'1' 
embryos to test the prediction that shd/ALK expression would be absent in els'1' embryos.
Results confirmed the predictions made: At 27 hpf shd/ALK expression on the e ls ''' eye 
(Figure 5.8b) was completely absent, although iridophore expression was prominent in 
wild-type siblings (Figure 5.8a). At this stage we noted the absence of expressing cells 
above the yolk in the ventral stripe of els'1' embryos (Figure 5.8d) in contrast to the 
presence of labelled cells in the wild-type siblings (Figure 5.8c). Wild-type expressing cells 
appeared to be migrating down through the medial pathway (Figure 5.8ef). Again this 




Figure 5.8 els'' embryos lack shd/ALK expression in neural crest derivatives, (a) 27 hpf wild- 
type eye showing expressing iridoblasts (b) absence of expressing cells in a els1' eye from the 
same cross. The pigmented cells in the c/s'A mutant eye are melanophores from the pigmented 
retinal epithelium that is not crest-derived, (c) Expressing iridoblasts in the ventral stripe of 
wild-type embryos in contrast to (d) absence of any labelled cells in a els1' sibling, (e-f) 
Iridoblasts at 27 hpf appear to be migrating through the medial pathway in wild-type embryos 
(e) dorsal view (f) lateral view.
5.3.3 Other neural crest derivatives in are 
unaffected
We have shown that shcf1' embryos have a profound defect in the iridophore lineage but 
not on other pigment lineages. To ask whether other neural crest derivatives might be 
affected was particularly interesting because severe shd A have an unexplained lethality. 
We thus asked whether the enteric ganglia and dorsal root ganglia (DRGs) were normal by
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using an anti-Hu immunostaining approach (Marusich et al., 1994). This antibody labels 
the cell bodies of differentiating neurons.
Our results showed no significant differences between mutants and wild-type embryos in 
respect to number, position and shape of both DRG neurons and enteric ganglia (Figure 
5.9 a,b). We confirmed the observations for enteric ganglia made in whole mount embryos 
(Figure 5.9 c,d), in both dissected guts (Figure 5.9 e,f) and gut cryosections (Figure 5.9 
g,n) using the peroxidase -antiperoxidase system. It is therefore concluded that the DRGs 
and enteric ganglia are normal in shd homozygous mutants and are not associated with 
the cause of lethality.
Figure 5.9 Neural crest derived dorsal root ganglia (DRGs) and enteric ganglia are normal in 
shd'f' embryos.(a,c,e,g) wild-type embryos at 5 days post fertilisation showing (a) DRG pattern 
and (c) enteric neuron pattern in whole mount immunostaning with anti-Hu. (b,d) Sibling mutant 
embryos show no detectable differences in these patterns, respectively. The same applies to 
dissected guts (e,f) and gut cryosections (g,h).
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5.3.4 shd functions cell autonomously in 
iridophores
To learn whether shd mutations affect iridophores autonomously, cells were transplanted 
between wild-type and shd embryos. Results from the mosaic analysis are illustrated in 
Figure 5.10 and presented fully in Table 5.1. We achieved good survival rates in our 
transplantation experiments with 64.6% survival of host embryos until 72 hpf when the shd 
ty82/ty82 phenotype was first detectable. As expected, approximately, 25% of the embryos 
were shd Among the 40 identified shd ''' embryos, about half (22) were chimaeric but 
only 7 of these had rescued iridophores. Iridophores were usually donor-derived; low level 
of occasional unlabelled iridophores reflects the normal ty82 phenotype. Rescued shd ''' 
were distinguished by exceptionally higher number of iridophores. When labelled 
iridophores were detected in an embryo these were at least 4. In some cases more than 
20 were seen in the eyes, perhaps reflecting a high degree of proliferation in the eyes. The 
very few non-labelled iridophores detected in shd chimaeric embryos do not seem to 
correlate with the position of the rescued ones suggesting that they were not involved in 
short distance signalling that could have enabled the wild-type iridophores to develop. 
Labelled cells in rescued chimaeras were sometimes restricted to iridophores (see 
experiment 3 on Table 5.1). Together, these data strongly argue for cell autonomy of shd 






Figure 5.10 Rescued iridophores in wild-type ^  shdty82/ty82 chimaeras are all donor-derived.
The region shown is the same in the three panels and corresponds to a close up of the region 
of the ventral stripe near the tail of the chimaeric embryo described in experiment no. 8 (Table 
5.1). 5 rescued iridophores are seen with incident light (a), and all show rhodamine 
fluorescence (b) and are thus donor (WT) derived. Confirmation of this is shown in panel c) 
where biotin-detection labels all 5 iridophores (in dark orange).
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Table 5.1. Transplantation of labelled wild-type cells into tyQ2''' embryos suggest shd functions cell autonomously in iridophores.












No. chimaeric ty8Z 















1 19 19(100) 5 (26.3) 5 (CNS; muscle) 0 0 0
2 16 13 (81.2) 3(23) 1 (CNS; muscle) 0 0 0
3 38 28 (73.6) 5(17.8) 2 (ventral and dorsal stripe 
iridophores; yolk)





4 20 12(60) 3(25) 0 0 0 0
5 34 9 (26.4) 2 (22.2) 2 (CNS; blood) 0 0 0
6 35 20 (57.1) 4(20) 4 (CNS; melanophores; 
eye iridophores)
1 >20 (one eye) 0
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No. chimaeric ty82 














7 20 8(40) 1 (12.5) 1 (CNS; muscle; skin; eye 
iridophores; lateral patch 
iridophores)
1 >20 (one eye) 
>20 (lateral patch 
on the same side 
as eye)
1 (dorsal stripe)
8 31 16 (51.6) 4(25) 2 (CNS; ventral stripe 
iridophores; fin skin; PNS 
neuron)
1 9 (ventral stripe 
near the tail)
0
9 40 30 (75) 6 (20) 5 (melanophores; skin; 
stomach wall; eye and 
dorsal stripe iridophores; 
eye blood vessels; blood)
2 4 (dorsal stripe) 
>20 (one eye)
2 (lateral patch) 
1 (lateral patch)
10 38 33 (86.8) 7(21.2) 0 0 0 0




From the in situ hybridisation and immunocytochemistry analyses presented here we 
propose that shd homozygous mutant phenotype seems to be specific to the iridophore 
lineage at least within the neural crest derived cell types. There is a strong decrease in the 
number of iridophores that varies with the allele being considered, but no effect was 
detected in other pigment cell lineages. Other neural crest derivatives such as dorsal root 
ganglia and enteric ganglia were also normal in shd' embryos. We showed that shd 
functions cell autonomously in iridophores which was useful when it came to look at the 
expression pattern of shd/ALK (Chapter 4). We knew, from this result that a shd candidate 
gene should be expressed in the actual iridophore and/or its precursors. Taken together, 
these results confirmed that shd/ALK function in the developing neural crest is likely to be 
specific to the iridophore lineage. Furthermore, the almost complete absence of expression 
when using a shd/ALK probe in shcfA confirms that shd/ALK functions very early in 
iridophore development. Thus, as it has been suggested earlier by Kelsh et al. (1996), shd 
represents a good candidate gene for the specification of iridophores. However, the 
preliminary observations of FoxD3 transcripts in cells that occupy iridoblast positions even 
in shcf1' embryos make the specification argument less plausible. It is discussed here 
whether shd/ALK might still have a specification, a survival or an early differentiation role in 
the iridophore lineage from the neural crest.
The work already done on fish melanophores is important for helping us to distinguish the 
role of genes involved in specification vs. differentiation and survival. Dutton et al. (2001) 
suggest that cls/sox10 has a primary role in specification of non-ectomesenchymal crest 
derivatives (pigment cells, neurons and glia from the PNS). Wnt signalling was shown to 
promote the formation of pigment cells at the expense of neurons and glia (Dorsky et al.,
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1998) and hence specifies non-ectomesenchymal cells to a pigment cell fate. Other genes, 
downstream of els and Wnt signalling would then be expected to specify individual 
lineages such as melanophores, xanthophores and iridophores (see Figure 5.11). This 
illustrates the principal of progressive fate restriction reviewed by (Kelsh and Raible, 2002). 
Of these three pigment lineages the best studied is that of melanophores. For instance we 
know that cls/sox10 directly activates nac/mitfa (Elworthy et al., 2003) probably together 
with the previous demonstrated activation by the Wnt signalling (Dorsky et al., 2000) and 
that nac/mitfa is necessary and sufficient to make melanophores (Lister et al., 1999). 
Therefore, we assign the melanophore specification event to nac/mitfa activation. 
Consistent with this Mitf in mice is required for the transcription of many melanocyte 
genes, including tyrosinase-related genes with roles in melanocyte differentiation (Le 
Douarin and Kalcheim, 1999; (Kelsh et al., 2000b). Downstream of nac/mitfa there are 
other genes with important roles such as spa/c-kit (Parichy et al., 1999b) which is needed 
for melanophore dispersal and survival (Kelsh et al., 2000b; Parichy et al., 1999b). dct 
expression patterns in spa embryos demonstrate that melanoblasts are present in 
normal numbers (Kelsh et al., 2000b). We shall use this knowledge on melanophore 
development to hypothesise the role of shd/ALK in iridophore development.
Although data is limited, ours and others, results to date do not deny the chromatoblast 
theory proposed by (Bagnara et al., 1979) where all pigment cell types have a common 
progenitor the chromatoblast. We describe a model of iridophore development 
incorporating this concept (Figures 5.11 and 5.12). The chromatoblast cell generates each 
of the three pigment cell-types, perhaps by the action of three different early specification 
genes. Based on results reported here and elsewhere we propose that specification 
occurs progressively via a melano-iridoblast. The absence of shd/ALK expression in neural 
crest cells of els1' embryos is consistent with sox10 function being required for 
development of the chromatoblast.
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Evidence for a common precursor for zebrafish melanoblasts and iridoblasts arises from 
the work done by Lister et al. (1999) in the nac mutant (mitfa). This is based on the fact 
that nacA mutants lack melanophores and their precursors but show an increased number 
of iridophores. These authors went further to explain the iridophore phenotype in nac1' and 
suggested that another transcription factor FoxD3 might be repressing nac/mitfa in this 
bipotent precursor cell to allow the iridophore lineage to develop (J. Lister personal 
communication). The role of foxD3 in repressing melanogenesis thereby allowing other 
neural crest derivatives to differentiate has been shown in avian embryos before (Kos et 
al., 2001). foxD3 morpholinos had no effect on iridophore number in nacA embryos 
suggesting the increase in iridophore number results from the absence of nac function (J. 
Lister personal communication). On the other hand, it was demonstrated that the same 
foxD3 morpholino injected into spa'A mutants (which have reduced numbers of 
melanophores and normal numbers of iridophores (Parichy et al., 1999a) decreases the 
number of iridophores and increases melanophore number (J.Lister personal 
communication). These experiments point a) to the existence of a common precursor for 
iridoblasts and melanoblasts and b) to foxD3 having an inhibiting effect on nac/mitfa 
allowing iridoblasts to develop.
In the current work, it was shown that foxD3 seems to be expressed by iridoblasts at 30 
and 49 hpf. It is therefore suggested that at 30 hpf those cells might be the common 
precursor proposed by Lister (1999) where foxD3 is simply shutting down nac/mitfa 
function and by doing so, allowing them to be specified for the first time as iridoblasts. A 
very important fact is that homozygous mutants for the foxD3 gene, named mother 
superior, have a severe reduction of iridophores (Ella Knapik personal communication) 
confirming that this gene is likely to have a role in iridophore development in addition to its 




The fact that we have found no differences between wild-type and shcf1' embryos in foxD3 
expression studies means that this gene is acting independently of the shd/ALK function. 
This result was surprising because it was telling us that even in the absence of shd/ALK 
gene function there are still cells that behave as if they were specified to the iridophore 
fate. This finding, if proved to be correct, is revealing that foxD3 is acting upstream of 
shd/ALK. On the other hand, the fact that foxD3 is still expressed at 49 hpf in these 
iridoblasts is intriguing as its inhibitory function would be expected to have finished by 
then. Perhaps foxD3 has some other early role in the iridophore lineage, also prior to the 
shd/ALK function. Conceivably, it might be actively involved in shd/ALK recruitment as the 
next step in iridophore specification. Alternatively, may be shd/ALK is responsible for 
iridoblast survival or even for a very early differentiation step in iridoblasts that have 
already been specified by foxD3. It would be interesting to follow these links in the future 
(see Figure 5.12).
One other intriguing result presented here was the delayed expression of iridoblast 
markers in nac1' embryos. The observation of an increased number of iridophores in nac'/' 
embryos would predict that many iridoblasts should be identified at 30 hpf using shd/ALK 
as a marker. This was not the case and only later could these cells be detected. The same 
applied to ednrbl expression that was detected later than 56hpf as opposed to 48 hpf in a 
wild-type situation. We suggested that in nac'1' embryos there was approximately a 10 hour 
delay in expressing these two markers. Therefore, a delay in the expression of iridoblast 
markers indicates that the lack of a functional Mitfa does not immediately result in the 
presence of more iridoblasts by default. In stead, it seams to take longer for such cells to 
form. One explanation would be that iridoblasts to become identifiable by shd/ALK and 
ednrbl markers need to have interacted with differentiated melanophores around 30 hpf. 
Perhaps because they need some factor secreted by melanophores. In the absence of this 
cell type as in the nac'1' situation, maybe the shd/ALK receptor has to be activated by a
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different process that takes longer or has to wait for the same secreted factor to be 
generated by other cells types.
Coming back to the model and having added the early action of foxD3 in the iridophore 
lineage, we need to include shd/ALK as a late specification gene, an iridoblast survival 
gene, or an early differentiation gene in iridophore development. The early differentiation 
role places shd/ALK in the same step as dct for the melanophore lineage development 
(Kelsh et al., 2000b). However, the Dct phenotype in mice is very different from the shd '1' 
phenotype, it shows a reduction in melanin and therefore the presence of paler 
melanocytes as opposed to absence of these cells (Le Douarin and Kalcheim, 1999). We 
therefore tend to discard this possibility.
An argument against shd/ALK being involved in survival or proliferation, in spite of having 
been assigned with this role in human tumours, is again based on the observation that the 
shd ''' phenotype is very strong. Unlike for example that of spa‘A embryos, which encode an 
RTK (c-kit) with proliferation/survival activity, where even the strongest phenotypes are 
never completely depleted of melanophores. On the other hand, we know that both in 
zebrafish and in mice the requirement for c-kit has been suggested to be after melanoblast 
proliferation (reviewed by Le Douarin and Kalcheim, 1999; Kelsh and Eisen, 2000). 
Therefore, an argument in favour of shd/ALK having a survival role is still possible if this 
function is vital for iridoblast survival before they proliferate. So that, in a strong phenotype 
we can not detect any iridoblasts.
The possibility of shd/ALK being involved in iridophore specification implies that it must be 
expressed in other cells apart from iridoblasts. At the moment we have no evidence that 
that is the case because we did not perform any double in situ hybridisations. However, 
the number, position and pattern of shd/ALK expressing cells strongly suggest that this 
gene is specifically expressed by iridoblasts from 30 hpf. Futhermore, the absence of
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shd/ALK expression in shcf1' embryos supports this prediction. Consequently, it is plausible 
that shd/ALK expression is a marker of specification rather than a specifying sign. For this 
reason we shall consider both these scenarios from now on.
shd/ALK seems to start being down-regulated in the actual iridophore cell, again 
supporting that this gene is probably not involved in late iridophore maintenance or 
survival. In fact, such a role might be performed by ednrbl which is expressed by 
iridophores at later stages. Without the function of ros/ednrb1, adult iridophores are absent 
as shown by the ros'A adult phenotype (Parichy et al., 2000a). A similar role in survival has 
been shown to be performed by spa/c-kit function in embryonic melanophores (Parichy et 
al., 1999b). However, the evidence for ednrbl having a survival role in embryonic 
iridophores is poor and we must remember that other genes will probably be identified for 
the iridophore lineage which might be better candidates for this function.
In addition to this speculative late function of ednrbl we question whether it might also 
have an early role in iridoblasts or indeed in common precursor pigment cells. Evidence for 
this is not robust as it arises solely from expression patterns. Nevertheless, expression of 
this gene between wild-type and shd 'A embryos is detectable as early as 24 hpf. At 30 hpf 
expression of ednrbl was detected in melanising cells too. According to Parichy (2000) 
this gene is expressed by all three pigment cell precursors until the time that each of them 
becomes differentiated. This indicates that at an early stage, possibly before melanisation, 
the cells expressing ednrbl might be the common precursors for all the pigment cell 
lineages proposed by Bagnara et al. (1979).
The fact that ednrbl expression ceases with differentiation of the different cell types makes 
us speculate that perhaps this gene has a role in keeping cells away from terminal 
differentiation during migration. Similar function was reported for this gene in the mouse 
(Shin, 1999), where the Ednrb/Edn3 system has been proposed to be involved in retaining
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an undifferentiated status of neural crest cells so that these undergo migration through the 
whole gut. May be this function is conserved in fish pigment cells, so that by indirectly 
regulating the timing of migration they become progressively differentiated, first in 
melanophores and xanthophores and at last in iridophores.
Finally, for the model to be complete, genes involved in the differentiation of the actual 
reflective platelets would need to be identified. Candidates for these genes would be the 
genes causing duil iridophore phenotypes isolated in the Tuebingen screen in 1996, such 
as brassy, punkt, pepita or pile-up (Kelsh et al., 1996).
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Figure 5.11 Progressive fate restriction of neural crest cells in zebrafish. Adapted from (Kelsh 
and Raible, 2002). A neural crest cell (NC) gives rise to ectomesenchymal (E) and non- 
ectomesenchymal (NE) progenitors. The former cells generate craniofacial cartilage (C) and fin 
mesenchyme (F) amongst other fates. Non-ectomesenchymal precursors are initially 
pluripotent and els gene function is needed for all its different derivatives. It is suggested here 
that there might be a common pigment cell precursor known as a chromatoblast (Cb) and a 
common neuron-glial precursor (NG) which will give rise to neurons (N) and glia (G). Wnt 
signaling and sox10 are implicated in generating the pigment cell lineage. The chromatoblast 
(Cb) theory was suggested by Bagnara et al.(1979). It is possible that a chromatoblast then 
becomes fate restricted to a Melano-iridoblast (Ml) that in turn through the action of specific 
genes gives rise to melanophores (M) and iridophores (I) (see Figure 5.12 for close up of this 
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Figure 5.12 Model for the common pigment cell precursor. The chromatoblast (Cb) hypothesis 
is supported by ednrbl expression in cells that co-express specific markers for each pigment 
cell type (expression of shd/ALK to be confirmed). It is possible that a chromatoblast then 
becomes fate restricted to a melano-iridoblast (Ml) where the transcriptional repressor foxD3 
inhibits mitfa during a period of time to allow iridoblasts (lb) to develop. Normally, mitfa would 
continue to form melanoblasts (Mb), which express both mitfa and dct, and would fully 
differentiate into melanised cells with the help of dct amongst other genes. Then, 
melanophores would need c-Kit function to disperse properly and survive. For the iridophore 
lineage to form the function of shd/ALK is necessary but perhaps not sufficient as foxD3 
expression in late iridoblasts suggests an additional unknown role for this gene in these cells. It 
is conceivable that foxd3 might be directly or indirectly transcriptionaly activating shd/ALK as a 
specification step. Differentiated iridophores (I) express ednrbl perhaps involved in 
maintenance and survival of these cells. Iridophores also express shd/ALK at lower levels 
indicating down-regulation of this gene. It is questioned whether iridophores might still express 
foxD3. Much less is known about the xanthophore lineage (X) at the current time, except that 
in a elsA embryo these are the only cells that develop (although in lower numbers) perhaps 
because xanthophores are a default state for pigment cells. However, we can not rule out the 
possibility of the presence of a Melano-xanthoblast. Xanthoblasts (Xb) and xanthophores 
express gch and xdh, two markers of xanthophore differentiation. Genes expressed by the 




General Discussion and conclusions
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As part of a positional cloning project the starting point of this work was to map shd to one of 
the zebrafish 25 linkage groups. The region of previously mapped genes otxl and id2 on 
linkage group 17 was closest to the markers nearest shd . Synteny between this region and 
human chromosome 2p13-2p25 was confirmed for four zebrafish genes which suggested that 
a human homologue of shd would likely lie within this region of chromosome 2p. Isolation of 
genomic clones and application of combined restriction analysis, phenotypic rescue by 
genomic DNA micro-injection and sequencing narrowed down the genomic interval containing 
shd to a region where only one candidate gene could be identified. This predicted candidate 
gene was an RTK similar to both human ALK and LTK genes. One of them, ALK, had indeed 
been mapped to a position within the region of human chromosome 2p13-2p25. However, 
human LTK on chromosome 15 is very close to both IVD and ITPKA, genes orthologous to 
zebrafish predicted ivd and itpka that were found in our genomic contig (PACs 1 and 3, 
respectively). It was therefore concluded that in terms of synteny both these RTKs could be 
candidates for shd. It was only after a detailed phylogenetic analysis (in collaboration with 
Professor Laurence Hurst, University of Bath) that we could conclude that shd is the true 
orthologue of the mammalian ALK genes.
cDNA cloning and expression analysis of the zebrafish ALK/LTK gene strengthened its 
candidacy since: a) its expression pattern included iridophores and their precursors and b) a 
morpholino designed to this RTK successfully phenocopied the shd mutant phenotype.
Two different cDNA clones were identified, these were identical except for the presence of 78 
nucleotides encoding an extra 26 amino acids in clone 1. The difference between clones 
appeared not to be caused by a differential splice event since consensus splice sites were 
absent in the genomic sequence. It seemed more likely therefore, to result from a deletion 
during the cloning procedure.
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Mammalian ALK proteins showed much wider similarity to zebrafish RTK predicted ORF in 
both the extracellular and intracellular region than did LTK proteins. Thus, structurally, the 
zebrafish RTK was more reminiscent of an ALK protein than an LTK. In particular, the MAM 
domains identified in the zebrafish RTK are only present in ALK proteins. Again, it was only 
through the phylogenetic analysis based on the most conserved domain (tyrosine kinase 
domain) between zebrafish, mouse, rat and human ALKs and LTKs, both at nucleotide and 
amino acid levels, that we confirmed that our RTK was indeed an ALK orthologue.
The comparison of expression patterns between zebrafish RTK and the two mammalian 
genes was not informative because mammals lack iridophores. The only pigment cell type 
present in mammals is the melanocyte (melanophore equivalent in a homeothermic organism) 
but there are no reports of ALK or even LTK expression in these cells.
Antibodies raised against the ALK ligand binding domain (within one of the mouse MAM 
domains) inhibit PTN and MK from binding to mouse ALK (Stoica et al., 2001; Stoica et al., 
2002). We thus know that both PTN and MK are potential ligands for the mammalian ALK 
receptor (Stoica et al., 2001; Stoica et al., 2002). There is evidence that these proteins in 
higher vertebrates are involved in a wide range of activities. MK has a neurotrophic function 
as it promotes outgrowth and survival of cultivated neurons (Michikawa et al., 1993), its up- 
regulation has been observed in a number of tumours (including those involving ALK), where 
it seems to have a role in invasion and survival of tumour cells (Stoica et al., 2002). 
Furthermore, it has been reported in angiogenesis, wound healing and tissue repair processes 
(Muramatsu, 2002; Wada et al., 2002; Yoshida et al., 1995). For instance, MK expression 
(which is normally very restricted in the adult) re-emerges in the adult brain during pathologic 
alterations such as Alzheimer’s disease or cerebral infarction (Yoshida et al., 1995). PTN has 
also been implicated in endothelial cell proliferation and angiogenesis and it has been
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demonstrated to function as a tumour growth factor (Muramatsu, 2002; Stoica et al., 2001; 
Stoica et al., 2002).
There are two paralogous midkine (mdk) genes recently identified in zebrafish and one EST 
for the pleiotrophin (ptn) gene (Winkler et al., 2003). Therefore, zebrafish appears to have 
orthologues of both the tetrapod genes that have products implicated in ALK signalling. One of 
the fish midkines, mdkb, has been suggested to act as a planar signal in early neural 
patterning. Its later expression in the dorsal neural tube together with the finding that ectopic 
mdkb promotes neural crest cell formation (Winkler and Moon, 2001) makes this gene the 
best candidate for encoding a zebrafish shd/ALK ligand.
Later expression of zebrafish mdkb or indeed of the ptn EST have not been reported. These 
expression studies would be critical in revealing whether mdkb and/or ptn have the right 
localisation during iridophore development to be seriously considered as encoding candidates 
for shd/ALK ligands. Therefore, we strongly suggest such studies should constitute the next 
step in the line of research of this project.
We would like to end this thesis by proposing a model for the likely role of shd/ALK in the 
iridophore pigment cell lineage. We begun these studies considering shd to be involved in an 
early step in iridophore development, perhaps fate specification (see Chapter 1). However, by 
the end of this work we propose at least three possible roles for shd (models A, B and C), 
based on the following key observations:
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Model A- shd/ALK as a gene needed for iridophore specification
This model considers that the foxD3 expressing cells described in Chapter 5 are bipotent 
melano-iridoblast cells. These bipotent cells would reach their presumptive iridophore 
locations in the embryonic zebrafish and wait for further instructions on whether to follow the 
iridophore lineage. Because foxD3 positive cells are present at 30 and 49 hpf both in wild- 
types and shd'1' in numbers and locations that are typical of final destinations for iridophores, 
it may reflect that this gene has an early role in iridophore specification before the shd/ALK 
function. Hence we believe the presumptive function of foxD3 in these cells is to enable the 
bipotent cells to become iridoblasts by repressing the early melanoblast specifying gene mitfa. 
The role of shd/ALK could therefore be one of specification, perhaps directly or indirectly 
activated by foxD3 (model A in Figure 6.1). The specification hypothesis assumes that 
shd/ALK is necessary for restricting the fate of the bipotent melano-iridoblast to iridoblast. 
Consequently, in a shd "/_ environment the foxD3 expressing cells that we saw would be this 
bipotent precursor waiting for the final fate restriction step. What happens to these cells is 
worth investigation. Thus, we propose to look for cell death at around 49-50 hpf. On the other 
hand, in a wild-type environment we predict that foxD3 would be co-expressed with shd/ALK.
To assign a definite role for shd/ALK in iridophore development it would be crucial to 
understand the outcome of signalling through this RTK. Our predictions, in case shd/ALK is 
the specifying gene, are that the signalling through the shd/ALK receptor will result in the 
transcription of early differentiation iridophore genes responsible, for example, for the 
formation of guanine platelets (model A in Figure 6.1).
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Model B- shd/ALK as a gene needed for iridoblast survival
Alternatively, the specification role might be performed by foxD3 as a result of inhibiting mitfa 
and shd/ALK may be involved in early survival of iridoblasts. Therefore the survival hypothesis 
(model B in Figure 6.1) assumes that the ‘bipotent’ cell is already specified to an iridoblast by 
foxD3 action, perhaps in conjunction with other genes. As a result, in a shcfA environment, the 
foxD3 expressing cells would almost certainly die whilst in a wild-type environment we also 
expect these cells to co-express foxD3 and shd/ALK. Whether foxD3 is maintained in 
iridophores or is down regulated after 49 hpf has to be further investigated. We propose to test 
for apoptosis by TUNEL and follow the fate of these cells by single cell iontophoretic labeling.
In case shd/ALK is a survival gene (model B in Figure 6.1), we predict that the signalling 
outcome might result in the activation of the PI3-kinase axis resulting in phosphorylation of the 
downstream target molecule Akt, an anti-apoptotic effector of PI3-kinase signalling (Brunet et 
al., 1999). This cascade of events has been reported in human cell-lines caused by activation 
of ALK by MK and PTN binding (Stoica et al., 2002). We propose that the same signal 
transduction pathway may be needed for iridoblast survival. The ability of Akt to promote cell 
survival by inhibiting transcription of genes that belong to the apoptotic machinery is well 
documented (Brunet et al., 1999; Brunet et al., 2001a; Brunet et al., 2001b; Datta et al., 1999).
Model C- shd/ALK as a gene needed for iridoblast maintenance
Other possibility, (model C in Figure 6.1) is that foxD3 while repressing mitfa, activates an 
iridophore fate gene, which in turn activates the transcription of the shd/ALK gene. The 
signalling through the mature shd/ALK receptor could then result in the regulation of the 
upstream iridophore fate gene, by a positive feedback loop. Consequently, the function of
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shd/ALK would be maintenance of the iridoblast fate. This model is consistent with our 
observation that shd/ALK expression is absent in shdA mutants, because in this context 
shd/ALK signalling would be needed to maintain shd/ALK gene expression. We would expect 
to find apoptotic iridoblasts in the absence of shd/ALK function.
A similar regulatory model has been suggested for c-kit signalling (Hemesath et al., 1998). 
These authors have shown that c-kit signalling in vitro activates the ERK/MAP kinase 
pathway, which in turn was able to phosphorylate Mitf in melanocytes The ability of Mitf to 
transactivate was successfully tested on a luciferase reporter driven by the tyrosinase 
promoter (Hemesath et al., 1998). We suggest that shd/ALK signalling might also use a MAP 
kinase pathway for targeting the phosphorylation of the putative iridophore fate gene because 
in addition to the reported IP3 kinase pathway, human ALK has also been shown to activate 
the MAP kinase transduction pathway (Stoica et al., 2002).
The activation of the shd/ALK receptor by the putative growth factors mdkb or ptn assumes 
that in the environment around this receptor there must be growth factor secreting cells. We 
suggest that perhaps a close source for these factors might be the melanophore cells, since 
iridophores always appear somehow associated with melanophores (see wild-type phenotype 
in Chapter 5). In fact, because iridophores fully differentiate around 20 hours after 
melanophores it means that melanophores could secrete the growth factors that activate the 
shd/ALK receptor in their neighbouring melano-iridoblasts/iridoblasts (see Figure 6.1). This 
hypothesis would also explain why in a nac'embryo (which lacks all melanophores) we see a 
delay in iridoblast development (Chapter 5). It is conceivable that melanophores are the 
closest but not the only source of these growth factors explaining why iridophores are still 

































In summary, we have positionally cloned shd and shown it encodes an RTK orthologue to the 
mammalian ALK gene which has a poorly understood normal function, in contrast to its better 
known role in human cancer. The phenotypic observations on zebrafish shd mutants and 
other iridophore mutants compared to their wild-type siblings allowed us to generate models in 
which we suggest that shd/ALK plays an important role in either iridoblast specification, 
survival or maintenance. We suggest further experiments for testing these roles as well as for 
testing the candidacy of the ligands for the zebrafish shd/ALK receptor.
< -------------------------------------------------------------------------------------------------------------------------------
Figure 6.1 Model for the specification activity of the shd/ALK gene. (A) We propose that in the 
bipotent melano-iridoblast cell the transcription factor foxD3 inhibits the transcription of mitfa and 
thereby allows the iridophore lineage to develop. foxD3 is also activating the transcription of 
shd/ALK either directly or indirectly (dotted red arrow). The mature shd/ALK receptor is then 
activated by the binding of putative growth factors (green diamonds), such as mdkb and/or ptn. We 
speculate that these factors might be secreted by melanophores amongst other cells. Ligand 
binding results in receptor dimerisation and consequent RTK intracellular signalling (green arrows). 
We suggest this cascade of events has the final objective of activating the transcription of 
iridophore differentiation genes that will be responsible for the formation of shiny iridophores by, for 
example producing the platelets made of stacks of guanine crystals. (B) Alternatively, the role of 
shd/ALK gene is needed for iridoblast survival whereby shd/ALK signalling activates the IP3K/AKT 
pathway that is known to inhibit the transcription of apoptotic genes and may therefore mediate 
iridoblast cell survival. (C) A third possibility would consist in shd/ALK signalling result in the 
transcriptional regulation of an iridophore fate gene, downstream of foxD3, by a positive feedback 




1. CLUSTAL W (1.82) multiple sequence alignment between wild-type clones 1 to 3. 
Sequencing primers are annotated in pink. The 12 00bp fragment used for to the 
riboprobe is annotated with blue stars with respective primers in blue. Long 
distance PCR primers are in green and RACE PCR primers are in light blue. Start 
and Stop codons are boxed in red. Morpholino sequence is in bold.
vector
c lo n e lw t
c lo n e 3 w t
clone2W T
c lo n e lw t






AGTGGACAGAGAGATTAGGCTAACAAACACTTTATCT 6 0 
'AGTGGACAGAGAGATTAGGCTAACAAACACTTTATCT 6 0 
AGTGGACAGAGAGATTAGGCTAACAAACACTTTATCT 6 0 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
START
C CGGGATC CTTTTTAAGGAGCCATGGATTATATTACTCGACAAACTTTTGTAAAACTTGC 120 
CCGGGATCCTTTTTAAGGAGCCATGGATTATATTACTCGACAAACTTTTGTAAAACTTGC 120 
CCGGGATCCTTTTTAAGGAGCCATGGATTATATTACTCGACAAACTTTTGTAAAACTTGC 120 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
c lo n e lw t





* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
c lo n e lw t
c lo n e 3 w t
clone2W T
CCCAGTGCATCCAAATCCTCTTCAATCCAGTCCAGCAGAAGACAGCGATGTTTCGTTCTG 24 0 
CCCAGTGCATCCAAATCCTCTTCAATCCAGTCCAGCAGAAGACAGCGATGTTTCGTTCTG 240  
CCCAGTGCATCCAAATCCTCTTCAATCCAGTCCAGCAGAAGACAGCGATGTTTCGTTCTG 240  
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
c lo n e lw t
c lo n e 3 w t
clone2W T
TGATTTCGAGTCTCCGTGTTCTTGGACATTATCCAGTCACAGCACTGGAGGAGACTGGTT 3 00 
TGATTTCGAGTCTCCGTGTTCTTGGACATTATCCAGTCACAGCACTGGAGGAGACTGGTT 300 
TGATTTCGAGTCTCCGTGTTCTTGGACATTATCCAGTCACAGCACTGGAGGAGACTGGTT 3 00 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
c lo n e lw t
c lo n e 3 w t
clone2W T
TATCACTTCAGCACAGCAGCACAGATCTAACAGACGCGACACCCAGCCTATCAGAGATTA 360  
TATCACTTCAGCACAGCAGCACAGATCTAACAGACGCGACACCCAGCCTATCAGAGATTA 360  
TATCACTTCAGCACAGCAGCACAGATCTAACAGACGCGACACCCAGCCTATCAGAGATTA 360
★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ a * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
c lo n e lw t
c lo n e 3 w t
clone2W T
CTCCACTGGAAAATCTGAAGGACATTTTCTGCTGCTGAAGCCCAGCTCCAGTCATCTGTC 420  
CTCCACTGGAAAATCTGAAGGACATTTTCTGCTGCTGAAGCCCAGCTCCAGTCATCTGTC 420  
CTCCACTGGAAAATCTGAAGGACATTTTCTGCTGCTGAAGCCCAGCTCCAGTCATCTGTC 420  
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
c lo n e lw t
c lo n e 3 w t
clone2W T
 W T7-1
TGCAGGCAGATGTAGTTTCCACATGACCAGTCCTGTAGTTCTCAGCAGTGGGCCATTTTG 480  
TGCAGGCAGATGTAGTTTCCACATGACCAGTCCTGTAGTTCTCAGCAGTGGGCCATTTTG 4 80 
TGCAGGCAGATGTAGTTTCCACATGACCAGTCCTGTAGTTCTCAGCAGTGGGCCATTTTG 4 80 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *  * * * * * * * * *
c lo n e lw t
c lo n e 3 w t
clone2W T
5GSP
TCATCTCCAACTCGCTCGCTTTCAACCAGAGCCACACGCTGGAAACATATCAGCCTTCGT 54 0 
TCATCTCCAACTCGCTCGCTTTCAACCAGAGCCACACGCTGGAAACATATCAGCCTTCGT 54 0 
TCATCTCCAACTCGCTCGCTTTCAACCAGAGCCACACGCTGGAAACATATCAGCCTTCGT 54 0
★  ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ■ i t * * * * * * * * * * * * * * * * * * * * * * *
c lo n e lw t
c lo n e 3 w t
clone2W T
GAAGCACACCGACTCTATCGACATCAAACCCATTGACCTTACAATCAAAGAACAAGAAAG 600  
GAAGCACACCGACTCTATCGACATCAAACCCATTGACCTTACAATCAAAGAACAAGAAAG 600  
GAAGCACACCGACTCTATCGACATCAAACCCATTGACCTTACAATCAAAGAACAAGAAAG 600




CGACAGCTCGCAGTGGGAGGTCTTGGAGGCTGTGATTGGTCAGTTGAATGAGCCCTTCCA 660  






GGTGACAGTGCAGTACTCTGCCTGTAGCAGTCATGAAGTTGGGTTTCTGGCATTCGATTC 720  
GGTGACAGTGCAGTACTCTGCCTGTAGCAGTCATGAAGTTGGGTTTCTGGCATTCGATTC 720  
GGTGACAGTGCAGTACTCTGCCTGTAGCAGTCATGAAGTTGGGTTTCTGGCATTCGATTC 720
★  ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ i t * * * *
c lo n e lw t
c lo n e 3 w t
clone2W T
ACTGGAGCTGAAGAACTGTGTCATGGGTGATGATTATGTGGATTTGGGTTCCGACTGTGA 780 
ACTGGAGCTGAAGAACTGTGTCATGGGTGATGATTATGTGGATTTGGGTTCCGACTGTGA 7 8 0 
ACTGGAGCTGAAGAACTGTGTCATGGGTGATGATTATGTGGATTTGGGTTCCGACTGTGA 780  
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
c lo n e lw t
c lo n e 3 w t
clone2W T
GAAATACTCATCTCTTCAATGTCATTCTGGAGGCTGCATTGAGAAACAAAGAGTGTGTGA 84 0 
GAAATACTCATCTCTTCAATGTCATTCTGGAGGCTGCATTGAGAAACAAAGAGTGTGTGA 84 0 
GAAATACTCATCTCTTCAATGTCATTCTGGAGGCTGCATTGAGAAACAAAGAGTGTGTGA 84 0 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
c lo n e lw t
c lo n e 3 w t
clone2W T
TTTCCACACTGACTGCCCAGAAGGGGAGGACGAGGGCTTAATATGCAGCACTTTACCTTT 900  
TTTCCACACTGACTGCCCAGAAGGGGAGGACGAGGGCTTAATATGCAGCACTTTACCTTT 900  
TTTCCACACTGACTGCCCAGAAGGGGAGGACGAGGGCTTAATATGCAGCACTTTACCTTT 900  
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
c lo n e lw t
c lo n e 3 w t
clone2W T
GGGTTCATACTGTTCATTTGAGTTGGGCTCCTGTGGTTGGTCAGCGGCTGACACACAGTC 96 0 
GGGTTCATACTGTTCATTTGAGTTGGGCTCCTGTGGTTGGTCAGCGGCTGACACACAGTC 960  
GGGTTCATACTGTTCATTTGAGTTGGGCTCCTGTGGTTGGTCAGCGGCTGACACACAGTC 960  
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
c lo n e lw t
c lo n e 3 w t
clone2W T
TTCTTGGAGACTAGTTAGTGGACAACAGCTGATTGAAGACACACACCTGCTGGGCACAAC 1020  
TTCTTGGAGACTAGTTAGTGGACAACAGCTGATTGAAGACACACACCTGCTGGGCACAAC 1020  
TTCTTGGAGACTAGTTAGTGGACAACAGCTGATTGAAGACACACACCTGCTGGGCACAAC 1020  
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
c lo n e lw t
c lo n e 3 w t
clone2W T
T7-2
TCTGAAGAACACTCAAGGGCATTTCCTTTTCTTGAAGGTCAGAGGTCACGGTGATGAAAG 1080  
TCTGAAGAACACTCAAGGGCATTTCCTTTTCTTGAAGGTCAGAGGTCACGGTGATGAAAG 108 0 
TCTGAAGAACACTCAAGGGCATTTCCTTTTCTTGAAGGTCAGAGGTCACGGTGATGAAAG 1080  
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *  -*4 ----------
T7-2RC
c lo n e lw t
c lo n e 3 w t
clone2W T
AGAGGCGCTGGTTCAAAGCCCTGCATTGCCTTCAACTATATCCAATCAGGACTGTCAGTT 1140  
AGAGGCGCTGGTTCAAAGCCCTGCATTGCCTTCAACTATATCCAATCAGGACTGTCAGTT 114 0 
AGAGGCGCTGGTTCAAAGCCCTGCATTGCCTTCAACTATATCCAATCAGGACTGTCAGTT 1140  
★★********★*★*******★**********★★★*★★★*★★★★★*★★***★★***
c lo n e lw t
c lo n e 3 w t
clone2W T
GCAGTTTTCTCTCTACCGGTATGGGGATTTCAATGGAACAGTGCTTTTGTCTGTGGTGGA 12 00 
GCAGTTTTCTCTCTACCGGTATGGGGATTTCAATGGAACAGTGCTTTTGTCTGTGGTGGA 12 00 
GCAGTTTTCTCTCTACCGGTATGGGGATTTCAATGGAACAGTGCTTTTGTCTGTGGTGGA 12 00 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
c lo n e lw t
c lo n e 3 w t
clone2W T
GAGCGGAGCCTCAGCACCAGCACTGATTTGGGAGAGATCCGGACACTGGAAAGACGCCTG 1260  
GAGCGGAGCCTCAGCACCAGCACTGATTTGGGAGAGATCCGGACACTGGAAAGACGCCTG 1260  
GAGCGGAGCCTCAGCACCAGCACTGATTTGGGAGAGATCCGGACACTGGAAAGACGCCTG 1260  
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
c lo n e lw t
c lo n e 3 w t
clone2W T
GCAAGAGATCACTCTGCCGATCACAGAGATTTTAAATGGCTTCCATCTTAAAGTGCAGGC 132 0 
GCAAGAGATCACTCTGCCGATCACAGAGATTTTAAATGGCTTCCATCTTAAAGTGCAGGC 132 0 
GCAAGAGATCACTCTGCCGATCACAGAGATTTTAAATGGCTTCCATCTTAAAGTGCAGGC 132 0 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
c lo n e lw t
c lo n e 3 w t
clone2W T
TTTCTGGACTTCTGGCTCCAAGGCTGACATTGCACTCGATGACATTTCATTAAGTGCAGC 13 80 
TTTCTGGACTTCTGGCTCCAAGGCTGACATTGCACTCGATGACATTTCATTAAGTGCAGC 1380  
TTTCTGGACTTCTGGCTCCAAGGCTGACATTGCACTCGATGACATTTCATTAAGTGCAGC 13 80 




ATGTTTTGACACAGAACTGAATGAACTGCTTCATGAAGGACTACCGCATGATTTAGACTT 144 0 
ATGTTTTGACACAGAACTGAATGAACTGCTTCATGAAGGACTACCGCATGATTTAGACTT 144 0 
ATGTTTTGACACAGAACTGAATGAACTGCTTCATGAAGGACTACCGCATGATTTAGACTT 144 0 





c lo n e lw t





★  ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ • A - * * * * * * * * * * * * * * * * * * * * * * * * * * * *
-► Forward shdl
CTGTGGAGCGAGTGGACCTTTCGGCCCGACTCAAGCCCAGTGTGACAGTGCCTACCGAAA 1560 
CTGTGGAGCGAGTGGACCTTTCGGCCCGACTCAAGCCCAGTGTGACAGTGCCTACCGAAA 1560  
CTGTGGAGCGAGTGGACCTTTCGGCCCGACTCAAGCCCAGTGTGACAGTGCCTACCGAAA 1560  
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
c lo n e lw t





★ I * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
c lo n e lw t





* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
c lo n e lw t




AAAGAAC CATAACAAGCGCTCACACGGTGTGTT CATCT CAGC CAC CTT C CCCCTGGAGAA 1740  
AAAGAACCATAACAAGCGCTCACACGGTGTGTTCATCTCAGCCACCTTCCCCCTGGAGAA 174 0
c lo n e lw t
c lo n e 3 w t
clone2W T
AGGTGACATCCTCTACATCTTAATTGGCCACCAAGGAGAAGATGCCTGTCCAGGAAGGAA 1800  
AGGTGACATCCTCTACATCTTAATTGGCCACCAAGGAGAAGATGCCTGTCCAGGAAGGAA 1800  
AGGTGACATCCTCTACATCTTAATTGGCCACCAAGGAGAAGATGCCTGTCCAGGAAGGAA 1800  
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
c lo n e lw t
c lo n e 3 w t
clone2W T
CCCCCAAACCCATAAAATCTGTCTGGGCGAGTCGTCTGTGATTGAAGATGGTTTTGACAG 1860  
CCCCCAAACCCATAAAATCTGTCTGGGCGAGTCGTCTGTGATTGAAGATGGTTTTGACAG 1860  
CCCCCAAACCCATAAAATCTGTCTGGGCGAGTCGTCTGTGATTGAAGATGGTTTTGACAG 1860  
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
c lo n e lw t
c lo n e 3 w t
clone2W T
CGACGGTTCAGCCTTGAAGTGGGCAGGGGGTGGCGGCGGTGGAGGGGGAGCCACATATAT 1920 
CGACGGTTCAGCCTTGAAGTGGGCAGGGGGTGGCGGCGGTGGAGGGGGAGCCACATATAT 1920  
CGACGGTTCAGCCTTGAAGTGGGCAGGGGGTGGCGGCGGTGGAGGGGGAGCCACATATAT 1920 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
c lo n e lw t
c lo n e 3 w t
clone2W T
ATATCGGATGGAGAACGGGCAACCACTTCCTTTGCTGATTGCAGCTGGAGGGGGAGGAAA 1980  
ATATCGGATGGAGAACGGGCAACCACTTCCTTTGCTGATTGCAGCTGGAGGGGGAGGAAA 1980  
ATATCGGATGGAGAACGGGCAACCACTTCCTTTGCTGATTGCAGCTGGAGGGGGAGGAAA 1980  
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
c lo n e lw t
c lo n e 3 w t
clone2W T
GGCCTACCTTGAGGATCCAGAAAGCAGCCAGGACCAGAGTTTTCGGGAACAGTACGAGAA 2 04 0 
GGCCTACCTTGAGGATCCAGAAAGCAGCCAGGACCAGAGTTTTCGGGAACAGTACGAGAA 204 0 
GGCCTACCTTGAGGATCCAGAAAGCAGCCAGGACCAGAGTTTTCGGGAACAGTACGAGAA 2 04 0
★  ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ • A T * * * * * * * * * * *
c lo n e lw t
c lo n e 3 w t
clone2W T
TGACACCACCGTTTCTGGTGTCAGTGGCAGATCTGGAGCAGCAGGTGGAGGAGGTGGATG 2100  
TGACACCACCGTTTCTGGTGTCAGTGGCAGATCTGGAGCAGCAGGTGGAGGAGGTGGATG 2100  
TGACACCACCGTTTCTGGTGTCAGTGGCAGATCTGGAGCAGCAGGTGGAGGAGGTGGATG 2100
★  ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ■ A T * * * * * * * * * * *
c lo n e lw t
c lo n e 3 w t
clone2W T
GAGCGACGTGTCCTCTCTCTCATGGGCAGGGAAATCTCTTGTTGAAGGGGGTCAAGGAGG 2160  







CTCATCCTGTCCTGAGGCTTTGTCAGTGCTGGGATGGGCTACATTTGGAGGATTCGGAGG 222 0 
CTCATCCTGTCCTGAGGCTTTGTCAGTGCTGGGATGGGCTACATTTGGAGGATTCGGAGG 222 0 
CTCATCCTGTCCTGAGGCTTTGTCAGTGCTGGGATGGGCTACATTTGGAGGATTCGGAGG 222 0






AGGAGGAGGCGCGTGCTCCGCTGGAGGGGGCGGTGGAGGATACAGAGGTGGTGATGCACC 2280  
AGGAGGAGGCGCGTGCTCCGCTGGAGGGGGCGGTGGAGGATACAGAGGTGGTGATGCACC 2280  
AGGAAGAGGCGCGTGCTCCGCTGGAGGGGGCGGTGGAGGATACAGAGGTGGTGATGCACC 2280  
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
 ^  T7-4b
C lo n e 1w t TCTTCTTGACGACATCTCAGCAGATGGACAAGATGGCCTCTCTTTTGTTCACCCCATGGG 2340
C1one 3w t TCTTCTTGACGACATCTCAGCAGATGGACAAGATGGCCTCTCTTTTGTTCACCCCATGGG 2340
Clone2W T TCTTCTTGACGACATCTCAGCAGATGGACAAGATGGCCTCTCTTTTGTTCACCCCATGGG 2340
* * * * * * * * * * * * * * * * * *  * * * * * * * * * * * * * * * * * * * * * * * *
c lo n e lw t
c lo n e 3 w t
clone2W T
AAAGATATTTCTGCAACCTCTGGCAGCCATGGAGAGTCACGGCGAAGCTGAAATTGTGGT 24 00 
AAAGATATTTCTGCAACCTCTGGCAGCCATGGAGAGTCACGGCGAAGCTGAAATTGTGGT 24 00 
AAAGATATTTCTGCAACCTCTGGCAGCCATGGAGAGTCACGGCGAAGCTGAAATTGTGGT 2400  
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
c lo n e lw t
c lo n e 3 w t
clone2W T
CTATCTGAACTGCAGCCACTGTAAAACCCAGAGCTGCAAGCGCGATGAAGACACCAAGCT 2460  
CTATCTGAACTGCAGCCACTGTAAAACCCAGAGCTGCAAGCGCGATGAAGACACCAAGCT 24 60 
CTATCTGAACTGCAGCCACTGTAAAACCCAGAGCTGCAAGCGCGATGAAGACACCAAGCT 24 60 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
c lo n e lw t
c lo n e 3 w t
clone2W T
CATCCTGTGCCTCTGCGACAGCGACGAGGTTCTGGCACCAGACAACGTCACCTGCGCAGG 2520  
CATCCTGTGCCTCTGCGACAGCGACGAGGTTCTGGCACCAGACAACGTCACCTGCGCAG- 2519  
CATCCTGTGCCTCTGCGACAGCGACGAGGTTCTGGCACCAGACAACGTCACCTGCGCAG- 2519  
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
c lo n e lw t
c lo n e 3 w t
clone2W T
TACCAAACACAGCCTCTGCCAATTTATCAACAAACATCTCCAACACAACTCCTCTCCCTT 2580
c lo n e 1w t GGTGTGTCCTCCTCTAGTGGTTCCTATGGGCTCTCTGGCAGACGGGCCTCCATCCCTGGT 2640
c lo n e 3 w t  TGGTTCCTATGGGCTCTCTGGCAGACGGGCCTCCATCCCTGGT 2562
clone2W T  TGGTTCCTATGGGCTCTCTGGCAGACGGGCCTCCATCCCTGGT 2562
c lo n e lw t  CTTCATCATGGCAGTGATCGTGTCCACAGTGGTGACCGGTGTCGTTCTGACCTGTGCCAG 2700
C1o ne3w t CTTCATCATGGCAGGGATCGTGTCCACAGTGGTGACCGGTGTCGTTCTGACCTGTGCCAG 2622
C1one2WT CTTCATCATGGCAGGGATCGTGTCCACAGTGGTGACCGGTGTCGTTCTGACCTGTGCCAG 2622
* * ** * * * * * * * * * *  * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
c lo n e lw t  CCTGACTCTCATATATTATCGTAAGAAGAACCACCTGCATGCGGTCAGGATTCGACTGCA 2760
C1one 3w t CCTGACTCTCATATATTATCGTAAGAAGAACCACCTGCATGCGGTCAGGATTCGACTGCA 2682
C1one 2WT CCTGACTCTCATATATTATCGTAAGAAGAACCACCTGCATGCGGTCAGGATTCGACTGCA 2682
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
Reverse shdl ^
C lo n e lw t GAGTCCAGAGTACAAGCTTAGCAAAATTCGCTCGTCCACCATCATGACCGACTACAACCC 282 0
C1one 3 w t GAGTCCAGAGTACAAGCTTAGCAAAATTCGCTCGTCCACCATCATGACCGACTACAACCC 2742
C1one 2WT GAGTCCAGAGTACAAGCTTAGCAAAATTCGCTCGTCCACCATCATGACCGACTACAACCC 274 2
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
C1o n e lw t CAACTATGGTTATTTCGGAAAGGCAGCCTCTCTGAGTGAACTGAAGGAAGTGCCGCGTAA 2 880
c 1one 3w t CAACTATGGTTATTTCGGAAAGGCAGCCTCTCTGAGTGAACTGAAGGAAGTGCCGCGTAA 28 02
clone2W T CAACTATGGTTATTTCGGAAAGGCAGCCTCTCTGAGTGAACTGAAGGAAGTGCCGCGTAA 2802
★  ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ i t *
C lo n e lw t AAACATCACCCTCCTCAGGGCGTTGGGACACGGTGCCTTTGGGGAAGTGTATGAAGGACA 2 940
c lo n e 3 w t AAACATCACCCTCCTCAGGGCGTTGGGACACGGTGCCTTTGGGGAAGTGTATGAAGGACA 2862
c 1one 2WT AAACATCACCCTCCTCAGGGCGTTGGGACACGGTGCCTTTGGGGAAGTGTATGAAGGACA 2862












































































* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *

















AAACTTCACTACTATTTTAGAGAGGATCAACTACTGTACACAGGATCCTGATGTCATCAA 3720  
AAACTTCACTACTATTTTAGAGAGGATCAACTACTGTACACAGGATCCTGATGTCATCAA 3642  
AAACTTCACTACTATTTTAGAGAGGATCAACTACTGTACACAGGATCCTGATGTCATCAA 3642
★  ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ i f * * * * * * * * * * * * * * * * * * * * * * * *
c lo n e lw t
c lo n e 3 w t
clone2W T
CACCCCTCTTCCAGTGGAGTGTGGTCCTCCTGTTGAAGAAGAAGGGGGCACTGTGATCCG 3780  
CACCCCTCTTCCAGTGGAGTGTGGTCCTCCTGTTGAAGAAGAAGGGGGCACTGTGATCCG 3702  
CACCCCTCTTCCAGTGGAGTGTGGTCCTCCTGTTGAAGAAGAAGGGGGCACTGTGATCCG 3702  
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
c lo n e lw t
c lo n e 3 w t
clone2W T
CCCTGACGGATCAGGCAGCATGACCCCTCTTCTAGTTGCCCGCTCTTTGTCCCAGGATGC 3 84 0 
CCCTGACGGATCAGGCAGCATGACCCCTCTTCTAGTTGCCCGCTCTTTGTCCCAGGATGC 3762  
CCCTGACGGATCAGGCAGCATGACCCCTCTTCTAGTTGCCCGCTCTTTGTCCCAGGATGC 3762  
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
c lo n e lw t
c lo n e 3 w t
clone2W T
TTCCCCTCGAGCAAGCATCACCAGTGTCACTCCACAGGCCCTCAAACCCCGTTTGCAGCT 3 900 
TTCCCCTCGAGCAAGCATCACCAGTGTCACTCCACAGGCCCTCAAACCCCGTTTGCAGCT 3 822 
TTCCCCTCGAGCAAGCATCACCAGTGTCACTCCACAGGCCCTCAAACCCCGTTTGCAGCT 3822  
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
c lo n e lw t
c lo n e 3 w t
clone2W T
ACAAAGACCAGTCCACCTCACACAAGAAGTGGGCACATACCGAGAGACACTGGAGCCCTG 3 960 
ACAAAGACCAGTCCACCTCACACAAGAAGTGGGCACATACCGAGAGACACTGGAGCCCTG 3882  
ACAAAGACCAGTCCACCTCACACAAGAAGTGGGCACATACCGAGAGACACTGGAGCCCTG 3882
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * SP6-3b * * * * * * * *
c lo n e lw t
c lo n e 3 w t
clone2W T
c lo n e lw t
c lo n e 3 w t
clone2W T
TTGGGCAGAGCCTGTTCCTGCTTCAGGAGTCTGTCCAGGACCATGGCTTCAAGTCCCAGA 4 020 
TTGGGCAGAGCCTGTTCCTGCTTCAGGAGTCTGTCCAGGACCATGGCTTCAAGTCCCAGA 3 94 2 
TTGGGCAGAGCCTGTTCCTGCTTCAGGAGTCTGTCCAGGACCATGGCTTCAAGTCCCAGA 3 942 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * SP6-2
SP6-2RC
GCATCGGCCATGCTCCAGAAGTAGTTCATCATCGGGCAGCCAGAAGCTAAAGAACAAGAC 4 080 
GCATCGGCCATGCTCCAGAAGTAGTTCATCATCGGGCAGCCAGAAGCTAAAGAACAAGAC 4 0 02 
GCATCGGCCATGCTCCAGAAGTAGTTCATCATCGGGCAGCCAGAAGCTAAAGAACAAGAC 4 002
c lo n e lw t
c lo n e 3 w t
clone2W T
TAAAAACCTCTGGAACCCCACCTACGGTTCCTGGGTCCTAGAGAGCTTTGGACGTGGAAA 414 0 
TAAAAACCTCTGGAACCCCACCTACGGTTCCTGGGTCCTAGAGAGCTTTGGACGTGGAAA 4 062 
TAAAAACCTCTGGAACCCCACCTACGGTTCCTGGGTCCTAGAGAGCTTTGGACGTGGAAA 4 062 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
c lo n e lw t
c lo n e 3 w t
clone2W T
GTCAGCTCTGTGCCACACTCAGTCTATGCCTCTCTCCTGCAACCCCACATCTGTTTCTGC 42 00 
GTCAGCTCTGTGCCACACTCAGTCTATGCCTCTCTCCTGCAACCCCACATCTGTTTCTGC 4122  
GTCAGCTCTGTGCCACACTCAGTCTATGCCTCTCTCCTGCAACCCCACATCTGTTTCTGC 4122  
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
c lo n e lw t
c lo n e 3 w t
clone2W T
c lo n e lw t
c lo n e 3 w t
clone2W T
CCCGTCCTCTACCTCGGAGCACACAGACCCTGTAGTAGAAGTTAATGCAAATGTTTCAGC 4260  
CCCGTCCTCTACCTCGGAGCACACAGACCCTGTAGTAGAAGTTAATGCAAATGTTTCAGC 4182  
CCCGTCCTCTACCTCGGAGCACACAGACCCTGTAGTAGAAGTTAATGCAAATGTTTCAGC 4182
★ ★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★I****
 ►  N3GSP
TTCCCCACCTCCATCTGCTGCACCCTCACAAACTACGTTGACTCCCACAGCGGCTCCCTC 4320  
TTCCCCACCTCCATCTGCTGCACCCTCACAAACTACGTTGACTCCCACAGCGGCTCCCTC 4242  
TTCCCCACCTCCATCTGCTGCACCCTCACAAACTACGTTGACTCCCACAGCGGCTCCCTC 4242
★  ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ■ A : * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
c lo n e lw t
c lo n e 3 w t
clone2W T
TAGGAAGAGTCCCACAGGGGCTGCTGGTGTCTCACTTGCCACTGTTATGGACTTAGCAAA 43 80 





GCTTCAGAGCTTCCCATGTGGCAACGTAAACTATGCGTATGATGAACAGAGCTACGAGAC 44 40 
GCTTCAGAGCTTCCCATGTGGCAACGTAAACTATGCGTATGATGAACAGAGCTACGAGAC 43 62 
GCTTCAGAGCTTCCCATGTGGCAACGTAAACTATGCGTATGATGAACAGAGCTACGAGAC 43 62





TGAGAGTTTGCCTGTGGTTGTGTCCAAATCTCTGGAGCCCAGCACCAGCTCTGCAGCTAC 4 500 
TGAGAGTTTGCCTGTGGTTGTGTCCAAATCTCTGGAGCCCAGCACCAGCTCTGCAGCTAC 44 22 
TGAGAGTTTGCCTGTGGTTGTGTCCAAATCTCTGGAGCCCAGCACCAGCTCTGCAGCTAC 4422
c lo n e lw t
c lo n e 3 w t
clone2W T
ATCTTCACTGGTTGCCCTCAGCCAAGCCAGCAGCTTTACCCACAAACCATTGGTGAAGCG 4 560 
ATCTTCACTGGTTGCCCTCAGCCAAGCCAGCAGCTTTACCCACAAACCATTGGTGAAGCG 4482  
ATCTTCACTGGTTGCCCTCAGCCAAGCCAGCAGCTTTACCCACAAACCATTGGTGAAGCG 44 82
c lo n e lw t
c lo n e 3 w t
clone2W T
TCATGCCAGTTATGGACATGAGGATGTAAGGAGGTACACCCAGCCTGAGAAGCCCACCAG 4620  
TCATGCCAGTTATGGACATGAGGATGTAAGGAGGTACACCCAGCCTGAGAAGCCCACCAG 4 542 
TCATGCCAGTTATGGACATGAGGATGTAAGGAGGTACACCCAGCCTGAGAAGCCCACCAG 4542  
* * * * * * * * * * * * * * * * * *  _ * * * * * * * * * * * * * * * * * *
SP6-2b SP6-1
c lo n e lw t
c lo n e 3 w t
clone2W T
c lo n e lw t




GGACAGGGATT C TGGCTTTTCCTTGTCTGAAGAC CTGAGTGTCAC C C CTGT 
GGACAGGGATTCTGGCTTTTCCTTGTCTGAAGACCTGAGTGTCACCCCTGTi 




*  *  *
:a a t g
:a a t g
:a a t g











c lo n e lw t
c lo n e 3 w t
clone2W T
TTTTTTATGTGAACTGCAATGGATTAGCTGGAGCTGGGGCGTCAAATCCTGATCCAGCTT 4 800 
TTTTTTATGTGAACTGCAATGGATTAGCTGGAGCTGGGGCGTCAAATCCTGATCCAGCTT 4 722 
TTTTTTATGTGAACTGCAATGGATTAGCTGGAGCTGGGGCGTCAAATCCTGATCCAGCTT 4722
★  ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ■ i t * * * * * * * * * * * * *
c lo n e lw t
c lo n e 3 w t
clone2W T
CAACACACTTGCCTGGAGTTTTCAATAATTAGTCTGAAGACCTTGATTTGAAAACTTTGC 4 860 
CAACACACTTGCCTGGAGTTTTCAATAATTAGTCTGAAGACCTTGATTTGAAAACTTTGC 4 782 
CAACACACTTGCCTGGAGTTTTCAATAATTAGTCTGAAGACCTTGATTTGAAAACTTTCSC 4782
c lo n e lw t
c lo n e 3 w t
clone2W T
TGGATTAAACAGCTGGTTTTGGACACCCCTGAGCTACAGGCACSAGTCSGCAGGTTAAGGCT 4 920 
TGGATTAAACAGCTGGTTTTGGACACCCCTGAGCTACAGGCAGAGTGGCAGGTTAACSGCT 4 84 2 
TGGATTAAACAGCTGGTTTTGGACACCCCTGAGCTACAGGCAGAGTGGCAGCSTTAAGGCT 4 842
c lo n e lw t
c lo n e 3 w t
clone2W T
c lo n e lw t

















c lo n e lw t
c lo n e 3 w t
clone2W T
GTTAATGAGATGACA- TGATTTTGCCCATAAAATTCCAGTAAACACCAAACCACGTAACT 5099  
GTTAATGAGATGACA-TGATTTTGCCCATAAAATTCCAGTAAACACCAAACCACGTAACT 5021
c lo n e lw t





































2. CLUSTAL W (1.82) multiple sequence alignment between translated clones 1 to 3 
Different domains are annotated in the same colours as diagram in Figure 41
c lo n e l
c lo n e 3
c lo n e 2
c lo n e l
c lo n e 3





WTLSSHSTGGDWFITSAQQHRSNRRDTQPIRDYSTGKSEGHFLLLKPSSSHLSAGRCS FH 120 
WTLSSHSTGGDWFITSAQQHRSNRRDTQPIRDYSTGKSEGHFLLLKPSSSHLSAGRCSFH 120 
WTLSSHSTGGDWFITSAQQHRSNRRDTQPIRDYSTGKSEGHFLLLKPSSSHLSAGRCSFH 120 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
c lo n e l  MTSPWLSSGPFCHLQLARFQPEPHAGNISAFVKHTDSIDIKPIDLTIKEQESDSSQWEV 180
c lo n e 3  MTSPWLSSGPFCHLQLARFQPEPHAGNISAFVKHTDSIDIKPIDLTIKEQESDSSQWEV 180
C1one2 MTS PWLSSGPFCHLQLARFQPEPHAGNISAFVKHTDSIDIKPIDLTIKEQESDSSQWEV 180
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
c lo n e l
c lo n e 3
c lo n e 2
LEAVIGQLNEPFQVTVQYSACSSHEVGFLAFDSLELKNCVMGDDYVDLGSDCEKYSSLQC 24 0 
LEAVIGQLNEPFQVTVQYSACSSHEVGFLAFDSLELKNCVMGDDYVDLGSDCEKYSSLQC 24 0 
LEAVIGQLNEPFQVTVQYSACSSHEVGFLAFDSLELKNCVMGDDYVDLGSDCEKYSSLQC 24 0
c lo n e l
c lo n e 3
c lo n e 2
HSGGCIEKQRVCDFHTDCPEGEDEGLICSTLPLGSYCSFELGSCGWSAADTQSSWRLVSG 3 00 
HSGGCIEKQRVCDFHTDCPEGEDEGLICSTLPLGSYCSFELGSCGWSAADTQSSWRLVSG 3 00 
HSGGCIEKQRVCDFHTDCPEGEDEGLICSTLPLGSYCSFELGSCGWSAADTQSSWRLVSG 3 00
★  ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ i t * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
 ► LDLa  ► MAM2
c lo n e l
c lo n e 3
c lo n e 2
QQLIEDTHLLGTTLKNTQGHFLFLKVRGHGDEREALVQSPALPSTISNQDCQLQFSLYRY 3 60 
QQLIEDTHLLGTTLKNTQGHFLFLKVRGHGDEREALVQSPALPSTISNQDCQLQFSLYRY 3 60 
QQLIEDTHLLGTTLKNTQGHFLFLKVRGHGDEREALVQSPALPSTISNQDCQLQFSLYRY 360 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
c lo n e l  
c lo n e 3  
c lo n e 2
GDFNGTVLLSWESGASAPALIWERSGHWKDAWQEITLPITEILNGFHLKVQAFWTSGSK 4 2 0 
GDFNGTVLLSWESGASAPALIWERSGHWKDAWQEITLPITEILNGFHLKVQAFWTSGSK 420  
GDFNGTVLLSWESGASAPALIWERSGHWKDAWQEITLPITEILNGFHLKVQAFWTSGSK 420  
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
c lo n e l
c lo n e 3
c lo n e 2
ADIALDDISLSAACFDTELNELLHEGLPHDLDFSPLPEPSASEASPITWWFTSCGASGPF 480  
ADIALDDISLSAACFDTELNELLHEGLPHDLDFSPLPEPSASEASPITWWFTSCGASGPF 480  
ADIALDDISLSAACFDTELNELLHEGLPHDLDFSPLPEPSASEASPITWWFTSCGASGPF 4 80 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
c lo n e l
c lo n e 3
c lo n e 2




c lo n e l
c lo n e 3




* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
C lo n e l AGGGGGGGGATYIYRMENGQPLPLLIAAGGGGKAYLEDPESSQDQSFREQYENDTTVSGV 660
C1one 3 AGGGGGGGGATYIYRMENGQPLPLLIAAGGGGKAYLEDPES SQDQSFREQYENDTTVSGV 660
c lo n e 2  AGGGGGGGGATYIYRMENGQPLPLLIAAGGGGKAYLEDPESSQDQSFREQYENDTTVSGV 660
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *  
-----------^  G-rich
C lo n e l SGRSGAAGGGGGWSDVSSLSWAGKSLVEGGQGGSSCPEALSVLGWATFGGFGGGGGACSA 720
c lo n e 3  SGRSGAAGGGGGWSDVSSLSWAGKSLVEGGQGGSSCPEALSVLGWATFGGFGGGGGACSA 720
c lo n e 2  SGRSGAAGGGGGWSDVSSLSWAGKSLVEGGQGGSSCPEALSVLGWATFGGFGGGRGACSA 720





c lo n e l
c lo n e 3
c lo n e 2
c lo n e l
c lo n e 3
c lo n e 2
c lo n e l  
c lo n e 3  
c lo n e 2
c lo n e l
c lo n e 3
c lo n e 2
c lo n e l
c lo n e 3
c lo n e 2
c lo n e l  
c lo n e 3 
c lo n e 2
c lo n e l
c lo n e 3
c lo n e 2
c lo n e l
c lo n e 3
c lo n e 2
c lo n e l
c lo n e 3
c lo n e 2
c lo n e l
c lo n e 3
c lo n e 2
c lo n e l
c lo n e 3
c lo n e 2
c lo n e l
c lo n e 3




* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
KTQSCKRDEDTKLILCLCDSDEVLAPDNVTCAGTKHSLCQFINKHLQHNSSPLVCPPLW 840
KTQS CKRDEDTKLILCLCDSDEVLAPDNVTCA------------------------- W  814
KTQS CKRDEDTKLI LCLCDSDE VLAPDNVTCA------------------------- W  814
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *  * *
PMGSLADGPPSLVFIMAVIVSTWTGWLTCASLTLIYYRKKNHLHAVRIRLQSPEYKLS 900 
PMGS LADGP P S L VFI MAG I VS TWTGWLTCAS LTLIY YRKKNHLHAVRIRLQSPEYKLS 874 
PMGSLADGPPSLVFIMAGIVSTWTGWLTCASLTLIYYRKKNHLHAVRIRLQSPEYKLS 874 
* * * * * * * * * * * * * * * * *  * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
 ►  TM  ►  PTK
VYEGQVLGMNGE 960KIRSSTIMTDYNPNYGYFGKAASLSELKEVPRKNITLLRAI .GHGAFG 
KIRS STIMTDYNPNYGYFGKAASLS ELKEVPRKNITLLRAI,GHGAFG
KIRSSTIMTDYNPNYGYFGKAASLSELKEVPRKNITLLRAIiGHGAFG^VYEGQVLGMNGE S34
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 4 * * * * * *
ATP
!VYEGQVLGMNGE 934
i t * * * * * * * * * * * *






* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
PDRVAKIGDFGMARDIYRASYYRKGGRAMLPVKWMP PEAFLEGIFTCKTDTWSFGVLLWE 114 0 
PDRVAKIGDFGMARDIYRASYYRKGGRAMLPVKWMPPEAFLEGIFTCKTDTWSFGVLLWE 1114 
PDRVAKIGDFGMARDIYRASYYRKGGRAMLPVKWMPPEAFLEGIFTCKTDTWSFGVLLWE 1114 








* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
SVTPQALKPRLQLQRPVHLTQEVGTYRETLEPCWAEPVPASGVCPGPWLQVPEHRPCSRS 1320 
SVTPQALKPRLQLQRPVHLTQEVGTYRETLEPCWAEPVPASGVCPGPWLQVPEHRPCSRS 12 94 
SVTPQALKPRLQLQRPVHLTQEVGTYRETLEPCWAEPVPASGVCPGPWLQVPEHRPCSRS 12 94 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
SSSSGSQKLKNKTKNLWNPTYGSWVLESFGRGKSALCHTQSMPLSCNPTSVSAPSSTSEH 13 80 
SSSSGSQKLKNKTKNLWNPTYGSWVLESFGRGKSALCHTQSMPLSCNPTSVSAPSSTSEH 1354 
SSSSGSQKLKNKTKNLWNPTYGSWVLESFGRGKSALCHTQSMPLSCNPTSVSAPSSTSEH 1354 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
TDPWEVNANVSASPPPSAAPSQTTLTPTAAPSRKSPTGAAGVSLATVMDLAKLQSFPCG 144 0 
TDPWEVNANVSASPPPSAAPSQTTLTPTAAPSRKSPTGAAGVSLATVMDLAKLQSFPCG 1414 
TDPWEVNANVSASPPPSAAPSQTTLTPTAAPSRKSPTGAAGVSLATVMDLAKLQSFPCG 1414 




* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
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c lo n e l  DVRRYTQPEKPTRDRDSGFSLSEDLSVTPV 1530
c lo n e 3  DVRRYTQPEKPTRDRDSGFSLSEDLSVTPV 1504
c lo n e 2  DVRRYTQPEKPTRDRDSGFSLSEDLSVTPV 1504
3. Coding sequence with correspondent aminoacid translation. The 1200bp fragment 
used for the riboprobe synthesis is annotated in red.
1 ATG GAT TAT ATT ACT CGA CAA ACT TTT GTA AAA CTT GCC CTT TTC 4 5
1 M D Y I T R Q T  F V K L A L F  15
46 ATC TTC ACA GTT GTG AGG AGC AGT TGT GCT CTG TTG GAA AAA GCT 90
16 I F T V V R S S C A L L E K A 30
91 GCA GAA GAC CCA GTG CAT CCA AAT CCT CTT CAA TCC AGT CCA GCA 135
31 A E D P V H P N P L Q S S P A 45
136 GAA GAC AGC GAT GTT TCG TTC TGT GAT TTC GAG TCT CCG TGT TCT 180
46 E D S D V S F C D F E S P C S 60
181 TGG ACA TTA TCC AGT CAC AGC ACT GGA GGA GAC TGG TTT ATC ACT 225
61 W T L S S H S T G G D W F I T 75
226 TCA GCA CAG CAG CAC AGA TCT AAC AGA CGC GAC ACC CAG CCT ATC 270
76 S A Q Q H R S N R R D T Q P I 90
271 AGA GAT TAC TCC ACT GGA AAA TCT GAA GGA CAT TTT CTG CTG CTG 315
91 R D Y S T G K S E G H F L L L 105
316 AAG CCC AGC TCC AGT CAT CTG TCT GCA GGC AGA TGT AGT TTC CAC 360
106 K P S S S H L S A G R C S F H 120
361 ATG ACC AGT CCT GTA GTT CTC AGC AGT GGG CCA TTT TGT CAT CTC 405
121 M T S P V V L S S G P F C H L 135
406 CAA CTC GCT CGC TTT CAA CCA GAG CCA CAC GCT GGA AAC ATA TCA 450
136 Q L A R F Q P E P H A G N I S 150
451 GCC TTC GTG AAG CAC ACC GAC TCT ATC GAC ATC AAA CCC ATT GAC 495
151 A F V K H T D S I D I K P I D 165
496 CTT ACA ATC AAA GAA CAA GAA AGC GAC AGC TCG CAG TGG GAG GTC 540
166 L T I K E Q E S D S S Q W E V 180
541 TTG GAG GCT GTG ATT GGT CAG TTG AAT GAG CCC TTC CAG GTG ACA 585
181 L E A V I G Q L N E P F Q V T 195
586 GTG CAG TAC TCT GCC TGT AGC AGT CAT GAA GTT GGG TTT CTG GCA 630
196 V Q Y S A C S S H E V G F L A 210
631 TTC GAT TCA CTG GAG CTG AAG AAC TGT GTC ATG GGT GAT GAT TAT 675
211 F D S L E L K N C V M G D D Y 225
676 GTG GAT TTG GGT TCC GAC TGT GAG AAA TAC TCA TCT CTT CAA TGT 720
226 V D L G S D C E K Y S S L Q C 240
721 CAT TCT GGA GGC TGC ATT GAG AAA CAA AGA GTG TGT GAT TTC CAC 765
241 H S G G C I E K Q R V C D F H 255
766 ACT GAC TGC CCA GAA GGG GAG GAC GAG GGC TTA ATA TGC AGC ACT 810
256 T D C P E G E D E G L I C S T 270
811 TTA CCT TTG GGT TCA TAC TGT TCA TTT GAG TTG GGC TCC TGT GGT 855
271 L P L G S Y C S F E L G S C G 285
856 TGG TCA GCG GCT GAC ACA CAG TCT TCT TGG AGA CTA GTT AGT GGA 900
286 W S A A D T Q S S W R L V S G 300
901 CAA CAG CTG ATT GAA GAC ACA CAC CTG CTG GGC ACA ACT CTG AAG 945
301 Q Q L I E D T H L L G T T L K 315
946 AAC ACT CAA GGG CAT TTC CTT TTC TTG AAG GTC AGA GGT CAC GGT 990
316 N T Q G H F L F L K V R G H G 330
217
991 GAT GAA AGA GAG GCG CTG GTT CAA AGC CCT GCA TTG CCT TCA ACT 1035
331 D E R E A L V Q S P A L P S T 345
1036 ATA TCC AAT CAG GAC TGT CAG TTG CAG TTT TCT CTC TAC CGG TAT 1080
346 I S N Q D C Q L Q F S L Y R Y 360
1081 GGG GAT TTC AAT GGA ACA GTG CTT TTG TCT GTG GTG GAG AGC GGA 1125
361 G D F N G T V L L S V V E S G 375
1126 GCC TCA GCA CCA GCA CTG ATT TGG GAG AGA TCC GGA CAC TGG AAA 1170
376 A S A P A L I W E R S G H W K 390
1171 GAC GCC TGG CAA GAG ATC ACT CTG CCG ATC ACA GAG ATT TTA AAT 1215
391 D A W Q E I T L P I T E I L N 405
1216 GGC TTC CAT CTT AAA GTG CAG GCT TTC TGG ACT TCT GGC TCC AAG 1260
406 G F H L K V Q A F W T S G S K 420
1261 GCT GAC ATT GCA CTC GAT GAC ATT TCA TTA AGT GCA GCA TGT TTT 1305
421 A D I A L D D I S L S A A C F 435
1306 GAC ACA GAA CTG AAT GAA CTG CTT CAT GAA GGA CTA CCG CAT GAT 1350
436 D T E L N E L L H E G L P H D 450
1351 TTA GAC TTC AGT CCT CTT CCA GAA CCA TCA GCA TCA GAG GCG TCT 1395
451 L D F S P L P E P S A S E A S 465
1396 CCA ATT ACA TGG TGG TTT ACA TCC TGT GGA GCG AGT GGA CCT TTC 1440
466 P I T W W F T S C G A S G P F 480
1441 GGC CCG ACT CAA GCC CAG TGT
W
GAT AGT GCC TAC CGA AAC ACC AAT 1485
481 G P T Q A Q C D S A Y R N T N 495
1486 GTC AGC GTT GTG GTG GGG AAA GAG GGT CCT CTC AGG GGT GTA CAG 1530
496 V S V V V G K E G P L R G V Q 510
1531 ATG TGG AAG GTC CCT GCT ACC AAC ACG TAC AAG ATT TCA GCC TAT 1575
511 M W K V P A T N T Y K I S A Y 525
1576 GGA GCT GCA GGA GGC AAA GGA GCA AAG AAC CAT AAC AAG CGC TCA 1620
526 G A A G G K G A K N H N K R S 540
1621 CAC GGT GTG TTC ATC TCA GCC ACC TTC CCC CTG GAG AAA GGT GAC 1665
541 H G V F I S A T F P L E K G D 555
1666 ATC CTC TAC ATC TTA ATT GGC CAC CAA GGA GAA GAT GCC TGT CCA 1710
556 I L Y I L I G H Q G E D A C P 570
1711 GGA AGG AAC CCC CAA ACC CAT AAA ATC TGT CTG GGC GAG TCG TCT 1755
571 G R N p Q T H K I C L G E S S 585
1756 GTG ATT GAA GAT GGT TTT GAC AGC GAC GGT TCA GCC TTG AAG TGG 1800
586 V I E D G F D S D G S A L K W 600
1801 GCA GGG GGT GGC GGC GGT GGA GGG GGA GCC ACA TAT ATA TAT CGG 1845
601 A G G G G G G G G A T Y I Y R 615
1846 ATG GAG AAC GGG CAA CCA CTT CCT TTG CTG ATT GCA GCT GGA GGG 1890
616 M E N G Q P L P L L I A A G G 630
1891 GGA GGA AAG GCC TAC CTT GAG GAT CCA GAA AGC AGC CAG GAC CAG 1935
631 G G K A Y L E D P E S S Q D Q 645
1936 AGT TTT CGG GAA CAG TAC GAG AAT GAC ACC ACC GTT TCT GGT GTC 1980
646 S F R E Q Y E N D T T V S G V 660
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1981 AGT GGC AGA TCT GGA GCA GCA GGT GGA GGA GGT GGA TGG AGC GAC 2025
661 S G R S G A A G G G G G W S D 675
2026 GTG TCC TCT CTC TCA TGG GCA GGG AAA TCT CTT GTT GAA GGG GGT 2070
676 V S S L S W A G K S L V E G G 690
2071 CAA GGA GGC TCA TCC TGT CCT GAG GCT TTG TCA GTG CTG GGA TGG 2115
691 Q G G S S C P E A L S V L G W 705
2116 GCT ACA TTT GGA GGA TTC GGA GGA GGA GGA GGC GCG TGC TCC GCT 2160
706 A T F G G F G G G G G A C S A 720
2161 GGA GGG GGC GGT GGA GGA TAC AGA GGT GGT GAT GCA CCT CTT CTT 2205
721 G G G G G G Y R G G D A P L L 735
2206 GAC GAC ATC TCA GCA GAT GGA CAA GAT GGC CTC TCT TTT GTT CAC 2250
736 D D I S A D G Q D G L S F V H 750
2251 CCC ATG GGA AAG ATA TTT CTG CAA CCT CTG GCA GCC ATG GAG AGT 2295
751 p M G K I F L Q P L A A M E S 765
2296 CAC GGC GAA GCT GAA ATT GTG GTC TAT CTG AAC TGC AGC CAC TGT 2340
766 H G E A E I V V Y L N C S H C 780
2341 AAA ACC CAG AGC TGC AAG CGC GAT GAA GAC ACC AAG CTC ATC CTG 2385
781 K T Q S C K R D E D T K L I L 795
2386 TGC CTC TGC GAC AGC GAC GAG GTT CTG GCA CCA GAC AAC GTC ACC 2430
796 C L C D S D E V L A P D N V T 810
2431 TGC GCA GTG GTT CCT ATG GGC TCT CTG GCA GAC GGG CCT CCA TCC 2475
811 C A V V P M G S L A D G P P S 825
2476 CTG GTC TTC ATC ATG GCA GTG ATC GTG TCC ACA GTG GTG ACC GGT 2520
826 L V F I M A V I V S T V V T G 840
2521 GTC GTT CTG ACC TGT GCC AGC CTG ACT CTC ATA TAT TAT CGT AAG 2565
841 V V L T C A S L T L T Y Y R K 855
2566 AAG AAC CAC CTG CAT GCG GTC AGG ATT CGA CTG CAG AGT CCA GAG 2610
856 K N H L H A V R I R L Q S P E 870
2611 TAC AAG CTT AGC AAA ATT CGC TCG TCC ACC < —ATC ATG ACC GAC TAC 2655
871 Y K L S K I R S S T I M T D Y 885
2656 AAC CCC AAC TAT GGT TAT TTC GGA AAG GCA GCC TCT CTG AGT GAA 2700
886 N P N Y G Y F G K A A S L S E 900
2701 CTG AAG GAA GTG CCG CGT AAA AAC ATC ACC CTC CTC AGG GCG TTG 2745
901 L K E V P R K N I T L L R A L 915
2746 GGA CAC GGT GCC TTT GGG GAA GTG TAT GAA GGA CAG GTT TTG GGT 2790
916 G H G A F G E V Y E G Q V L G 930
2791 ATG AAT GGA GAA AAC ACA GCC ATG CAA GTC GCT ATA AAG ACT CTT 2835
931 M N G E N T A M Q V A I K T L 945
2836 CCA GAA ATC TGC TCT GAG CAG GAC GAG ATG GAT TTC CTA ATG GAG 2880
946 P E I C S E Q D E M D F L M E 960
2881 GCT CTG ATC ATG AGT AAG TTC AGC CAT CAG AAC ATT GTC CGC TGC 2925
961 A L I M S K F S H Q N I V R C 975
2926 ATT GGC GTC AGT CTG CAG ATC CTG CCA CGC TTC ATC CTG CTG GAG 2970
976 I G V S L Q I L P R F I L L E 990
2971 CTC ATG ACA GGA GGA GAC ATG AAG AGC TTC TTG AGA CTC AAT CGA 3015
991 L M T G G D M K S F L R L N R 1005
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3016 CCC AGA ACT AAC CAT TCG TCT TCT CTA AGC ATG CTG GAG CTT CTT 3060
1006 P R T N H S S S L S M L E L L  1020
3061 CAT ATG GCC AGA GAC ATC GCT CTT GGC TGT CGC TAC CTT GAA GAA 3105
1021 H M A R D I A L G C R Y L E E  1035
3106 AAC CAC TTC ATC CAC AGG GAC ATC GCC GCT CGC AAC TGC CTT TTG 3150
1036 N H F I H R D I A A R N C L L  1050
3151 ACT TGT CCT GGT CCA GAC AGA GTG GCT AAA ATT GGA GAT TTC GGG 3195
1051 T C P G P D R V A K I G D F G  1065
3196 ATG GCC CGA GAT ATT TAC AGG GCC AGT TAC TAT AGG AAG GGT GGC 324 0
1066 M A R D I Y R A S Y Y R K G G  1080
3241 CGT GCC ATG CTG CCA GTC AAA TGG ATG CCA CCT GAA GCT TTC CTA 3285
1081 R A M L P V K W M P P E A F L  1095
3286 GAG GGC ATT TTT ACA TGC AAG ACT GAC ACC TGG TCA TTC GGG GTA 3330
1096 E G I F T C K T D T W S F G V  1110
3331 CTG CTG TGG GAG ATT TTC TCT CTT GGG TAC ATG CCT TAT CCC TGC 3375
1111 L L W E I F S L G Y M P Y P C  1125
337 6 AAA ACT AAC CAG GAA GTG CTG GAG TTT GTA ACT GGT GGA GGT CGC 3420
1126 K T N Q E V L E  F V T G G G R  1140
34 21 ATG GAT CCA CCT AAG AGC TGC CCT GGG CCT GTT TAT CGG ATC ATG 34 65
1141 M D P P K S C P G P V Y R I M  1155
34 66 ACA CAG TGT TGG CAA CAC TGT CCA GAA CAC AGA CCA AAC TTC ACT 3510
1156 T Q C W Q H C P E H R P N F T  1170
3511 ACT ATT TTA GAG AGG ATC AAC TAC TGT ACA CAG GAT CCT GAT GTC 3555
1171 T I L E R I N Y C T Q D P D V  1185
3556 ATC AAC ACC CCT CTT CCA GTG GAG TGT GGT CCT CCT GTT GAA GAA 3600
1186 I N T P L P V E C G P P V E E  1200
3 601 GAA GGG GGC ACT GTG ATC CGC CCT GAC GGA TCA GGC AGC ATG ACC 364 5
1201 E G G T V I R P D G S G S M T  1215
3646 CCT CTT CTA GTT GCC CGC TCT TTG TCC CAG GAT GCT TCC CCT CGA 3690
1216 P L - L V A R S L S Q D A S  P R  1230
3 691 GCA AGC ATC ACC AGT GTC ACT CCA CAG GCC CTC AAA CCC CGT TTG 37 35
1231 A S  I T S V T P Q A L K P R L  1245
3736 CAG CTA CAA AGA CCA GTC CAC CTC ACA CAA GAA GTG GGC ACA TAC 37 80
1246 Q L Q R P V H L T Q E V G T Y  1260
3781 CGA GAG ACA CTG GAG CCC TGT TGG GCA GAG CCT GTT CCT GCT TCA 3825
1261 R E T L E P C W A E P V P A S  1275
3826 GGA GTC TGT CCA GGA CCA TGG CTT CAA GTC CCA GAG CAT CGG CCA 387 0
1276 G V C P G P W L Q V P E H R P  1290
3871 TGC TCC AGA AGT AGT TCA TCA TCG GGC AGC CAG AAG CTA AAG AAC 3915
1291 C S R S S S S S G S Q K L K N  1305
3916 AAG ACT AAA AAC CTC TGG AAC CCC ACC TAC GGT TCC TGG GTC CTA 3960
1306 K T K N L W N P T Y G S W V L  1320
3 961 GAG AGC TTT GGA CGT GGA AAG TCA GCT CTG TGC CAC ACT CAG TCT 4 005
1321 E S F G R G K S A L C H T Q S  1335
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4 006 ATG CCT CTC TCC TGC AAC CCC ACA TCT GTT TCT GCC CCG TCC TCT 4 050
1336 M P L S C N P T S V S A P S S  1350
4 051 ACC TCG GAG CAC ACA GAC CCT GTA GTA GAA GTT AAT GCA AAT GTT 4 095
1351 T S E H T D P V V E V N A N V  1365
4 0 96 TCA GCT TCC CCA CCT CCA TCT GCT GCA CCC TCA CAA ACT ACG TTG 414 0
1366 S A S P P P S A A P S Q T T L  1380
4141 ACT CCC ACA GCG GCT CCC TCT AGG AAG AGT CCC ACA GGG GCT GCT 4185
1381 T P T A A P S R K S  P T G A A  1395
418 6 GGT GTC TCA CTT GCC ACT GTT ATG GAC TTA GCA AAG CTT CAG AGC 4 230
1396 G V S L A T V M D L A K L Q S  1410
4 231 TTC CCA TGT GGC AAC GTA AAC TAT GCG TAT GAT GAA CAG AGC TAC 427 5
1411 F P C G N V N Y A Y D E Q S Y  1425
427 6 GAG ACT GAG AGT TTG CCT GTG GTT GTG TCC AAA TCT CTG GAG CCC 4 320
1426 E T E S L P V V V S K S L E P  1440
4 321 AGC ACC AGC TCT GCA GCT ACA TCT TCA CTG GTT GCC CTC AGC CAA 4 365
1441 S T S S A A T S S L V A L S Q  1455
4 3 66 GCC AGC AGC TTT ACC CAC AAA CCA TTG GTG AAG CGT CAT GCC AGT 4 410
1456 A S S F T H K P L V K R H A S  1470
4 411 TAT GGA CAT GAG GAT GTA AGG AGG TAC ACC CAG CCT GAG AAG CCC 4 455
1471 Y G H E D V R R Y T Q P E K P  1485
4 4 56 ACC AGG GAC AGG GAT TCT GGC TTT TCC TTG TCT GAA GAC CTG AGT 4 500
1486 T R D R D S G F S L S E D L S  1500
4 501 GTC ACC CCT GTG TAG 
1501 V T P V *
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4. CLUSTAL W (1.82) multiple sequence alignment showing aminoacid sequences for zebrafish clonel 
and clone3 (Z1 and Z3), human ALK (HALK) and mouse ALK (MALK)
Z l  MDYITRQTFVKLALFIFTWRSSCALLEKAAEDPVHPNPLQS-SPAEDSDVS FCDF 55
Z3 MDYITRQTFVKLALFIFTVVRSSCALLEKAAEDPVHPNPLQS-SPAEDSDVS FCDF 55
HALK MGAIG--LLWLLPLLLSTAAVGSGMGTGQRAGSPAAGSPLQPREPLSYSRLQRKSLAVDF 58
MALK MGAAG— FLWLLPPLLLAAASYSGAATDQRAGSPASGPPLQPREPLSYSRLQRKSLAVDF 58
k  • k  • • * ★  ★ ★ ★  k  k • ★ ★
Z l  ESP------------------------------------------------------------------------------------------------------------------------------ 58
Z3 ESP------------------------------------------------------------------------------------------------------------------------------ 58
HALK WPSLFRVYARDLLLPP— SSSELKAGRPEARGSLALDCAPLLRLLGPAPGVSWTAG— S 114
MALK VVPSLFRVYARDLLLPQPRSPSEPEAGGLEARGSLALDCEPLLRLLGPLPGI3WADGASS 118
Z l   CSWTLSSHSTGG----------------------------------------------------------------------------------------------------70
Z3  CSWTLSSHSTGG----------------------------------------------------------------------------------------------------70
HALK PAPAEARTLSRVLKGGSVRKLRRAKQLVLELGEEAILEGCVGPPGE-AAVGLLQFNLSEL 173
MALK PSPEAGPTLSRVLKGGSVRNVRRAKQLVLELGEETILEGCIGPPEEVAAVGILQFNLSEL 17 8
k k  k  k  k
Z l  -DWFITSAQQHR---------------------------------------------- SNRRDTQP----- IRDYSTGKSEGHFLLLK 106
Z3 -DWFITSAQQHR---------------------------------------------- SNRRDTQP----- IRDYSTGKSEGHFLLLK 106
HALK FSWWIRQGEGRLRIRLMPEKKASEVGREGRLSAAIRASQPRLLFQIFGTGHSSLESPTNM 233
MALK FSWWILHGEGRLRIRLMPEKKASEVGREGRLSSAIRASQPRLLFQIFGTGHSSLESPSET 238
• •  • k  • k  k  • • • k  k  • k
Z l  PSS---------------------------------------------- SHLSAG— RCSFHMTSPWLS------------------------------------ 128
Z3 PSS---------------------------------------------- SHLSAG— RCSFHMTSPWLS------------------------------------ 128
HALK PSPSPDYFTWNLTWIMKDSFPFLSHRSRYGLECSFDFPCELEYSPPLHDLRNQSWSWRRI 2 93
MALK PSP-PGTFMWNLTWTMKDSFPFLSHRSRYGLECSFDFPCELEYSPPLHNHGNQSWSWRHV 297
Z l -SGPFCHLQLARFQPEPHAG---------------------- NISAFVKHT---------------D S ID IK P ID L T IK E  170
Z3 -SGPFCHLQLARFQPEPHAG---------------------- NISAFVKHT---------------D S ID IK P ID L T IK E  170
HALK PSEEASQMDLLDGPGAERSKEMPRGSFLLLNTSADSKHTILSPWMRSSSEHCTLAVSVHR 353
MALK PSEEASRMNLLDGPEAEHSQEMPRGSFLLLNTSADSKHTILSPWMRSSSDHCTLAVSVHR 357
★ • •  ★ ★ ★ ★ ★ ★  » • • • •
Z l  QESDSS QWEVLEAVIGQLNEPFQVTVQYSACSSHE 205
Z3 QESDSS QWEVLEAVIGQLNEPFQVTVQYSACSSHE 205
HALK HLQPSGRYIAQLLPHNEAAREILLMPTPGKHGWTVLQGRIGRPDNPFRVALEY— ISSGN 411
MALK HLQPSGRYVAQLLPHNEAGREILLVPTPGKHGWTVLQGRVGRPANPFRVALEY— ISSGN 415
Z l  VGFLAFDSLELKNCVMGDDYVDLGSDCEKYSSLQCHSGGCIEKQRVCDFHTDCPEGEDEG 2 65
Z3 VGFLAFDSLELKNCVMGDDYVDLGSDCEKYSSLQCHSGGCIEKQRVCDFHTDCPEGEDEG 2 65
HALK RSLSAVDFFALKNCSEG TSPGSKMALQSSFTCWNGTVLQLGQACDFHQDCAQGEDES 4 68
MALK RSLSAVDFFALKNCSEG TSPGSKMALQSSFTCWNGTVLQLGQACDFHQDCAQGEDEG 4 72
Z l  LICSTLPLGSYCSFELGSCGWSAADTQSSWRLVSGQQLIEDTHLLGTTLKNTQGHFLFLK 325
Z3 LICSTLPLGSYCSFELGSCGWSAADTQSSWRLVSGQQLIEDTHLLGTTLKNTQGHFLFLK 325
HALK QMCRKLPVGFYCNFEDGFCGWTQG TLSPHTPQWQVRTLKDARFQDHQDHALLLS 522
MALK QLCSKLPAGFYCNFENGFCGWTQS PLSPHMPRWQVRTLRDAHSQGHQGRALLLS 52 6
* ★  k k k k k k k k k k k *  k  • k  • * k  • k  • k
Z l  VRGHGDEREALVQSPALPSTISNQDCQLQFSLYRYGDFNGTVLLSWES— GASAPALIW 383
Z3 VRGHGDEREALVQSPALPSTISNQDCQLQFSLYRYGDFNGTVLLSVVES— GASAPALIW 383
HALK TTDVPASESATVTSATFPAPIKSSPCELRMSWLIRGVLRGNVSLVLVENKTGKEQGRMVW 582
MALK TTDILASEGATVTSATFPAPMKNSPCELRMSWLIRGVLRGNVSLVLVENKTGKEQSRTVW 58 6
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Z l ERSG-HWKDAWQEITLPITEILNGFHLKVQAFWTSGSKADIALDDISLSAACFDTELN—  440
Z3 ERSG-HWKDAWQEITLPITEILNGFHLKVQAFWTSGSKADIALDDISLSAACFDTELN—  4 40
HALK HVAAYEGLSLWQWMVLPLLDVSDRFWLQMVAWWGQGSRAIVAFDNISISLDCYLTISGED 642
MALK HVATDEGLSLWQHTVLSLLDVTDRFWLQIVTWWGPGSRATVGFDNISISLDCYLTISGEE 64 6
• A  A  A  • • •  • ★ ■ A - . *  • • A  A  A  • A  • • A  • A  A  • A  A  • A
Z l ELLHEGLPHD LDFSPLPEPSASEASP-------------------- 1TWWFTSCGASGPFGPTQAQCD 4 88
Z3 ELLHEGLPHD LDFSPLPEPSASEASP ITWWFTSCGASGPFGPTQAQCD 4 88
HALK KILQNTAPKSRNLFERNPNKELKPGENSPRQTPIFDPTVHWLFTTCGASGPHGPTQAQCN 7 02
MALK KMSLNSVPKSRNLFEKNPNKESKSWANISGPTPIFDPTVHWLFTTCGASGPHGPTQAQCN 7 06
• • • A  • • •  A  A  • A  A A * A A A A A A  A A A A A A A *
Z l  SAYRNTNVSVWGKEGPLRGVQMWKVPATNTYKISAYGAAGGKGAKNHNKRSHGVFISAT 54 8
Z3 SAYRNTNVSVWGKEGPLRGVQMWKVPATNTYKISAYGAAGGKGAKNHNKRSHGVFISAT 54 8
HALK NAYQNSNLSVEVGSEGPLKGIQIWKVPATDTYSISGYGAAGGKGGKNTMMRSHGVSVLGI 7 62
MALK NAYQNSNLSVWGSEGPLKGVQIWKVPATDTYSISGYGAAGGKGGKNTMMRSHGVSVLGI 7 66
A A * A * A * A A  A  A  A, A A A * A * A * A A A - A A A * A A  A A  A A A A A A A A  A A  A A A A A  •
Z l FPLEKGDILYILIGHQGEDACPGRNPQTHKICLGESSVIEDGFDSDGSALKWAGGGGGGG 608
Z3 FPLEKGDILYILIGHQGEDACPGRNPQTHKICLGESSVIEDGFDSDGSALKWAGGGGGGG 608
HALK FNLEKDDMLYILVGQQGEDACPSTNQLIQKVCIGENNVIEEEIRVNRSVHEWAGGGGGGG 822
MALK FNLEKGDTLYILVGQQGEDACPRANQLIQKVCVGENNVIEEEIRVNRSVHEWAGGGGGGG 82 6
A  A A A  A  A A A A  • A  •  A A A A A A A  A  • A  • A  •  A  A  A A A  • • • A  » A A A A A A A A A
Z l GATYIYRMENGQPLPLLIAAGGGGKAYLEDPESSQDQSFREQYENDTTVSGVSGRSGAAG 668
Z3 GATYIYRMENGQPLPLLIAAGGGGKAYLEDPESSQDQSFREQYENDTTVSGVSGRSGAAG 668
HALK GATYVFKMKDGVPVPLIIAAGGGGRAYG AKTDTFHPERLENNSSVLGLNGNSGAAG 87 8
MALK GATYVFKMKDGVPVPLIIAAGGGGRAYG AKRETFHPERLESNSSVLGLNGNSGAAG 882





A A A A A  A  i  A A  A A A A A *  A A  A A  A A A  .  A  • A A  A  A A A A A A A A  A A  • A A A A A A A
Z1 GGDAPLLDDISADGQDGLSFVHPMGKIFLQPLAAMESHGEAEIVVYLNCSHCKTQSCKRD 7 88
Z3 GGDAPLLDDISADGQDGLSFVHPMGKIFLQPLAAMESHGEAEIVVYLNCSHCKTQSCKRD 788
HALK GGNAASNNDPEMDGEDGVSFISPLGILYTPALKVMEGHGEVNIKHYLNCSHCEVDECHMD 998
MALK GGNAASNNDPEMDGEDGV S F IS  PLGILYT PALKVMEGHGEVNIKHYLNCSHCEVDECHMD 1002
A  A  • A  • A  A A  • A A  • A A  • A  • A  • •  A  A A  A A A  * A  A A A A A A A *  • A  • A
Z l  EDTKLILCLCDSDEVLAPDNVTCAGTKHSLCQFINKHLQHNSSPLVCPPLVVPMGSLADG 84 8
Z3 EDTKLILCLCDSDEVLAPDNVTCA WPMGSLADG 822
HALK PESHKVICFCDHGTVLAEDGVSCI VSPTPEP 102 9
MALK PESHKVICFCDHGTVLADDGVSCI VSPTPEP 1033
 A  • A A  A  A  A  A  A  • A  • •




*  . * . . * .  *  . . *  . . *  *  *  * ■ * • * * • * * • * ■ * • * * . * . * * * *
Z l TDYNPNYGYFGKAASLSELKEVPRKNITLLRALGHGAFGEVYEGQVLGMNGENTAMQVAI 968
Z3 TDYNPNYGYFGKAASLSELKEVPRKNITLLRALGHGAFGEVYEGQVLGMNGENTAMQVAI 94 2
HALK TDYNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAV 114 9
MALK TDYNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAV 1153
****■*•■*■* . - A - * . . * . * . * * * * * * * * * * * . *  * * * * * * * * * * * * * *  * *  . . . * * * .










Z1 DFGMARDIYRASYYRKGGRAMLPVKWMPPEAFLEGIFTCKTDTWSFGVLLWEIFSLGYMP 114 8
Z3 DFGMARDIYRASYYRKGGRAMLPVKWMPPEAFLEGIFTCKTDTWSFGVLLWEIFSLGYMP 1122
HALK DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 132 9
MALK DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 1333





*  *  * . * * * * * * * * *  * * * * * * * *  * * * * * * * * * * * * * * *  *  *  *  *  *  *  . * * * * * . * * * * *
Z1 PDVINTPLPVECGPPVEEEGGTVIRPDGSGSMTPLLVARSLSQDASPRASITSVTPQALK 12 68
Z3 PDVINTPLPVECGPPVEEEGGTVIRPDGSGSMTPLLVARSLSQDASPRASITSVTPQALK 1242
HALK PDVINTALPIEYGPLVEEEEKVPVRPKDPEGVPPLLVSQQAKREE---------------- ERSPAAPP 14 42
MALK PDVINTALPIEYGPWEEEEKVPMRPKDPEGMPPLLVSPQPAKHE---------------- EAS-AAPQ 144 5
•k'k'k’k'k'k'k'km'k'k'k'k'k'kic • • ★
Z1 PRLQLQRPVHLTQEVGTYRETLEPCWAEPVPASGVCPG-PWLQVPEHRPCSRSSSSSGSQ 1327
Z3 PRLQLQRPVHLTQEVGTYRETLEPCWAEPVPASGVCPG-PWLQVPEHRPCSRSSSSSGSQ 1301
HALK PLPTTSSGKAAKKPTAAEVSVRVPRGP AVEGGHVNMAFSQSNPPSELHKVHGS- 14 95
MALK PAALTAPGPSVKKPPGAGAGAGAGAGAGPVPRGAADRGHVNMAFSQPNPPPELHKGPGS- 1504
★ • •  ★ • • ★ ★★
Z1 KLKNKTKNLWNPTYGSWVLESFGRGKSALCHTQSMPLSCNPTSVSAPSSTSEHTDPWEV 1387
Z3 KLKNKTKNLWNPTYGSWVLESFGRGKSALCHTQSMPLSCNPTSVSAPSSTSEHTDPWEV 1361
HALK — RNKPTSLWNPTYGSWFTE------------------------------------------ KPTKKNNPIAKKEPHDRGNLG 1534
MALK — RNKPTSLWNPTYGSWFTA------------------------------------------ KPAKKTHPPPGAEPQARAG-A 154 2
Z1 NANVSASPPPSAAPSQTTLTPTAAPSRKSPTGAAGVSLATVMDLAKLQSFPCGNVNYAYD 14 47
Z3 NANVSASPPPSAAPSQTTLTPTAAPSRKSPTGAAGVSLATVMDLAKLQSFPCGNVNYAYD 14 21
HALK LEGSCTVPPNVATGRLPGASLLLEPSSLTAN----------------MKEVPLFRLRHFPCGNVNYGYQ 1587
MALK AEGGWTGPG— AGPRRAEAALLLEPSALSAT----------------MKEVPLFRLRHFPCPNVNYGYQ 1593
Z1 EQSYETESLPVWSKSLEPSTSSAATSSLVALSQASSFTHKPLVKRHASYGHEDVRRYTQ 1507
Z3 EQSYETESLPVWSKSLEPSTSSAATSSLVALSQASSFTHKPLVKRHASYGHEDVRRYTQ 14 81
HALK QQ----------------------- GLPLEAATAPGAGHYEDTILKSKNSMNQPGP--------------------------------------1620
MALK QQ----------------------- GLPLEATAAPG DTMLKSKNKVTQPGP--------------------------------------1621






5.CLUSTAL W (1.82) multiple sequence alignment between the aminoacid sequences 
from human ALK, mouse ALK, human LTK precursor (LHp), human LTK (LH), mouse LTK 

















Z1 PCSWTLSSHS----------------TGGDWFITSAQQHRSNRRDTQPIR DYSTGKSEGH 101
Z3 PCSWTLSSHS----------------TGGDWFITSAQQHRSNRRDTQPIR DYSTGKSEGH 101
DALK LHEQPLPLPQPTLPVATQYEDYEAAPPGSRRDNKRRLAQMAQRPGSGNGGRRGMESLRKE 120






Z1 FLLLKPSSSHLSAGRCS-FHMTSPWLSSGPFCHLQLARFQPEPHAGN IS  150
Z3 FLLLKPSSSHLSAGRCS-FHMTSPWLSSGPFCHLQLARFQPEPHAGN IS  150
DALK LMNPSVGGPGGGISGGGSGYPSYSATSSIGRIDGLGQGLGSADRYGALYDQLRQPSGMAA 180
HALK WWIRQGEGRLRIRLMPEKKASEVGREGRLSAAIRASQPRLLFQIFGTGHSSLESPTNMPS 235





Z1 AFVKHTDSID IKPIDLTIKEQ E-----------------------SDSSQWEVLEAVIG--------QLNEPFQVTV 196
Z3 AFVKHTDSID IKPIDLTIKEQ E-----------------------SDSSQWEVLEAVIG--------QLNEPFQVTV 196
DALK MTAGPLGGPYSTRFPPLYAGVDDQPKRSNRKNSISELYKLKKALNQADEPAGGVTHGNFE 240
HALK PSPDYFTWNLTWIMKDSFPFLS---------------------------- HRSRYGLECSFDFPCELEYSPPLHD 282





Z1 QYSACSSHEVGFLAFDSLELKN---------------------------- CVMG DDYVDLGSDCEKYSSLQC 24 0









Z l  HSGGCIEKQRVCDFHTDCPEGEDEGLICSTLPLGSYCSFELGSCGWSAADTQSSWRLVSG 300
Z3 HSGGCIEKQRVCDFHTDCPEGEDEGLICSTLPLGSYCSFELGSCGWSAADTQSSWRLVSG 300
DALK YSDGFQVITGTELSKRNLTGLLPGPAADSIDDANGHFLYARVNPSSRPLNLTSPEFSTTM 360
HALK EHCTLAVSVH-RHLQP-SGRYIAQLLPHNEAAREILLMPTPGKHGWTVLQGRIGRPDNPF 4 00








HALK RVALEYISSGNRSLSAVDFFALKNCS---------- EGTSPGSKMALQSSFTCWNGTVLQLGQAC 455
MALK RVALEYISSGNRSLSAVDFFALKNCS---------- EGTSPGSKMALQSSFTCWNGTVLQLGQAC 459
LHp  MGCWGQLLVWFGAAG 15
LH  MGCWGQLLVWFGAAG 15
LM ------------------------------------------------------------------------------------------------------------------------------------
LMp  MGCSHRLLLWLGAAG 15
Z1 -CQLQFSLYRYGDFNGTVLLSWESG----------- ASAPALIWERSGHWKDAWQEITLPITEIL 4 04
Z3 -CQLQFSLYRYGDFNGTVLLSWESG----------- ASAPALIWERSGHWKDAWQEITLPITEIL 4 04
DALK RIVFEWPDLRVGQKGHVALDNLRMVNCFPEGTKSEKCSTSQVKCTSSKVPVCIHLPRIC 4 80
HALK DFHQDCAQGEDESQMCRKLPVGFYCNFEDGFCGWTQGTLSPHTPQWQVRTLKDARFQDHQ 515
MALK DFHQDCAQGEDEGQLCSKLPAGFYCNFENGFCGWTQSPLSPHMPRWQVRTLRDAHSQGHQ 519
LHp ------------------------- AILCSSPGS---------------------------------------------------------------------------------------- 24
LH ------------------------- AILCSSPGS---------------------------------------------------------------------------------------- 24
LM -----------------------------------------------------------------------------------------------------------------------------------
LMp ------------------------- TILCSNSEF---------------------------------------------------------------------------------------- 24
Z1 N--------------------------GFHLKVQAFWTS-------------------------------------------------------------------------------- 417
Z3 N--------------------------GFHLKVQAFWTS-------------------------------------------------------------------------------- 417
DALK DITRDCDEAEDEQQSCDKIPYGGRCDFEEDWCGWRDSGKTTLTWSRHTGSSPTHDTGPDG 54 0
HALK DHALLLSTTDVPASESATVTSATFPAPIKSSPCELRMSWLIRGVLRGNVSLVLVENKTGK 575
MALK GRALLLSTTDILASEGATVTSATFPAPMKNSPCELRMSWLIRGVLRGNVSLVLVENKTGK 579
LHp -QETFLRSSPLPLASPSPQDPKVSAPPSILEPASP--------------------- ------------------- LNSPGT 64
LH -QETFLRSSPLPLASPSPRDPKVSAPPSILEPASP--------------------- ------------------- LNSPGT 64
LMp -QAPFLTPSLLPVLVLNSQEQKVTPTPSKLEPASL--------------------- ------------------- PNPLGT 64
Z1 GSKADIALDDISLS-AACFDTELNELLHEGLPHDLDFS-------------- -------------- PLPEPSAS 462




LHp EGS----------------------------------------------------------------------------------------------------------------------------  67
LH EGS----------------------------------------------------------------------------------------------------------------------------  67
LM -----------------------------------------------------------------------------------------------------------------------------------
LMp RGP----------------------------------------------------------------------------------------------------------------------------  67
Z1------------------------------- EAS----------------------------------------------------------------------------------------------------------------------------  4 65
Z3------------------------------- EAS---------------------------------------------------------------------------------------------------------------------------- 4 65
DALK RNSCWRFFIHQFGKNPGSINLSVVEMKEKENITTTLWWSTKNQGSDWMRAEYVLPNITS 660
226
HALK LTISGEDKILQNTAPKSRNLFERNPNKELK PGENSPRQTPIFD 678







DALK KYYLQFEARMGMRIYSDVAVDDFSLSPECFGLNIPEDHLGGYNYWDVRQNLKSPTYKDFE 72 0
HALK PTVHWLFTTCGASGPHGPTQAQCNNAYQNSN-------------- LSVEVGSEGPLKGIQIWKVPATD 7 32
MALK PTVHWLFTTCGASGPHGPTQAQCNNAYQNSN-------------- LSWVGSEGPLKGVQIWKVPATD 736
LHp -------- WLFSTCGASGRHGPTQTQCDGAYAGTS-------------- VWTVGAAGQLRGVQLWRVPGPG 117
LH -------- WLFSTCGASGRHGPTQTQCDGAYAGTS-------------- VWTVGAAGQLRGVQLWRVPGPG 117
LM ------------------------------------------------------------------------------------------------------------------------------------
LMp -------- WVFNTCGASGRSGPTQTQCDGAYTGSS--------------VMVTVGAAGPLKGVQLWRAPDTG 117
Z l  -PITWWFTSCGASGPFGPTQAQCDSAYRNTN-------------- VSWVGKEGPLRGVQMWKVPATN 518
Z3 -PITWWFTSCGASGPFGPTQAQCDSAYRNTN-------------- VSWVGKEGPLRGVQMWKVPATN 518
DALK YTNYLELTTCDTRGMIGPSQAQCEAAYREQNKTHVLREVHVVEDQSSYKGMQKWKVPHEG 7 80
HALK TYSISGYGAAGGKGGKNTMMRSHGVSVLGIFNLEKDDMLYILVGQQGEDACPSTNQLIQK 7 92
MALK TYSISGYGAAGGKGGKNTMMRSHGVSVLGIFNLEKGDTLYILVGQQGEDACPRANQLIQK 7 96
LHp QYLISAYGAAGGKGAKNHLSRAHGVFVSAIFSLGLGESLYILVGQQGEDACPGGSPESQL 17 7
LH QYLISAYGAAGGKGAKNHLSRAHGVFVSAIFSLGLGESLYILVGQQGEDACPGGSPESQL 177
LM ------------------------------------------------------------------------------------------------------------------------------------
LMp QYLISAYGAAGGKGAQNHLSRAHGIFLSAVFFLRRGEPVYILVGQQGQDAC PGG SPESQL 177
Z l  TYKISAYGAAGGKGAKNHNKRSHGVFISATFPLEKGDILYILIGHQGEDACPGRNPQTHK 57 8
Z3 TYKISAYGAAGGKGAKNHNKRSHGVFISATFPLEKGDILYILIGHQGEDACPGRNPQTHK 57 8
DALK HYTIIAKGASGGLGS-GGVGSSRGSVAVAILELHKNEELYFLVGQQGENACIKSMGVLKE 839
HALK VCIGENNVIEEEIRVNRS------------------- VHEWAGGGGGGGGATYVFKMKDGVPVPLIIAAGG 84 4
MALK VCVGENNVIEEEIRVNRS------------------- VHEWAGGGGGGGGATYVFKMKDGVPVPLIIAAGG 84 8
LHp VCLGESRAVEEHAAMDGSEG---------VPGSRRWAGGGGGGGGATYVFRVRAGELEPLLVAAGG 234
LH VCLGESRAVEEHAAMDGSEG-------- VPGSRRWAGGGGGGGGATYVFRLRAGELEPLLVAAGG 234
LM ------------------------------------------------------------------------------------------------------------------------------------
LMp VCLGES GEHATTYGTER---------1PGWRRWAGGGGGGGGATSIFRLRAGEPEPLLVAAGG 231
Z l  ICLGESSVIEDGFDSDGS--------------------ALKWAGGGGGGGGATYIYRMENGQPLPLLIAAGG 630
Z3 ICLGESSVIEDGFDSDGS--------------------ALKWAGGGGGGGGATYIYRMENGQPLPLLIAAGG 630
DALK AGCGTDHDLDLAQYSFRSKQDMVKNIYIENGAGGGGGGSYVFLLNQAKNEAVPLLVAGGG 8 99
HALK GGRAY GAKT DT--------FHPERLENNSSVLGLNGN------ ------SGAAGGGGGWNDNTSLLWAGK 894
MALK GGRAYGAKRET--------FHPERLESNSSVLGLNGN------ ------SGAAGGGGGWNDNTSLLWAGK 898
LHp GGRAYLRPRDRGRTQASPEKLENRSEAPGSGGR------ ------GGAAGGGGGWTSRAPSPQAGR 288
LH GGRAYLRPRDRGRTQASPEKLENRSEAPGSGGR------ ------GGAAGG--------------------------------- 273
LM 19
LMp GGRSYRRRPDRGRTQAVPERLETRAAAPGSGGR------ ------GGAAGGGSGWTSRAHSPQAGR 285
Z l GGKAYLEDPESSQDQSFREQYENDTTVSGVSGR------ ------S GAAGGGGGWS DVS S LSWAGK 684
Z3 GGKAYLEDPESSQDQSFREQYENDTTVSGVSGR------ ------SGAAGGGGGWSDVSSLSWAGK 684
DALK GGLGIGQYIDEDFQHGQKAKPLQAPESGQINGEPLNKKTAGPGGGWRAKEDQALSPTYGA 959
★ ★ ★ ★
HALK SLQEGATGGHSCPQAMKKWGWETR GGFGGGGGGCSSGGGGGGYIGGNAASNNDPEM 950
MALK SLLEGAAGGHSCPQAMKKWGWETR GGFGGGGGGCSSGGGGGGYIGGNAASNNDPEM 954
LHp SLQEGAEGGQGCSEAWATLGWAAA GGFGGGGGACTAGGGGGGYRGGDASETDNLWA 34 4
LH  DASETDNLWA 283
LM  DTSESDLLWA 2 9
LMp SPREGAEGGEGCAEAWAALRWAAA GGFGGGGGACAAGGGGGGYRGGDTSESDLLWA 341
Z l  SLVEGGQGGSSCPEALSVLGWATF GGFGGGGGACSAGGGGGGYRGGDAPLLDDISA 74 0









Z l DGQDGLSFVHPMGKIFLQPLAAMESHGEAEIWYLNCSHCKTQSCKRDEDTKLILCLCDS 800
Z3 DGQDGLSFVHPMGKIFLQPLAAMESHGEAEIWYLNCSHCKTQSCKRDEDTKLILCLCDS 800
DALK GGSSYISPSRSLREISEIHAGASSGPGAIIIIPAIEGCGCDYRCVALDEFRSKVRCICPD  
★ ★ • ★ ★ • ★ • ★ ★
1079
HALK GTVLAE DGV S C I------------------------------------------- ------------ VSPT------PEPHLPLSLILSW T 1041
MALK GTVLADDGVSCI------------------------------------------- ------------ VSPT------PEPHLPLSLILSW T 1045
LHp GMELAVDNVTCM------------------------------------------- ------------ DLHK------ PPGPL------ VLMVAW 432
LH GMELAVDNVTCM------------------------------------------- ------------ DLHK------ PPGPL------ VLMVAW 371
LM GTELAVDNVTCM------------------------------------------- ------------ DLPT------TASPL------ ILM GAW 117
LMp GTELAVDNVTCM------------------------------------------- ------------ DLPT------TASPL------ ILM GAW 429
Z l DEVLAPDNVTCAGTKHSLCQFINKHLQHNSSPLVCPPLWPMGSLADGPPSLVFIMAVIV 860
Z3 DEVLAPDNVTCA------------------------------------------- ------------ WPMGSLADGPPSLVFIMAVIV 834
DALK GW S LKRDNHTACEIR-------------------------------------
ie ★ *
------------------------- EEAGKS S FQYLVSILM 1110
HALK SALVAALVLAFS GIMIVYRRKHQE LQAMQME- -LQSPEYKLSKLR------TSTIMTDYNPNY 1096
MALK SALVAALVLAFSGIMIVYRRKHQELQAMQIQ- -LQSPEYKLSKLR------TSTIMTDYNPNY 1100
LHp ATSTLSLLMVCGVLILVKQKKWQGLQEMR------ -LPSPELELSKLR------TSAIRTAPNPYY 485
LH ATSTLSLLMVCGVLILVKQKKWQGLQEMR------ -LPSPELELSKLR------TSAIRTAPNPYY 424
LM AALALSLLMMCAVLILVNQK-CQGLWGTR------ -LPGPELELSKLR------SSAIRTAPNPYY 169
LMp AALALS LLMMCAVLILVNQK-CQGLWGTR------ -LPGPELELSKLR------SSAIRTAPNPYY 481
Z l STW TGW LTCASLTLIYYRKKNHLHAVRIR- -LQSPEYKLSKIR------SSTIMTDYNPNY 915
Z3 S TVVT G W L T  CAS LT LIYYRKKNHLHAVRIR- -LQSPEYKLSKIR------SSTIMTDYNPNY 889
DALK ISLAVLFICIAALIFMLYNRYQRKKQSKKRHKMLVEQDLQLTRLRNNIDDSNLNNFNPNY 
• • • • • •  • ★ ★
1170
HALK CFAGKTSSIS------------- DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKT 1151
MALK CFAGKTSSIS------------- DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKT 1155
LHp CQVGLGPAQSWPLPPGVTEVSPANVTLLRALGHGAFGEVYEGLVIGLPGDSSPLQVAIKT 54 5
LH CQVGLGPAQSWPLPPGVTEVSPANVTLLRALGHGAFGEVYEGLVIGLPGDSSPLQVAIKT 4 84
LM CQVGLSPAQPWPLPPGLTEVSPANVTLLRALGHGAFGEVYEGLVTGLPGDSSPLPVAIKT 22 9
LMp CQVGLSPAQPWPLPPGLTEVSPANVTLLRALGHGAFGEVYEGLVTGLPGDSSPLPVAIKT 541
Z l GYFGKAASLS ELKEVPRKNITLLRALGHGAFGEVYEGQVLGMNGENTAMQVAIKT 97 0
Z3 GYFGKAASLS ELKEVPRKNITLLRALGHGAFGEVYEGQVLGMNGENTAMQVAIKT 944
DALK GCDGILNGHIDVN— SLPQVARDSLQLVNALGKGAFGEVYMALYRHRDGDAVEMGVAVKT 1228




LH LPELCSPQDELDFLMEALIISKFRHQNIVRCVGLSLRATPRLILLELMSGGDMKSFLRHS 54 4
LM LPELCSHQDELDFLMEALIISKFSHQNIVRCVGLSFRSAPRLILLELMSGGDMKSFLRHS 28 9
LMp LPELCSHQDELDFLMEALIISKFSHQNIVRCVGLSFRSAPRLILLELMSGGDMKSFLRHS 601







LM RPHPGQLAPLTMQDLLQLAQDIAQGCHYLEENHFIHRDIAARNCLLSCSGASRVAKIGDF 34 9
LMp RPHPGQLAPLTMQDLLQLAQDIAQGCHYLEENHFIHRDIAARNCLLSCSGASRVAKIGDF 661
Z l  RPRTNHSSSLSMLELLHMARDIALGCRYLEENHFIHRDIAARNCLLTCPGPDRVAKIGDF 1090
Z3 RPRTNHSSSLSMLELLHMARDIALGCRYLEENHFIHRDIAARNCLLTCPGPDRVAKIGDF 1064






LM GMARDIYQASYYRKGGRTLLPVKWMPPEALLEGLFTSKTDSWSFGVLLWEIFSLGYMPYP 4 09
LMp GMARDIYQASYYRKGGRTLLPVKWMPPEALLEGLFTSKTDSWSFGVLLWEIFSLGYMPYP 721
Z l  GMARDIYRASYYRKGGRAMLPVKWMPPEAFLEGIFTCKTDTWSFGVLLWEIFSLGYMPYP 1150
Z3 GMARDIYRASYYRKGGRAMLPVKWMPPEAFLEGIFTCKTDTWSFGVLLWEIFSLGYMPYP 1124
DALK GMSRDIYRSDYYRKGGKAMLPIKWMPPEAFLDGIFTSKTDVWSFGILLWEVFSLGRSPYP 14 08
k k » k k k k « *  k  k  k  • k  ★ ★ ★  k  k  k
HALK SKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD 1391
MALK SKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD 1395
LHp GRTNQEVLDFVVGGGRMDPPRGCPGPVYRIMTQCWQHEPELRPSFASILERLQYCTQDPD 7 85
LH GRTNQEVLDFWGGGRMDPPRGCPGPVYRIMTQCWQHEPELRPSFASILERLQYCTQDPD 724
LM GHTNQEVLDFIATGNRMDPPRNCPGPVYRIMTQCWQHQPELRPDFGSILERIQYCTQDPD 4 69
LMp GHTNQEVLDFIATGNRMDPPRNCPGPVYRIMTQCWQHQPELRPDFGSILERIQYCTQDPD 7 81
Z l  CKTNQEVLEFVTGGGRMDPPKSCPGPVYRIMTQCWQHCPEHRPNFTTILERINYCTQDPD 1210
Z3 CKTNQEVLEFVTGGGRMDPPKSCPGPVYRIMTQCWQHCPEHRPNFTTILERINYCTQDPD 1184
DALK GQHNTQVMELVVRGGRLGSPTECPVSIYKVMADCWNPTPEDRPTFITLLEHLTACTQDAS 14 68
• k  • ★ . • • •  k  k  • ★  ★ ★  r k * » k » » k k »  k  k  k  k  k  • k  k  * • k  k  k  k
HALK VINTALPIEYGPLVEEEEKVPVRPKDPEGVPPLLVSQQAKREEERSPAAPPPLPTTSSGK 14 51
MALK VINTALPIEYGPWEEEEKVPMRPKDPEGMPPLLVSPQPAKHEEAS-AAPQPAALTAPGP 1454
LHp VLNSLLPMELGPTPEEEGTSGLGNRSLECLR----------------------------------------PPQPQELSP— E 82 6
LH VLNSLLPMELGPTPEEEGTSGLGNRSLECLR----------------------------------------PPQPQELSP— E 7 65
LM VLNSPLPMEPGPILEEEEASRLGNRSLEGLR----------------------------------------SPKPLELSS— Q 510
LMp VLNSPLPMEPGPILEEEEASRLGNRSLEGLR----------------------------------------SPKPLELSS— Q 822
Z l  VINTPLPVECGPPVEEEGGTVIRPDGSGSMTPLLVAR-------------SLSQDASPRASITSVTPQ 12 65
Z3 VINTPLPVECGPPVEEEGGTVIRPDGSGSMTPLLVAR------------- SLSQDASPRASITSVTPQ 1239




LH KLKSWGGSPLGP---------------------------------------------------------- WLSSGLKPLKSR---------------------78 9
LM NLKSWGGGLLGS---------------------------------------------------------- WLPSGLKTLKPR---------------------534
LMp NLKSWGGGLLGS---------------------------------------------------------- WLPSGLKTLKPR---------------------84 6
Z l ALKPRLQLQRPVHLTQEVGTYRETLEPCWAEPVPASGVCPGPWLQVPEHRPCSRSSSSSG 1325
Z3 ALKPRLQLQRPVHLTQEVGTYRETLEPCWAEPVPASGVCPGPWLQVPEHRPCSRSSSSSG 12 99
DALK YVPELQRQQMSS---------------------------------------------------------- CTPPAVTSPAAP------------------------1548
HALK  RNKPTSLWNPTYGSWFTE KPTKKNNPIAKKEPHDRGN 1532
MALK  RNKPTSLWNPTYGSWFTA--------------------------------------KPAKKTHPPPGAEPQARAG 1541
LHp.  GLQPQNLWNPTYRS---------------------------------------------------------------------------------------------8 64
LH  GLQPQNLWNPTYRS------------------------------------------------------------------------------------------------803
LM  CLQPQNIWNPTYGSWTPR GPQGEDTGIEQCNGSSSSS 571
LMp  CLQPQNIWNPTYGSWTPR GPQGEDTGIEQCNGSSSSS 883
Z1 SQKLKNKTKNLWNPTYGSWVLES FGRGKSALCHTQSMPLSCNPTSVSAPS STSEHTDPW 1385
Z3 SQKLKNKTKNLWNPTYGSWVLESFGRGKSALCHTQSMPLSCNPTSVSAPSSTSEHTDPW 1359
DALK  HPRPVENIAPTSGDCWETS---------FILPNSKVEPPWGSGHDVPL 1588
HALK LGLEGSCTVPPNVATGRLPGASLLLEPSSLTAN------------------MKEVPLFRLRHFPCGNVNYG 1585
MALK -AAEGGWTGPG— AGPRRAEAALLLEPSALSAT------------------MKEVPLFRLRHFPCPNVNYG 15 91
LHp ------------------------------------------------------------------------------------------------------------------------------------
LH ------------------------------------------------------------------------------------------------------------------------------------
LM IP G IQ --------------------------------------------------------------------------------------------------------------------------57 6
LMp IP G IQ --------------------------------------------------------------------------------------------------------------------------888
Z l  EVNANVSASPPPSAAPSQTTLTPTAAPSRKSPTGAAGVSLATVMDLAKLQSFPCGNVNYA 14 45
Z3 EVNANVSASPPPSAAPSQTTLTPTAAPSRKSPTGAAGVSLATVMDLAKLQSFPCGNVNYA 1419
DALK AGGEEAKLISLDTPQPTPTTIQPPLSFASQLDG ITLDPSALTKSLPNGNAKQS 1641
229
HALK YQQQGLP------------------------LEAATAPGAGHYEDTILKSKNSMNQPGP------------------------------  1620





Z l  YDEQSYETESLPWVSKSLEPSTSSAATSSLVALSQASSFTHKPLVKRHASYGHEDVRRY 1505
Z3 YDEQSYETESLPVWSKSLEPSTSSAATSSLVALSQASSFTHKPLVKRHASYGHEDVRRY 147 9
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F ig u r e  A l .  D iag ra m  o f  th e  s h d / A L K  genom ic s t r u c t u r e .  C lo n es  1 -3  r e p r e s e n t  th e  3 
cDNA c lo n e s  i s o la t e d .  C lo n e  1 has a l a r g e r  exon 18 b eca u se  i t  has more 78 
n u c le o t id e s  th a n  c lo n e s  2 and 3 . C lo n e  1 a ls o  has a l a r g e r  exon 28 and an e x t r a  
exon 29 com pared to  th e  o th e r  c lo n e s . C lo n e s  2 and 3 p ro b a b ly  r e p r e s e n t  th e  same 
t r a n s c r ip t  w h ic h  was t r u n c a t e d  a t  d i f f e r e n t  p o s i t io n s  o f  exon 2 8 . D e t a i le d  
in fo r m a t io n  on th e  s iz e s  and p o s i t io n s  o f  e x o n s / in t r o n s  i s  p ro v id e d  in  T a b le  4 . 1 ,
231
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